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Abstract 
 
Embryonic stem (ES) cell pluripotency is sustained by a network of transcription 
factors centred on Oct4, Sox2 and Nanog. Whilst Oct4 and Sox2 expression is 
relatively uniform, ES cells fluctuate between states of high Nanog expression 
possessing high self-renewal efficiency, and low Nanog expression exhibiting 
increased differentiation propensity. Moreover, modulation in the level of Nanog 
expression determines the efficiency of ES cell self-renewal.  
 
To identify genes regulated by Nanog, genome-wide transcriptional profiling was 
performed on ES cells expressing different Nanog levels and Nanog-null ES cells 
expressing a Nanog-ER
T2
 fusion protein in which nuclear Nanog activity can be 
regulated by tamoxifen.  Surprisingly, only a minor fraction of the genes to which 
Nanog binds showed significant changes in response to Nanog induction. Prominent 
amongst Nanog-responsive genes is Estrogen-related receptor b (Esrrb). Nanog binds 
directly to Esrrb, enhances binding and pause-release of RNAPolII from the Esrrb 
promoter and stimulates Esrrb transcription. Consistent with these findings, elevation 
of Nanog produces a cell population that expresses uniformly high Esrrb levels. 
Moreover, double fluorescent reporter lines show that Esrrb and Nanog levels are 
strongly correlated in individual cells. Loss of Nanog is required for downregulation 
of Esrrb, which coincides with commitment to differentiate. 
 
Esrrb overexpression results in LIF independent self-renewal, and blocks neural 
differentiation, even in the absence of Nanog. Cell fusion experiments between ES 
and neural stem (NS) cells show that elevated Esrrb levels allow the reprogramming 
of the NS cell genome in the absence of Nanog. Esrrb can rescue stalled 
reprogramming during the derivation of Nanog
-/-
 induced pluripotent stem (iPS) 
cells. Moreover, targeted knock-in of Esrrb at the Nanog locus rescues the ability of 
Nanog null ES cells to maintain germ cell development beyond E12. Finally, Esrrb 
deletion abolishes the defining ability of Nanog to confer LIF-independent self-
renewal to ES cells.   
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Chapter 1: Introduction 
 
1.1:    Pluripotency and development. 
 
Specification of pluripotent cell identity is a fundamental trait of mammalian 
development. Pluripotency is established during the formation of the inner cell mass 
(ICM) in pre-implantation embryos. The resulting epiblast cells of the inner cell mass 
are the cells from which all specialised cells that make up the developing embryo, 
and indeed all tissues of the adult organism, trace their origins to. A state that shares 
common traits with pluripotency is established again around E8.5, when primordial 
germ cells (PGCs) begin transcriptional and epigenetic resetting before initiating 
gametogenesis, setting the stage for a new cycle of development. 
 
1.1.1:    From fertilization to implantation: specification of pluripotency 
during pre-implantation development. 
 
Fertilisation triggers completion of meiosis in the mouse oocyte and results in the 
formation of a 1 cell zygote in which the maternal and paternal genomes are still 
organised in two independent pronuclei. The first cleavage leads to the formation of 
two diploid cells which undergo a series of consecutive divisions to generate 
increasing number of progressively smaller cells, the blastomeres. The zygote is 
transcriptionally silent and initially relies on maternally inherited mRNAs and 
proteins (Bachvarova, 1985). Transcriptional activation of the zygotic genome occurs 
in a minor and major wave at the 1 and 2 cell stage respectively (Aoki et al., 1997; 
Hamatani et al., 2004) and is accompanied by active degradation of maternal 
transcripts (Bachvarova and Moy, 1985; Paynton et al., 1988; Piko and Clegg, 1982). 
After the third division the 8 cell embryo, now called morula, is constituted by 
relatively similar blastomeres.  Before dividing further, the 8 cell morula undergoes a 




are established between the blastomeres. The process of compaction leads to 
polarisation of the blastomeres (Johnson and Ziomek, 1981), and sets the conditions 
for future lineage decisions.  
 
During the transition from the compacted morula to the late blastocyst stages two 
fundamental lineage decisions occur in the developing embryo: first the specification 
of the trophectoderm (TE) and the inner cell mass  and subsequently the segregation 
of the primitive endoderm (PE) from the pluripotent epiblast (reviewed in Cockburn 
2010). The specification of the TE lineage is dependent on the function of two 
crucial transcription factors, Tead4 (Nishioka et al., 2008; Yagi et al., 2007) and 
Cdx2 (Strumpf et al., 2005), while three transcription factors are required for the 
formation of the pluripotent ICM: Oct4 (Nichols et al., 1998), Sox2 (Avilion et al., 
2003) and Nanog (Chambers et al., 2003; Mitsui et al., 2003). The blastomeres of the 
compacted 8 cell morula undergo both symmetric and asymmetric divisions that 
establish two distinct populations of polarised outer cells and apolar inner cells 
(Johnson and Ziomek, 1981). It was recently proposed that the extensive cell-cell 
contacts that characterise inner cells lead to activation of Hippo signalling in this 
population (Nishioka et al., 2009). Activated Hippo receptors promote 
phosphorylation of Yap proteins by Lat kinases, in turn resulting in their exclusion 
from the nucleus. Yap proteins are transcriptional coactivators essential for the 
function of Tead transcription factors. Yap becomes progressively confined to the 
nucleus of outer cells after the 8 cell stage, leading to transcriptional activation of 
Cdx2 by Tead4. In line with the crucial role of Yap in driving the initial events in TE 
specification, genetic ablation of Yap proteins results in embryonic lethality before 
the morula stage (Nishioka et al., 2009). Cdx2 activates expression of genes that are 
crucial for TE development and is involved in a reciprocal inhibitory transcriptional 
circuit with the master pluripotency regulator Oct4 (Niwa et al., 2005). At the 8 cell 
morula stage, Cdx2 starts being expressed and Oct4 is already present in all 
blastomeres (Dietrich and Hiiragi, 2007; Nishioka et al., 2009). Cdx2 is then 
downregulated in inner cells, so that at the 32 cell stage it is almost exclusively 
confined to the TE (Nishioka et al., 2009). Oct4 expression persists longer in outer 




(Dietrich and Hiiragi, 2007). As a consequence, it appears that the fully committed 
population of outer TE cells established in the E3.5 blastocyst (Pedersen et al., 1986) 
is defined by high Cdx2 expression rather than lack of Oct4. The notion that 
coexpression of Cdx2 and Oct4 in ES cells leads to the repression of Oct4 





 cells commit to trophectoderm fate.  
 
In the 32 cell morula, functional tight junctions are formed between TE cells and a 
water influx actively driven by the trophectoderm layer starts forming a large internal 
cavity known as the blastocoel. The ICM is localised on one side of this cavity, 
making contacts with both the TE and the blastocoel. As observed for Oct4 and Cdx2 
during trophectoderm specification, segregation of the PE and the epiblast is driven 
by the contrasting action of two key transcription factors, Nanog and Gata6 
(Chambers et al., 2003; Mitsui et al., 2003; Singh et al., 2007). Gata6 activity, in 
conjunction with another Gata factor, Gata4, is essential for endoderm specification: 
In Gata6 and Gata4 mutant embryos the PE is formed but fails to further differentiate 
into visceral endoderm (Koutsourakis et al., 1999; Morrisey et al., 1998; Soudais et 
al., 1995). Nanog and Gata6 are homogeneously expressed in the majority of the 
blastomeres up to the early blastocyst stage (Plusa et al., 2008). Instructive ERK 
signals (Chazaud et al., 2006), principally activated by fibroblast growth factor 4 
(FGF4), result in Nanog downregulation in some ICM cells after the 32 cell stage 
(Plusa et al., 2008), leading to almost mutually exclusive Nanog and Gata6 
expression in the 64 cell blastocyst (Chazaud et al., 2006; Dietrich and Hiiragi, 
2007). Gata6 positive cells become localised to the prospective PE layer lining the 
blastocoel at E4.5, through mechanisms that involve relocalisation of inner Gata6 
positive cells and apoptosis (Plusa et al., 2008). The pivotal role of FGF/ERK 
signalling in instructing PE specification is highlighted by defective endoderm 
formation in knockout embryos lacking FGF receptor 2 (Arman et al., 1998), FGF4 
(Feldman et al., 1995), and Grb2 (Chazaud et al., 2006; Cheng et al., 1998), an 
adaptor protein involved in signal transduction downstream of the FGF receptor. In 




embryos with ERK1/2 inhibitors results in the complete absence of PE at the 
blastocyst stage (Nichols et al., 2009). 
 
The fast developmental events occurring during the first days after fertilisation 
culminate in the formation of the E4.5 blastocyst. At the time of implantation, the 
blastocyst is composed of an external trophectoderm layer that will contribute to the 
formation of the placenta, a monolayer of primitive endoderm cells lining the surface 
of the epiblast that faces the blastocoel and destined to generate the visceral and 
parietal endoderm, and, enclosed by these, a central mass of cells, the epiblast. The 
cells of the epiblast are characterised by high levels of Oct4, Sox2 and Nanog 
expression  (Dietrich and Hiiragi, 2007; Plusa et al., 2008; Silva et al., 2009), have 
completed the process of X inactivation (Mak et al., 2004; Okamoto et al., 2004) and 
re-established levels of DNA methylation (Santos et al., 2002), H3K9 methylation 
(Santos et al., 2003) and H3K27 trimethylation (Erhardt et al., 2003) higher than 
those observed in the trophectoderm. These changes underlie the attainment of the 
pluripotent state that is required for this population to give rise to all tissues 
constituting the embryo proper and, later, the adult animal.                  
 
1.1.2:    Pluripotency after implantation and primordial germ cells. 
 
Primordial germ cells derive from the few cells of the proximal epiblast that activate 
expression of Prdm1 at embryonic day 6.25 (Ohinata et al., 2005) in response to 
instructive BMP4 and WNT signals originating from the extraembryonic ectoderm 
and the epiblast respectively (Ohinata et al., 2009). PGC precursors sequentially 
acquire expression of Prdm14 (Yamaji et al., 2008), relocate to the posterior 
extraembryonic mesoderm, upregulate Stella  and acquire high levels of alkaline 
phosphatase expression (Sato et al., 2002).  Prdm1 and Prdm14 drive PGC 
specification by repressing the transcriptional somatic programme activated in the 
epiblast after implantation and initiating epigenetic reprogramming (Kurimoto et al., 
2008; Ohinata et al., 2005; Yamaji et al., 2008). Around E8.0 PGCs start migrating 




et al., 2007), that will be completed between E11.5 and E13.5 in the developing 
gonads (Hajkova et al., 2008; Hajkova et al., 2002; Hajkova et al., 2010).       
 
Intriguingly, similarities exist between the transcriptional and epigenetic state 
characterising PGCs during their migration to the genital ridges and the pluripotent 
population of cells constituting the epiblast of pre-implantation embryos. Both cell 
populations display similar expression of key pluripotency regulators. In the post-
implantation epiblast, Oct4 is progressively downregulated in an anterior to posterior 
fashion at the onset of gastrulation (Yeom et al., 1996), but expression is maintained 
in the newly specified PGCs and there increases after E7.25 (Yoshimizu et al., 1999). 
Sox2 expression also appears to be regained in primordial germ cells after becoming 
restricted to the neuroectoderm around E7.0 (Avilion et al., 2003; Kurimoto et al., 
2008). Declining Nanog expression (Osorno et al., 2012) is upregulated again around 
E7.75 in PGCs accumulating in the posterior extraembryonic mesoderm region 
(Yamaguchi et al., 2005). In addition, these pluripotency factors, necessary for the 
specification of pluripotent cells in the early embryo ICM (Avilion et al., 2003; 
Mitsui et al., 2003; Nichols et al., 1998), are also crucial for PGC development. Oct4 
is essential for the development of the germ line (Kehler et al., 2004) and Nanog is 
required for the survival of PGCs beyond E11.5 (Chambers et al., 2007; Yamaguchi 
et al., 2009). In line with their common expression of core pluripotency regulators, 
pluripotent lines can be derived from both ICM cells and developing PGCs after day 
E8.5 (Evans and Kaufman, 1981; Matsui et al., 1992). Furthermore, PGCs undergo 
epigenetic changes that have similarities with early development.  In both 
developmental transitions, establishment of pluripotency is accompanied by 
reactivation of the inactive X chromosome in females (de Napoles et al., 2007; Mak 
et al., 2004; Okamoto et al., 2004; Sugimoto and Abe, 2007), preceded or 
accompanied by a wave of DNA demethylation (Hajkova et al., 2002; Hajkova et al., 
2010; Mayer et al., 2000; Santos et al., 2002) and linked to establishment of high 
levels of H3K27me3 (Erhardt et al., 2003; Seki et al., 2007). Nonetheless, 
differences also exist between these two cell populations. Notably, repressive 
H3K9me2 marks are erased in migratory PGCs (Seki et al., 2005) and DNA 




more radically reset in PGCs, involving progressive erasure of maternal and paternal 
imprints (Hajkova et al., 2002; Seki et al., 2005)  which are protected from 
demethylation in early embryos (Nakamura et al., 2007; Nakamura et al., 2012). 
Possibly, migratory PGCs, which have not yet completed erasure of methylation 
marks at imprinted loci (Hajkova et al., 2002) and still display detectable levels of 
genomewide DNA methylation (Seki et al., 2005), are more closely related to the 
pluripotent cells of the epiblast than E11.5 germ cells, which embark in a second 
wave of radical epigenetic changes after their entry into the gonads (Hajkova et al., 
2008; Hajkova et al., 2010). 
 
1.2:    In vitro culture of pluripotent stem cells. 
 
1.2.1:    From teratocarcinomas to embryonic stem cells 
 
The field of pluripotent stem cell biology traces its origins to a period, spanning more 
than two decades, of vibrant interest in the study of teratocarcinomas (Andrews, 
2002; Solter, 2006). Teratocarcinomas are tumours composed of disorganised 
aggregates of somatic tissues derived from all three embryonic germ layers that in 
humans normally occur in the ovaries and, more rarely, in the testis of young males. 
Teratocarcinomas are distinguished from the closely related teratomas by the 
presence of a component of histologically undifferentiated cells, termed embryonic 
carcinoma (EC) cells (Pierce and Verney, 1961), responsible for their malignant 
character. The study of teratocarcinomas, previously limited by the rare occurrence 
of such tumours in humans and mice, was the subject of a renewed interest after the 
report that the inbred 129 mice strain spontaneously develops these testicular 
tumours with an incidence of 1% (Stevens and Little, 1954). The embryonic origin of 
teratocarcinomas is suggested by the fact that they consist of a mixture of 
differentiated and more immature cell types, and in extreme cases present structures, 
called embryoid bodies, that closely resemble embryos at early stages of 
development (Pierce and Verney, 1961). In addition, upon intraperitoneal injection, 




Dixon, 1959) and these tumours can be observed in mice as early as at day 15 of 
development (Stevens, 1962). This led to speculation that EC cells are the stem cell 
component of embryonic origin of these tumours. It was proposed that EC cells can 
give rise to all differentiated cell types composing the teratocarcinoma by 
progressive differentiation, while retaining their ability to self-renew (Pierce and 
Dixon, 1959; Pierce et al., 1960). The stem cell origin of teratocarcinomas was 
formally demonstrated by the observation that single tumours cells could reconstitute 
the entire variety of somatic cell types observed in the parental population and give 
rise to EC cells after transplantation into syngeneic animals (Kleinsmith and Pierce, 
1964). The hypothesis that teratocarcinomas were derived from embryonic cells that 
fortuitously maintained their undifferentiated character was further supported by the 
finding that such tumours could be derived by ectopic transplantation of both pre- 
and post-implantation embryos (Solter et al., 1970; Stevens, 1968). Subsequent 
studies were able to show that teratocarcinoma cells injected into a blastocyst can 
contribute to the developing embryo and give rise to adult chimaeras (Brinster, 
1974), even though the observed contribution was low and germline transmission 
was not reproducibly achieved.  
 
A fundamental contribution to the successful derivation of ES cells came from the 
first attempts to culture in vitro teratocarcinoma derived EC lines. The use of 
conditioned medium and embryonic feeders allowed the derivation and cloning of 
cell lines that could maintain their pluripotency after indefinite propagation in vitro 
(Evans, 1972; Kahan and Ephrussi, 1970; Martin and Evans, 1974; Rosenthal et al., 
1970). Such studies provided the technical background for the direct derivation of 
pluripotent cell lines from pre-implantation mouse embryos in 1981 (Evans and 
Kaufman, 1981; Martin, 1981). These cells, thereafter called embryonic stem (ES) 
cells, proved to be markedly similar to EC lines, but show greater in-vitro 
differentiation potential and the absence of gross genomic abnormalities. Their full 
potential was unveiled by the demonstration that ES cells can extensively contribute 
to in vivo development and colonise the germline, and thus be transmitted to the 
offspring of chimaeric animals (Bradley et al., 1984). The uncompromised ability of 




of adult animals entirely originated from cultured ES cells in tetraploid 
complementation experiments (Nagy et al., 1993).                   
 
1.2.2:    Other pluripotent cell lines. 
 
Embryonic germ (EG) cells are pluripotent cell lines derived from E8.5-12.5 PGCs 
(Durcova-Hills et al., 2001; Matsui et al., 1992; Resnick et al., 1992). EG cells can 
be kept in culture by stimulation with LIF, basic fibroblast growth factor (bFGF) and 
stem cell factor (SCF) (Matsui et al., 1992; Resnick et al., 1992). Although they 
express markers characteristic of pluripotent cells and show very limited 
transcriptional differences with ES cells (Mise et al., 2008; Sharova et al., 2007), EG 
cells differ from ES cells in that they present signs of erasure of paternal and 
maternal imprints (Tada et al., 1998), consequent to the epigenetic changes occurring 
in the PGC population of origin. EG cells can contribute to embryonic development 
after blastocyst injection and occasionally show germline transmission, but 
developmental abnormalities are often observed in chimaeric animals (Tada et al., 
1998). Recently it has been demonstrated that EG lines can be successfully derived 
from E8.5 PGCs by direct culture in 2i/LIF (see chapter 1.3.3) (Leitch et al., 2010).    
 
Human ES cells (hESC) were first derived on a fibroblast feeder layer in medium 
containing basic FGF (Thomson et al., 1998). The development of feeder free culture 
conditions (Klimanskaya et al., 2005) revealed the existence of growth factor 
dependence differences between mouse ESC (mESC) and hESC. hESC are not 
responsive to LIF signalling (Thomson et al., 1998) but are maintained by conjunct 
stimulation with FGF and Activin (Vallier et al., 2005). A crucial difference between 
mESC and hESC resides in the X chromosome inactivation status. Female hESC 
show variable degrees of non-random X chromosome inactivation (Hall et al., 2008; 
Shen et al., 2008; Silva et al., 2008b). It has recently become clear that it is possible 
to derive hESC lines that maintain two active X chromosome by culture under 
physiological oxygen concentrations (Lengner et al., 2010) and that, like mESC, 




differentiation. It was thus proposed that a clonal selection mechanism underlies the 
generation of lines carrying one inactive X chromosome after culture in atmospheric 
oxygen (Lengner et al., 2010) and long term passaging (Silva et al., 2008a).      
 
Epiblast stem cells (EpiSC) are cell lines derived from the post-implantation 
blastocyst (Brons et al., 2007; Tesar et al., 2007). Despite being pluripotent, as 
shown by their differentiation potential in teratoma forming assays and after 
transplantation into post-implantation cultured embryos (Huang et al., 2012), EpiSC 
cells differ from ES cells in that they have lost the ability to contribute to chimaeric 
animals when introduced into pre-implantation embryos (Tesar et al., 2007). EpiSC 
also present a distinct growth factor dependence, and are maintained in culture by 
conjunct exposure to Activin and basic FGF. In accordance with their in-vivo origin, 
one of the two X chromosomes is inactive in EpiSC lines derived from female 
embryos (Guo et al., 2009). Murine EpiSC present similarities with hESC or human 
induced pluripotent stem (iPS) cells, including growth factor dependence, X 
inactivation status, and a transcriptional profile reminiscent of the post-implantation 
epiblast.   
 
1.3:    Extrinsic regulation of ES cell self-renewal 
 
1.3.1:    LIF signalling. 
 
ES cell derivation initially required the use of both feeder layers and EC conditioned 
media (Evans and Kaufman, 1981; Martin, 1981). It was subsequently shown that rat 
liver buffalo cells secrete a factor, named differentiation inhibitory activity (DIA), 
that promotes ES cell self-renewal in the absence of a feeder layer (Smith and 
Hooper, 1987). Two studies independently identified DIA as the glycoprotein 
Leukemia Inhibitory Factor (LIF) (Smith et al., 1988; Williams et al., 1988). The 
importance of LIF signalling in maintaining ES cell self-renewal was confirmed by 
the fact that LIF
-/-
 MEFs are almost unable to sustain ES cell cultures (Stewart et al., 




ligand triggers homo or heterodimerisation of the common chain gp130 receptor and 
leads to transphosphorylation of the receptor associated Jak kinases. Activated Jak 
kinases in turn phosphorylate the receptor intracellular domains, providing docking 
sites for STATs and other SH2 domain containing proteins. Phosphorylated STATs 
can then dimerise, migrate to the nucleus and activate transcription (Kishimoto et al., 
1994; O'Shea et al., 2002). In ES cells, signalling by LIF leads to the 
heterodimerisation of LIF receptor (LIFR) and gp130 (Gearing et al., 1992; Gearing 
et al., 1991). It was subsequently shown that signalling mediated by the gp130 
intracellular domain in sufficient to sustain ES self-renewal. Stimulation with IL-6 
and soluble IL6R maintains ES cell undifferentiated (Yoshida et al., 1994) even in 
the absence of LIFR (Chambers et al., 2003), and allows the derivation of ES lines 
(Nichols et al., 1994). Similarly, fusion of the intracellular domains of either LIFR or 
gp130 to the extracellular portion of the G-CSF receptor, and subsequent stimulation 
with G-CSF, showed that signalling through gp130, but not LIFR, is sufficient to 
sustain ES cell self-renewal (Niwa et al., 1998). Although different STAT proteins 
are expressed in ES cells, it was shown that only STAT3 is activated in response to 
LIF signalling (Boeuf et al., 1997). Gp130 dimerisation triggers STAT3 
phosphorylation (Matsuda et al., 1999), that in turn is required for DNA binding and 
activation of transcription (Boeuf et al., 1997; Niwa et al., 1998). These studies also 
showed that the transcriptional activity of STAT3 is essential for ES cell self-
renewal, since overexpression of a dominant negative form of this factor causes 
differentiation (Boeuf et al., 1997; Niwa et al., 1998). Conversely activation of a 
STAT3-ER fusion protein by 4OH-tamoxifen is sufficient to sustain ES cells cultures 
at high density (Matsuda et al., 1999). Activation of the LIF receptor in ES cells also 
triggers the ERK/MAPK cascade via phosphorylation of JAK, Grb2 and SHP-2 
proteins (Burdon et al., 1999; Dance et al., 2008; Ernst et al., 1996; Matsuda et al., 
1999; Niwa et al., 1998). Since ERK activity is instrumental in promoting ES cell 
differentiation (Kunath et al., 2007; Stavridis et al., 2007), a balance must exist so 






The requirement of LIF for ES cell self-renewal is in striking contrast with the notion 
that disruption of gp130 mediated signalling does not compromise pre-implantation 
development. Neither deletion of LIF, LIFR, gp130 nor STAT3 results in a 
phenotype at the blastocyst stage (Li et al., 1995; Stewart et al., 1992; Takeda et al., 
1997; Yoshida et al., 1996). The earliest phenotype manifests in STAT3 knock-out 
embryos, that show a reduction in the size of the epiblast at E6.5 and reduced 
dimensions of outgrowths after ICM explant (Takeda et al., 1997). Interestingly, the 
reciprocal pattern of LIF and LIFR/gp130 expression during development would 
suggest that LIF signalling plays an important role in the development of the ICM. 
Soluble LIF is expressed in the trophectoderm from the morulae to the egg cylinder 
stage, and both LIFR and gp130 are expressed in the ICM from the blastocyst stage 
until implantation (Nichols et al., 1996). This apparent contradiction might have been 
solved by a later study showing that LIF signalling protects cells in the ICM from 
differentiation during diapause (Nichols et al., 2001). In addition, LIF seems to play 
an independent role in the endometrial tissue and is required for the correct 
implantation of the embryo (Stewart et al., 1992). 
 
Recent studies showed that LIF stimulation has a profound transcriptional 
consequence in ES cells (Sekkai et al., 2005; Trouillas et al., 2009) and individuated 
in Klf4 one of the pluripotency factors most sensitive to LIF signalling (Niwa et al., 
2009). 
 
1.3.2:    BMP signalling. 
 
When cultured in serum free media, ES cells differentiate into neurons. In 2003, it 
was demonstrated that addition of BMP4 and LIF to chemically defined N2B27 
medium allows the efficient propagation of ES cells in the absence of serum (Ying et 
al., 2003). Signalling from BMPs via ALK receptors triggers the phosphorylation of 
SMAD transcription factors, which in turn activate ID genes transcription (Shi and 
Massague, 2003; Ying et al., 2003). ID proteins bind to ubiquitously expressed basic 
helix-loop-helix transcription factors, such as E47 and E2-2, impair their ability to 




programme (Ying et al., 2003). Activation of ID genes is a crucial component of 
BMP activity in ES cells, since forced expression of ID1 maintains ES cells 
undifferentiated in the absence of BMP4 (Ying et al., 2003).   
 
1.3.3:    FGF/ERK, WNT signalling and 2i culture conditions. 
 
Two othe signalling pathways, the FGF/ERK and the Wnt/glycogen synthase kinase-
3 (GSK-3) cascades, play an important role in balancing ES cell self-renewal and 
differentiation.  
 
Autocrine FGF signalling is required to prime ES cells for differentiation (Kunath et 
al., 2007) through activation of ERK phosphorylation (Stavridis et al., 2007). 
Conversely, suppression of ERK activity has been shown to promote ES cell self-
renewal (Burdon et al., 1999; Kunath et al., 2007; Stavridis et al., 2007; Ying et al., 
2008).  
 
A role for Wnt signalling in promoting self-renewal had been suggested by the 
observation that ES cells treated with small molecule inhibitors of GSK-3 can be 
maintained undifferentiated for a short period of time in the absence of LIF (Sato et 
al., 2004). Similarly, Wnt proteins were shown to synergise with LIF in promoting 
self-renewal of mouse ES cells (Ogawa et al., 2006).  In addition, genetic ablation of 
GSK activity in ES cells compromises their ability to differentiate (Doble et al., 
2007). 
 
Combining these two lines of evidence, a new chemically defined medium based on 
the concomitant inhibition of FGF/ERK signalling and GSK-3 activity was derived 
that allows the indefinite propagation of completely undifferentiated ES cells in the 
absence of BMP and LIF signals. Under these conditions, ES cells can be maintained 
even after ablation of STAT3 (Ying et al., 2008). Nonetheless, GSK-3 inhibition, 
ERK1/2 inhibition and LIF signalling act in an additive way, and in combination 




cells, GSK inhibition acts primarily by stabilising -catenin and elevating its nuclear 
levels. Direct transcriptional activation by -catenin is not required and this protein 
seems to act by relieving Tcf3 repression of the pluripotency network (Cole et al., 
2008; Wray et al.). Recently, Esrrb was identified as the principal target of the GSK-
3/Tcf3 axis in ES cells, and it was shown that GSK-3 inhibition cannot sustain the 
self-renewal of Esrrb
-/-
 cells (Martello et al., 2012).              
 
1.4:    Intrinsic determinants of ES cell self-renewal. 
 
ES cell self-renewal is regulated by the activity of a complex transcriptional network 
centred around the activity of three core pluripotency factors: Oct4, Sox2 and Nanog 
(reviewed in (Chambers and Tomlinson, 2009; Jaenisch and Young, 2008)). The 
activity of a number of additional proteins (Ivanova et al., 2006; Jiang et al., 2008; 
Niwa et al., 2009) confers robustness to this network and ensures its ability to 
respond to external stimuli (Niwa et al., 2009). Among these, and of central 
relevance to this thesis, is Esrrb. The structure, the mechanistic basis of DNA 
recognition and transcriptional activation, the expression pattern during development 
and the function in vivo and in ES cells are outlined here for Oct4, Sox2, Nanog and 
Esrrb.   
 
1.4.1:    Oct4 and Sox2: cooperative DNA binding and transcriptional 
activation.  
 
Oct4 is part of the Octamer class of transcription factors that binds the 8bp consensus 
sequence ATGCAAAT, initially identified in the promoter region of the 
immunoglobulin light chain genes (Clerc et al., 1988; Falkner and Zachau, 1984; 
Mason et al., 1985; Parslow et al., 1984; Sturm et al., 1988). Oct proteins, together 
with Unc and Pit proteins, form the POU (Pit Unc Oct) class of transcription factors 





Sox proteins are part of the High Mobility Group (HMG) superfamily. The HMG 
family is composed of proteins that either make sequence specific or aspecific 
contacts with the DNA. The first group, including TCF-like proteins, yeast mating 
type products and Sox proteins (Laudet et al., 1993), recognises a 
(A/T)(A/T)CAAAG consensus sequence on the DNA (Giese et al., 1991; Harley et 
al., 1992; Sugimoto et al., 1991; van de Wetering et al., 1991). The Sox (SRY-box) 
family is defined by the high levels of conservation of the HMG domain with that of 
the testis determining protein SRY (Denny et al., 1992; Gubbay et al., 1990). Sox2 is 
part of the subgroup b1 of the Sox family, which also includes Sox1 and Sox3 
(Bowles et al., 2000).  
 
1.4.1.1:    Oct4 and Sox2 proteins.  
 
The Oct4 protein presents both N-terminal and C-terminal transactivation domains 
flanking a central DNA binding POU domain (Ambrosetti et al., 2000). Oct factors 
DNA binding domain is bipartite (Sturm and Herr, 1988), including a low affinity 
POU specific (POUS) domain and a high affinity homeodomain (POUHD) (Klemm 
and Pabo, 1996) (Figure 1.1). The POUS domain makes contact with the ATGC 
sequence in the 5’ half of the octamer site, and the POUHD binds the adjacent AAAT 
sequence, with both domains contacting primarily the major groove of the DNA and 
binding to opposite sides of the double helix (Klemm et al., 1994). Despite the 
presence of an apparently unstructured linker between the POUHD and the POUS 
domains, the length of which varies between Oct proteins and can be altered without 
severely compromising binding to the DNA (Sturm and Herr, 1988), and despite the 
absence of direct contacts between the two domains bound to DNA (Klemm et al., 
1994), no spacing can be introduced between the two halves of the octamer site 
(Klemm and Pabo, 1996).  The affinity of the POUS domain for DNA is significantly 
augmented by the presence of an already bound POUHD and introduction of as little 
as 2 base pairs between the ATGC and AAAT sequences disrupts cooperative DNA 











Figure 1.1: Nanog, Oct4, Sox2 and Esrrb protein structure. 
 
Schematic representation of Nanog, Oct4, Sox2 and Esrrb dividing each protein into 
structural, functional or putative domains. TAD: Transactivation domains; HD: 
Homeodomain; WR: Tryptophan repeat; POUS: POU specific DNA binding domain; 
POUHD: POU homeodomain; HMG: High Mobility Group domain; DBD: DNA Binding 
Domain; LBD: Ligand Binding Domain. Transactivation domains are in yellow, DNA 






The Sox2 protein is constituted by a short N terminal domain, followed by a DNA 
binding HMG domain and a C-terminal transactivation domain (Ambrosetti et al., 
2000) (Figure 1.1). Sox2 DNA binding domain, as observed for other HMG class 
proteins, is composed by three  helixes and a  strand pack that arrange 
orthogonally in a L-shaped structure of which helixes 1 and 2 form the major wing 
and helix3 and the b strand form the minor wing (Weiss, 2001). The major wing 
makes base specific contacts with the minor groove of the DNA, expanding it and 
causing bending of the double helix with an angle of 90 degrees (Remenyi et al., 
2003). 
 
Oct4 and Sox2 binding sites are found in close proximity to one another at the 
promoter of many important pluripotency genes, including UTF1 (Nishimoto et al., 
1999), FGF4 (Yuan et al., 1995), Nanog (Kuroda et al., 2005; Rodda et al., 2005), 
Oct4 (Chew et al., 2005; Okumura-Nakanishi et al., 2005) and Sox2 (Chew et al., 
2005; Tomioka et al., 2002). In addition, searching both Oct4 and Sox2 bound 
regions identified by genomewide chromatin immunoprecipitation (ChIP) studies for 
overrepresented sequences led to the identification of very similar Oct and Sox 
binding motifs (Chen et al., 2008). These observations can be rationalised in light of 
the notion that binding to the DNA and activation of transcription by Oct factors and 
Sox2 is highly cooperative (Ambrosetti et al., 1997; Ambrosetti et al., 2000). 
Structural studies revealed that Sox2 binding to the minor grove of the DNA places 
its HMG domain on the same side of the double helix as the POUS domain of the Oct 
protein partner. Extensive contacts between POUS and Sox2 result in a more than 
ten-fold increase of the low affinity POU domain for the DNA (Williams et al., 
2004), orders the relatively unstructured C terminal  strand of the Sox2 HMG 
(Remenyi et al., 2003), and stabilises the contact of both domains with the double 
helix (Williams et al., 2004). The extent of this cooperative interaction is strongly 
dependent on the distance between the octamer site and the Sox2 binding motif, 
deteriorating with an increase in the spacing, and might explain the selectivity shown 




1.4.1.2:    Oct4 and Sox2 expression during development and 
consequences of loss of function. 
 
Oct4 and Sox2 messenger RNAs are maternally inherited and detected in all 
blastomeres throughout early cleavage. Oct4 is homogeneously expressed in all cell 
of the inner cells mass but downregulated in the trophectoderm after E3.5, and is 
then highly expressed in the epiblast at E4.5 (Avilion et al., 2003; Dietrich and 
Hiiragi, 2007; Rosner et al., 1990; Scholer et al., 1990; Yeom et al., 1996).   Seminal 
genetic studies indicated that Oct4 and Sox2 are required for early development. 
Inner cells from Oct4 or Sox2 null embryos fail to form a pluripotent ICM and are 
diverted to a trophoblast fate (Avilion et al., 2003; Nichols et al., 1998). In the 
epiblast of post-implantation embryos, Oct4 is progressively downregulated in an 
anterior to posterior fashion at the onset of gastrulation, but its expression is 
maintained in the newly specified PGCs and there increases after E7.25  (Rosner et 
al., 1990; Scholer et al., 1990; Yeom et al., 1996; Yoshimizu et al., 1999). Sox2 
expression becomes restricted to the neuroectoderm around E7.0, is lost in germ cells 
around E7.0 and regained after E7.25. (Avilion et al., 2003; Kurimoto et al., 2008). 
In accordance with its role during pre-implantation development, Oct4 is essential 
for the development of the germ line: Oct4 null PGCs are lost between E9.5 and 
E10.5 as a consequence of a pronounced wave of premature apoptosis (Kehler et al., 
2004). 
 
1.4.1.2:    Oct4 and Sox2 expression and function in ES cells. 
 
In accordance with the notion that both factors are strictly required for self-renewal, 
Oct4 and Sox2 expression is homogeneous in ES cells (Avilion et al., 2003; 
Chambers et al., 2007). Oct4 levels are strictly controlled in the cells: an increase of 
more that 50% leads to differentiation into extraembryonic endoderm and mesoderm, 
whereas a reduction to some level below the 50% of wildtype expression triggers 
differentiation into trophoblast (Niwa et al., 2000). The effects of Sox2 deletion, 




loss of Oct4, further highlighting the intimate connection between the activities of 
these two factors in ES cells (Masui et al., 2007). It was recently proposed that Sox2 
is required in ES cells uniquely to sustain Oct4 expression, since forced expression 
of Oct4 is able to maintain ES cells undifferentiated in the absence of Sox2. Other 
Sox proteins are expressed in ES cells and might exert a certain level of functional 
compensation in Sox2 knockout lines (Masui et al., 2007). 
 
In line with the requirement of these two factor for self-renewal, acute ablation of 
Oct4 and Sox2 triggers rapid and profound transcriptional changes in ES cells (Hall 
et al., 2009; Masui et al., 2007), placing these proteins at the core of the pluripotency 
network.       
 
1.4.2:    Nanog. 
 
Nanog was conjunctly identified by two studies aiming at the identification of novel 
regulators of ES cell self-renewal. The first study took a bioinformatic approach to 
identify genes specifically expressed in ES cells, and subsequently tested the effects 
of overexpressing the identified candidates for which a function in pluripotent cells 
was not reported (Mitsui et al., 2003). The second was based on the functional screen 
of a cDNA library for genes that were able to confer LIF independence to ES cells 
(Chambers et al., 2003). 
 
1.4.2.1:    Nanog protein. 
 
Nanog is a 305 amino acid long protein that can be classified as a divergent 
homeodomain transcription factor. The low levels of homology with other known 
homeodomain proteins make it impossible to assign Nanog to a specific family. 
Sequence homology with members of the closest family, Nk-2, is confined within the 
homeodomain and does not exceed 50% (Chambers et al., 2003; Mitsui et al., 2003). 
In addition, Nanog lacks the TN and NK2-SD domains characteristic of Nk-2 family 




other NK-2 proteins at positions involved in contacts with the DNA and which define 
sequence specificity, are also missing in Nanog (Jauch et al., 2008; Mitsui et al., 
2003). Nanog orthologs have been identified and studied in rat, human (Chambers et 
al., 2003; Mitsui et al., 2003), primates (Hart et al., 2004) and in other vertebrates, 
including urodele amphibians (Dixon et al.), birds (Lavial et al., 2007) and fish 
(Camp et al., 2009). 
 
The Nanog protein can be roughly divided into three distinct domains: an N-terminal 
domain, containing an acidic transactivation region, a homeodomain, and a C-
terminal domain, which is in turn divided in two parts, CD1 and CD2, by an 
intervening region characterised by 10 repetitions of a sequences in which every fifth 
residue is a tryptophan (WR repeat) (Chambers et al., 2003; Mitsui et al., 2003) 
(Figure 1.1).  The N terminal and the CD2 domains of mouse Nanog have been 
shown to possess a weak and a strong transactivatory activity respectively (Pan and 
Pei, 2005; Pan and Pei, 2003), while only the CD2 domain of the human protein can 
activate transcription (Oh et al., 2005). The homeodomain is responsible for the 
ability of Nanog to bind DNA. Despite substitutions in residues generally involved in 
conserving the architecture of the homeodomain in other members of the family, 
superimposition studies revealed that the overall structure of the core domain and the 
positioning of C atoms in the  helix backbone are strongly conserved in Nanog 
homeodomain (Jauch et al., 2008). Like other homeodomain proteins, Nanog 
presents two  helixes (1 and 3) running in an antiparallel fashion and a third helix 
(2) positioned almost orthogonally in a manner that facilitates its contacts with the 
major grove of the DNA (Jauch et al., 2008). The consensus binding motif emerged 
from SELEX and EMSA studies includes the canonical ATTA homeodomain 
recognition sequence and preference for G or C at the following two positions (Jauch 
et al., 2008; Mitsui et al., 2003). Interestingly, search for overrepresented sequences 
at Nanog bound genomic regions identified in ChIP-seq studies defined an 
Oct4/Sox2 binding motif as the Nanog binding consensus (Chen et al., 2008). This is 
of interest, since it highlights the diffuse clustering of these three transcription factors 
at the regulatory elements of many target genes of the pluripotency network, and 




Finally, the WR region has been shown to mediate homo-dimerisation of mouse 
Nanog and is required for Nanog ability to sustain LIF independent self-renewal 
(Mullin et al., 2008).  
 
Nanog protein is subject to different forms of post-translational modification that 
control its levels in the cells, as recently highlighted for human Nanog (Van Hoof et 
al., 2009). Nanog has been reported to be phosphorylated, and this could affect the 
stability of the protein (Moretto-Zita et al., 2010; Yates and Chambers, 2005). In 
addition, Nanog protein has been shown to be the target of caspase mediated 
proteolysis upon differentiation (Fujita et al., 2008). 
 
Nanog engages in a complex network of protein-protein interactions. Initial studies 
reported Nanog interaction with Smad1 (Suzuki et al., 2006) and Sall4 (Wu et al., 
2006). Immunoprecipitation of Nanog followed by mass spectrometry subsequently 
revealed interaction with a number of other mediators of ES cell self-renewal, such 
as Oct4, Nac1, Dax1 and Zfp281, and chromatin remodelers or repressor complexes, 
such as members of the SWI/SNF and NuRD complexes (Liang et al., 2008; Wang et 
al., 2006a). Among the identified interactors is Esrrb ((Wang et al., 2006a), see also 
supplementary material in (van den Berg et al., 2010)). 
   
1.4.2.2:    Nanog expression during development and in vivo 
consequences of loss of Nanog. 
 
In contrast to Sox2 and Oct4, Nanog is absent in unfertilised oocytes and becomes 
expressed from the 8 cell stage onward, shortly before specification of the ICM 
(Chambers et al., 2003; Dietrich and Hiiragi, 2007; Guo et al.; Hart et al., 2004; 
Plusa et al., 2008). Nanog expression, initially uniform in all blastomeres, becomes 
heterogeneous in the ICM around E3.5 (Chazaud et al., 2006; Dietrich and Hiiragi, 
2007). Maintenance or loss of Nanog expression is a key event in the choice between 
pluripotency and differentiation into primitive endoderm (Plusa et al., 2008). Cells 




resetting, form the epiblast of the post-implantation embryo and hence give rise to all 
tissues constituting the adult body. Further stressing an intimate connection between 
Nanog expression and pluripotency in the pre-implantation embryo, ICM cells 
gradually switch from mono to bi-allelic Nanog expression during the transition from 
early to late blastocyst (Miyanari and Torres-Padilla, 2012). Nanog expression is 
then transiently down-regulated in the epiblast immediately before implantation 
(Chambers et al., 2003) and becomes detectable again in the posterior epiblast at the 
egg cylinder stage before the onset of gastrulation. Nanog expression is lost in the 
entire epiblast around E8.0, and before then in the cells that migrate through the 
primitive streak and differentiate into mesoderm (Hart et al., 2004; Osorno et al., 
2012). Declining Nanog expression is upregulated again around E7.75 in PGCs 
accumulating posteriorly in the extraembryonic mesoderm region (Yamaguchi et al., 
2005), is detectable in germ cells throughout migration to the gonads, and remains 
expressed by the majority of PGCs until E12.5, declining thereafter and becoming 
almost undetectable at E15.5 and E14.5 in male and female embryos respectively 
(Chambers et al., 2007; Yamaguchi et al., 2005) (Figure 1.2). 
 
Nanog activity is essential at two different stages of development: in the pre-
implantation embryo and, later on, in the germline. Initially, genetic ablation studies 
revealed that Nanog is required in vivo at the peri-implantation stage (Mitsui et al., 
2003). Subsequently, detailed analysis  indicated that in Nanog
-/-
 E4.5 embryos an 
aberrant epiblast is formed that includes few cells showing very low Oct4 expression 
and, in female embryos, defective reactivation of the X chromosome (Silva et al., 
2009). The finding that Nanog can be deleted in ES cells allowed the study of Nanog 
role in later stages of development. Nanog
-/-
 cells contribute normally to 
development in chimaeric embryos generated by blastocyst injection (Chambers et 
al., 2007). In such embryos, PGC derived from the injected ES cells can be detected 
in the genital ridges until day E11.5, but contribution to the germline is undetectable 
in embryos dissected at days E12.5 or E13.5 of development. Knock-down studies 
seem to indicate that elevated levels of apoptosis and reduced proliferation during 
PGC migration to the genital ridges might contribute to this phenotype (Yamaguchi 








Figure 1.2: Nanog expression dynamics during murine development. 
 
Nanog protein is first detected in all blastomeres of the 8 cell stage embryo. Around 
E3.5 Nanog expression becomes heterogeneous in the ICM and segregation of 
Nanog positive and negative cells leads to the formation of the epiblast and 
hypoblast in the E4.5 blastocyst. Around implantation Nanog is downregulated 
before its expression is detected again in the posterior part of the epiblast. From 
E6.5 until the onset of somitogenesis Nanog expression remains regionalised and 
progressively declines. At E7.75 Nanog expression, confined to the proximal 
posterior part of the epiblast, is upregulated again in PGC. Nanog remains 
expressed by the majority of PGC until E12.5 and declines thereafter becoming 
almost undetectable at E15.5 and E14.5 in males and females respectively. Neither 






The timing of Nanog expression and the phenotype of Nanog null embryos suggest 
that Nanog plays an essential role in vivo in driving acquisition of pluripotency. 
Nonetheless, there is currently no mechanistic insight on how Nanog promotes this 
transition in the developing embryo.  
 
1.4.2.3:    Nanog in vitro function in the acquisition and maintenance of 
pluripotency 
 
Nanog is required for the successful derivation of ES cell lines (Mitsui et al., 2003). 
When the inner cell mass from a Nanog null blastocyst is isolated by immunosurgery 
and put in culture it fails to produce an outgrowth and differentiates in cells 
morphologically resembling trophoblast (Silva et al., 2009). The initial observations 
made by Mitsui and colleagues analysing knockout embryos and Nanog null ES cells 
led to the speculation that pluripotent cells are dependent on Nanog expression. 
Intriguingly, subsequent studies showed that it is possible to derive ES cells in which 
both Nanog alleles have been ablated by homologous recombination (Chambers et 
al., 2007). Combined with previous findings, this raised the hypothesis that the 
central role of Nanog in development is promoting the establishment of pluripotency, 
and that this factor is not strictly required once pluripotency is attained (Silva et al., 
2009). Despite this, in pluripotent cells Nanog regulates the self-renewal efficiency. 
Nanog overexpression abolishes ES cell ability to differentiate in response to the 
withdrawal of the otherwise essential signals provided by LIF and BMP (Chambers 
et al., 2003; Ying et al., 2003) and loss of function genetic studies showed that 
Nanog null ES cells are more prone to differentiate (Chambers et al., 2007). More 
importantly, ES cells spontaneously fluctuate in culture between states of high 
Nanog expression, characterised by efficient self renewal, and low Nanog 
expression, with increased propensity to differentiate (Chambers et al., 2007). 
Conversely, in culture conditions that lock ES cells in a completely undifferentiated 





Nanog is able to promote reprogramming of hybrids generated by fusion between 
neural stem cells (NS) and ES cells (Silva et al., 2006). Overexpression of Nanog 
accompanied by a change in culture conditions has also been shown to drive 
reprogramming of EpiSC to ES-like cells (Osorno and Chambers, 2011; Silva et al., 
2009). Even if it is not included in the quartet of canonical reprogramming factors, 
recent studies showed that Nanog expression in conjunction with other pluripotency 
factors, among which notably is Esrrb, allows the generation of induced pluripotent 
stem cells (iPS) from mouse embryonic fibroblasts (MEFs) (Buganim et al., 2012). 
Important indications about the role that Nanog plays in promoting the acquisition of 
pluripotency came from attempts to reprogram Nanog null somatic cells. Nanog is 
required for completion of the reprogramming process (Silva et al., 2009). Nanog 
null cells can transit to a state in which they acquire morphology and growth factor 
dependency characteristics of ES cells but fail to complete epigenetic resetting of 
their genome and do not turn on transcription of pluripotency factors from the 
endogenous alleles (Silva et al., 2009). In this state, resembling the partially 
reprogrammed intermediates observed during reprogramming of Nanog wild-type 
cells (Mikkelsen et al., 2008) “pre-iPS” cells do not silence expression of the 
transgenes encoding for the reprogramming factors. Enforcing Nanog expression in 
these lines allows transition to a fully reprogrammed state (Silva et al., 2009). Nanog 
was thus proposed to be exquisitely required for the acquisition of pluripotency in 
vitro, substantiating the current interpretation of its role during in vivo development 
(Theunissen and Silva, 2011). 
 
Interestingly, the role of Nanog in driving attainment of naive pluripotency could be 
conserved throughout vertebrate evolution. Indications in support of a conserved role 
for Nanog in other species came from in vitro studies reporting that human, rat, chick 
and zebrafish Nanog orthologs are able to trigger completion of the reprogramming 
process in pre-iPS lines derived from Nanog null mouse ES cells (Theunissen et al., 
2011a). Strikingly, mouse Nanog homeodomain (HD) was sufficient to complete 
reprogramming in this experimental setting. Thus, it was proposed that the 
homeodomain is the region of the Nanog protein principally responsible for Nanog 




1.4.3:    Esrrb. 
 
Estrogen related receptors (ERRs) belong to the NR3B subgroup of nuclear 
receptors, which is part of the wider NR3 class including estrogens, androgen, 
progesterone, aldosterone and cortisol receptors (reviewed in (Tremblay and 
Giguere, 2007)). The NR3B subgroup comprises three highly related members: 
Esrra, Esrrb and Esrrg (also named ERR1-3, NR3B1-3 or ERR). The first two 
member of this class, Esrra and Esrrb, were identified by screening a human testes 
cDNA library with a probe designed against the DNA binding domain of the 
estrogen receptor ER (Giguere et al., 1988). Ten years later, the presence of a 
third member of this family, Esrrg, was independently unveiled by biochemical and 
bioinformatic approaches (Eudy et al., 1998; Heard et al., 2000; Hong et al., 1999). 
In both mouse and human, a high degree of homology exist between these three 
proteins, with the DNA binding domain and the hormone binding domain being the 
most conserved regions, as commonly observed for other nuclear receptors. Esrrb 
and Esrrg are the most related proteins, with 99% homology in the DNA binding 
domains (93% with Esrra) and higher than 70% homology in the hormone binding 
domains (around 60% with Esrra), in both mice and humans (Heard et al., 2000; 
Hong et al., 1999). Not surprisingly, given the method used for their original 
identification, estrogen related receptors show the highest homology outside their 
subgroup to ER69% and 36% homology exists between the DNA and hormone 
binding domains of hEsrrg and hERa) (Giguere et al., 1988; Heard et al., 2000).   
 
1.4.3.1:    Esrrb protein. 
 
Estrogen related receptors are characterised by a common nuclear receptor domain 
organisation. The N-terminal region of nuclear receptors is the domain that presents 
the highest sequence variation among the member of this family. This region confers 
to nuclear receptors weak transactivation activity on a fraction of their target genes.  
The central part of the protein includes a zinc finger domain responsible for DNA 




and is also responsible for the ligand dependent ability of nuclear receptors to 
activate transcription (Hollenberg and Evans, 1988; Kumar et al., 1987). In hormone 
regulated receptors, an  helix at the C-terminal end of the LBD, the AF-2 helix, is 
relocated after ligand recognition, becoming able to interact with coactivators and 
trigger transcriptional activation (Wurtz et al., 1996). In contrast, ERRs are able to 
mediate transcriptional activation in the absence of any bound ligand (Greschik et al., 
2002; Heard et al., 2000; Hong et al., 1999; Vanacker et al., 1999a; Vanacker et al., 
1999b; Yang et al., 1996). Domain deletion studies demonstrated that the LBDs of 
Esrra and Esrrg, and specifically residues in the AF-2 helix, are required for the 
transactivation ability of these proteins (Heard et al., 2000; Hong et al., 1999; 
Vanacker et al., 1999a; Vanacker et al., 1999b). A very weak transactivation activity 
is also conferred by the N-terminal domain of Esrrg in luciferase assays (Vanacker et 
al., 1999b).  
 
X ray crystallography showed that the ligand binding domain of Esrrg is composed 
of 12  helixes and, very similarly to ER, adopts a canonical three layered  helix 
sandwich structure. The lack of ligand binding to ERRs is due to the reduced 
dimension of the ligand binding pockets in these receptors compared to ER 
(Greschik et al., 2004; Greschik et al., 2002). The major difference between ERRs 
and ER resides in the substitution of Leu-525 (ER) with a bulkier residue, Phe-
435 (Esrrg), that invades the ligand binding pocket and prevents docking of common 
steroidal estrogens (Wang et al., 2006b). The conservation of the residues lining the 
ligand binding cavity of Esrrb and Esrrg is striking, with only two amino acid 
changes (V313 to I, N346 to Y), making it possible to extrapolate the conclusions 
made analysing the structure of Esrrg to Esrrb (Greschik et al., 2002). In the Esrrg 
ligand binding domain the AF-2 helix is in an active conformation, able to interact 
with coactivators, in the absence of any ligand (Greschik et al., 2002).  
 
Estrogen receptors bind to inverted repeats of the sequence AGGTCA spaced by 
three nucleotides (ERE). In contrast, ERRs recognise a conserved motif comprising a 
5’-extended AGGTCA half-site. In vitro electrophoretic mobility shift assays 




the ERE half-site are crucial for DNA binding by this class of receptors, and 
identified a TCAAGGTCA consensus sequence (Johnston et al., 1997; Sladek et al., 
1997; Vanacker et al., 1999a; Vanacker et al., 1999b; Yang et al., 1996). Given the 
high conservation observed among the DNA binding domains of the three ERRs, it is 
not surprising that EMSA assays (Vanacker et al., 1999b) and genome-wide ChIP-
seq studies (Chen et al., 2008; Dufour et al., 2007) revealed an identical binding 
consensus for Esrra, Esrrb and Esrrg, and showed that ERRs share target genes. 
ERRs can bind to the DNA as monomers (Barry et al., 2006; Gearhart et al., 2003; 
Johnston et al., 1997; Pettersson et al., 1996), homodimers (Barry et al., 2006; 
Vanacker et al., 1999a) or heterodimers (Dufour et al., 2007), further extending the 
potential for cross regulation of transcription by these receptors. In addition, at least 
in vitro, ERRs can bind to palindromic ERE sites (Pettersson et al., 1996; Vanacker 
et al., 1999b), and form heterodimers with ER(Johnston et al., 1997).  
 
Resolution of the structure of the DNA binding domain of Esrrb bound to DNA 
(Gearhart et al., 2003) revealed a characteristic nuclear receptor zinc finger fold, in 
which an  helix, surrounded by the zinc binding cysteine residues, makes extensive 
contacts with the major groove of the DNA. In addition, immediately following the 
core zinc finger domain, the Esrrb DBD possesses a C-terminal extension, common 
to other nuclear receptor that bind extended ERE half-sites as monomers, which 
crosses the DNA phosphate backbone and makes additional contacts with the DNA 
minor groove. The C-terminal extension has been shown to be determinant for the 
interaction with the 3 nucleotide 5’-extension of the ERE half-site (Gearhart et al., 
2003).   
 
Despite the fact that no natural ligand is reported for ERRs, a variety of synthetic 
hormones has been shown to bind to these receptors and either inactivate (Greschik 
et al., 2004; Greschik et al., 2002; Wang et al., 2006b) or potentiate (Wang et al., 
2006a) their transactivation ability. In particular, 4-OH tamoxifen and 
diethylstilbestrol (DES) have been shown to contact the ligand binding pocket of 




dislocation and inhibition of transactivation (Tremblay et al., 2001a; Tremblay et al., 
2001b; Wang et al., 2006a). 
 
Esrrb protein has been shown to interact with numerous other pluripotency factors, 
including Nanog, Oct4, Sall4 and Dax1, in mouse ES cells (van den Berg et al., 
2010; Wang et al., 2006a). In addition, Esrrb contacts common estrogen receptors 
coactivators, like Ncoa-3, and components of the basal transcriptional machinery, 
including the mediator complex, TFIID and RNAPolII (van den Berg et al., 2010). It 
is thus possible that Esrrb may function as a bridge between pluripotency factors and 
component of the transcriptional initiation complex at the promoter of target genes of 
the pluripotency network.  
 
1.4.3.2:    Esrrb expression in vivo and phenotype of Esrrb loss of 
function. 
 
Esrrb expression is detected at extremely high levels in 1 cell embryos (Guo et al., 
2010), before transcription from the zygotic genome is activated (Schultz, 2002). 
Expression is maintained throughout pre-implantation development, becoming 
restricted to the ICM at the 32 cell stage. At the 64 cell stage, no expression is 
detected in cells expressing markers characteristic of the trophectoderm or primitive 
endoderm (Guo et al., 2010). After implantation, Esrrb expression is not detected in 
the epiblast and is restricted to the extra-embryonic ectoderm at E5.5. Later, 
expression is confined to the ectodermally derived regions of the amniotic fold at 
E6.5, and to the chorion in E7.5 embryos. Esrrb expression diminishes after fusion of 
the chorion with the ectoplacental cone, becoming restricted to the free margin of the 
chorion at E8.5 (Luo et al., 1997; Pettersson et al., 1996). Esrrb expression is 
reactivated in E11.5 post-migratory PGCs, and persists in germ cells until E14.5 and 
E15.5 in females and males embryos respectively (Mitsunaga et al., 2004). At E13.5 
Esrrb expression is also detected in the developing brain (Mitsunaga et al., 2004). 
After birth, Esrrb expression is broad, with high levels detected in the testes 




the kidneys and the thyroid (Bookout et al., 2005; Bookout et al., 2006). Lower 
levels of expression are detected in other organs, especially in the brain (Bookout et 
al., 2005; Bookout et al., 2006). The observation that high levels of Esrrb are 
detected in embryos at the 1 cell stage further suggests that Esrrb is expressed in the 




 embryos generated by mating heterozygous animals revealed that Esrrb 
expression is required for normal placental development. The chorion is nearly 
absent in Esrrb knockout E7.5 embryos, and abnormalities in the early placenta and 
the ectoplacental cone are evident at E8.5 (Luo et al., 1997). As a consequence, 
Esrrb
-/-
 E9.5 embryo show evident signs of growth retardation and no viable Esrrb
-/-
 
embryos are observed after 10.5. The increased numbers of secondary giant cells and 
the almost complete absence of diploid trophoblast cells observed at E8.5 (Luo et al., 
1997), coupled with the notion that DES treatment of trophoblast stem (TS) cells 
induces differentiation in ployploid giant cells (Tremblay et al., 2001b), suggests that 
Esrrb is required for self-renewal of trophoblast cells during early placental 
development. Tetraploid rescue experiments showed that Esrrb
-/-
 embryo defects are 
restricted to extraembryonic tissues at this time of development (Luo et al., 1997; 
Mitsunaga et al., 2004) and allowed the generation of viable adult knockout animals 
(Mitsunaga et al., 2004). Absence of Esrrb results in defective germline 
development, with reduced numbers of PGCs detected in the gonads of both male 
and female knockout embryos at E13.5-15.5 (Mitsunaga et al., 2004). Finally, 
epiblast specific Cre mediate deletion of Esrrb, demonstrated that Esrrb expression is 
required for the correct development of endolymph producing cells in the inner ear, 
leading to hearing and balance defects in null animals (Chen and Nathans, 2007).     
 
1.4.3.3:    Esrrb function in vitro. 
 
Esrrb is heterogeneously expressed in ES cells (van den Berg et al., 2008), while no 
expression is detected in EpiSC or human ES cells (Xie et al., 2009).  Genome-wide 
ChIP-seq studies revealed that Esrrb colocalises with other pluripotency factor at the 




cells (Chen and Nathans, 2007; Marson et al., 2008). Furthermore, Esrrb has been 
shown to activate Nanog expression in conjunction with Oct4 and Sox2 (van den 
Berg et al., 2008). Published work has also suggested that Esrrb can drive LIF 
independent self-renewal, but did not incontrovertibly demonstrate that Esrrb 
overexpression sustains ES cells in the complete absence of LIF signalling (Zhang et 
al., 2008).  
 
Knockdown studies concluded that Esrrb expression is required for ES cell-self-
renewal (Ivanova et al., 2006). Nonetheless, it was recently demonstrated that it is 
possible to genetically delete Esrrb in ES cells. The resulting knockout lines show 
increased propensity to differentiate and a strict dependency on LIF stimulation, but 
retain pluripotency in culture and can contribute to the developing embryo (this 
thesis and (Festuccia et al., 2012; Martello et al., 2012)). 
 
Esrrb is able to drive highly efficient reprogramming of EpiSC to ES cell 
pluripotency (Festuccia et al., 2012) and can substitute for Klf4 during iPS cell 
generation from MEFs (Feng et al., 2009). Furthermore, it was recently shown that 
Esrrb can promote reprogramming independently of the four canonical 
reprogramming factors, and is particularly efficient in this context when combined 
with Nanog (Buganim et al., 2012). 
 
The three estrogen related receptors are able to activate transcription by interacting 
with a number of coactivators, that are common partners to other nuclear receptors 
(Tremblay and Giguere, 2007). Among these Ncoa3 is expressed at high levels in ES 
cells (Percharde et al., 2012; Wu et al., 2012), while PRC, PRNC-2, Ncoa1, and Tle1 
show lower expression ((Percharde et al., 2012; Wu et al., 2012) and Table3.1). 
Recent studies demonstrated that Ncoa3 interacts with Esrrb in ES cells (Percharde et 
al., 2012; van den Berg et al., 2010), mediates its transcriptional activity, and is 
essential for efficient reprogramming and ES cell self-renewal (Percharde et al., 





1.5:    Aims of the thesis. 
 
The aim of this thesis is the identification of Nanog target genes in ES cells. Despite 
the fact that genomewide ChIP studies have recently identified an extensive list of 
binding sites for the principal pluripotency factors, little is known regarding which of 
the bound genes are responsive to fluctuations of single transcriptional regulators. 
Here a list of genes that show prompt response to the perturbation of Nanog levels is 
identified. Based on this novel information, the present work aims at exploring the 
molecular mechanisms of transcriptional regulation by Nanog, using single 
responsive genes as a paradigm for understanding the wider effects of Nanog on gene 
expression. 
 
Nanog heterogeneous expression has been recognised as a crucial determinant of cell 
fate decision between self-renewal and differentiation. This thesis aims at describing 
how fluctuations in Nanog level influence the expression of it target genes in single 
ES cells, and which are the functional consequences of such regulation.  
 
The role of specific Nanog targets in sustaining ES cell self-renewal is also assessed 
in the following chapters. In particular this work compares the effects of elevating or 
ablating expression of a prominent Nanog target, Esrrb, in wild-type ES cells or cells 
genetically devoid of Nanog, with the objective of understanding whether Esrrb 
mediates part of Nanog activity and can functionally complement for loss of Nanog. 
Special attention is devoted to assessing the ability of Esrrb to rescue the 
reprogramming and germline development defects of Nanog null ES cells. 
 
In a wider context, the data presented in this thesis aims at identifying differences 








Chapter 2: Materials and methods. 
 
2.1 ES cell culture 
 
2.1.1 ES culture materials 
 
Phosphate-buffered saline (PBS; Sigma, cat. D8537) 
 
GMEM/FCS/LIF 
500 ml Glasgow minimum essential medium (GMEM; Sigma, cat. G5154) 
51 ml fetal bovine serum 
11 ml of 100× glutamine/pyruvate solution (see recipe) 
5.5 ml of 100×MEMnon-essential amino acids (Invitrogen, cat. 11140-036) 
570 μl of 0.1 M 2-mercaptoethanol solution (see recipe)  
Supplemented with LIF (made in-house) at a final concentration of 100 U/ml 
 
Glutamine/pyruvate stock solution 
5.5ml of 100mMsodium pyruvate (Invitrogen, cat. 11360-039)  
5.5 ml of 200 mM L-glutamine (Invitrogen, cat. 25030-024) 
 
2-Mercaptoethanol stock solution, 1000×, 0.1M 
200 μl of 2-mercaptoethanol (14.3 M; Sigma, cat. M6250) 
28.2 ml ultra-high purity (UHP) water 
Gelatin, 0.1% 
Autoclaved 1% (w/v) solution of gelatin (Sigma, cat. G1890) in ultra-high purity 
(UHP).  
Before use, 11 ml of 1% gelatin were added to 100 ml PBS. 
 
Trypsin, 0.025% 
Filter sterilized solution of  0.186 g EDTA (Sigma, cat. E5134) in 500 ml PBS. 




5 ml of the concentrated trypsin stock (2.5%; Invitrogen, cat. 15090-046)  
 
N2B27 and 2i/LIF media 
50ml of DMEM:F12(1:1v/v, GIBCO cat. 12634010) 
50ml Neurobasal (GIBCO cat. 21103049) 
1ml of 100× glutamine (Invitrogen cat. 25030024) 
1 ml of 100×MEMnon-essential amino acids (Invitrogen, cat. 11140-036) 
100 μl of 0.1 M 2-mercaptoethanol solution (see recipe) 
1ml of 100x N2 supplement (GIBCO cat. 17502048)  
2ml of 50x B27 supplement(GIBCOcat. 17504044).   
Supplemented where indicated with PD0325901 (1μM) (Axon, cat. 1408), 
CHIR99021 (3μM) (Axon,cat. 1386) and 100U/ml LIF. 
 
2.1.2:    ES cell passaging  
 
ES cells were cultured on gelatin coated 25, 75 or 150 cm
2
 flasks (IWAKI cat. 3100-
025, 3110-075, 3120-150) in GMEM/FCS/LIF and incubated in a 37°C/ 7% CO2 
incubator. Cells were routinely passaged when they reached 70-80% confluence. 
Medium was changed every day or every two days depending on the cell line.  Flasks 
were treated with 0.1% gelatin in PBS for 10 min before use. ES cells were washed 
with pre-warmed PBS and incubated with 0.025% (v/v) trypsin in PBS at 37°C for 2 
min or until cells started detaching. ES cells were detached by vigorously tapping the 
flask and a volume of GMEM/FCS/LIF equivalent to 5 times the volume of trypsin 
was added to block the reaction. Cells were transferred to a universal 30-ml tube and 
centrifuged for 3 min at 290g. The pellet was resuspended in GMEM/FCS/LIF and 
cells were split 1:5 to1:15 at each passage.   
 
2.1.3:    ES cell freezing 
 
1-2 vials were frozen from an 80% confluent T25 cm
2
 flask. Before freezing ES cells 




resuspended in 1-2 ml of GMEM/FCS/LIF supplemented with 10% v/v DMSO. 
1ml of suspension was then dispensed into each cryotube (NUNC cat. 377224), and 
tubes transferred immediately to -80°C. The following day tubes were transferred to 
a N2(lq) tank for long term storage.   
 
2.1.4:    ES cell thawing 
 
1 vial of frozen cells was warmed up to 37°C in a waterbath and the ES cell 
suspension transferred to a universal tube containing 10ml of pre-warmed 
GMEM/FCS/LIF. Cells were collected by spinning at 200g for 3 min and 
resuspended in 10ml of GMEM/FCS/LIF before transfer to a gelatinised T25 flask.  
 
2.1.5:    Colony forming assay (in +/- LIF) 
 
ES cells were collected by trypsinisation as described for passaging and resuspended 
in 5ml of GMEM/FCS/LIF. Cells were counted and 600 or 3,600 cells respectively 
were replated in a gelatinised well of a six well plate (IWAKI cat. 3810-006) or in a 
10cm diameter dish (surface area  63cm
2
) (IWAKI cat. 3020-100). Cells were 
cultured for 7 days in GMEM/FCS/LIF with or without LIF, washed in PBS, and 
incubated for 1 minute in fixative solution made by mixing 25ml of citrate solution 
(18mM citric acid, 9mM sodium citrate, 12mM NaCl), 8ml of formaldehyde solution 
(37% v/v in water) and 65 ml of acetone. Fixed plates were washed in distilled water 
and stained for alkaline phosphatase (AP) expression using a leukocyte alkaline 
phosphatase kit (Sigma cat. 86R-1KT).   
When required LIF antagonist (hLIF-05) was added to the medium of cells cultured 
in the absence of LIF. hLIF-05 (Vernallis et al., 1997) was obtained by preparing 
conditioned medium from COS-7 cells transiently transfected with a hLIF-05 
expression plasmid. Briefly, COS-7 cells were grown in a large T150 cm
2
 flask 
(IWAKI cat. 3120-150) in GMEM/FCS until confluent. Cells were collected by 
trypsinisation, counted and 1.5 x 10
6
 cells/dish were replated in 10 cm diameter 




Fugene-6 transfection reagent (Roche cat. 11815091001) were diluted in 570l of 
GMEM in a 1.5 ml tube. After 5 min at RT, 18 g of circular plasmid DNA (AGS 
627) were added to the Fugene solution, mixed by flicking the tube and incubated at 
RT for 15 min. The DNA/Fugene mixture was added dropwise to the COS-7 plates. 
After 24 hours the medium was replaced and cells cultured for additional 4 days 
before harvesting and filtering the supernatant. 5,000 CPI ES cells were plated in 6 
separate wells of a 24 well plate (IWAKI cat. 3820-024) in ES cell medium 
containing 10U/ml LIF and incubated for 2 hours. Conditioned medium was added to 
each well by 1:2 serial dilutions so that a range of 1:5 to 1:320 (v/v) was tested. 4 
days later plates were stained with Leishman’s stain and the lowest concentration of 
conditioned medium that caused total inhibition of ES cells self-renewal was 
determined and used in further experiments.           
 




cells were plated in 6 well plates coated overnight with Poly-L-ornithine 
0.01% (Sigma cat. P4957), washed and coated 2 hours with laminin (Millipore cat. 
CC095) 5g/ml in PBS. Cells were culture in N2B27 alone (or supplemented with 
BMP, LIF, or BMP/LIF; made in-house) for 9 days, fixed and stained as described.  
 
2.1.8:    Stable transfection of DNA into ES cells 
 
70%-80% confluent ES cells were collected by trypsinisation as described (Chapter 
2.1.2), resuspended in 10ml PBS and counted. 10
7
 cells were collected by 
centrifugation for 3 min at 290g and resuspended in 10ml PBS. Cells were re-
centrifuged and resuspended in 700l PBS. The cell suspension was mixed with a 
solution of 25-50 g linearised DNA in 100ul of PBS. Cells were transferred to a 0.4 
mm gap electroporation cuvette (Biorad cat. 1652088) and electroporation was 
performed at 0.8 kV and 3 F using a Gene Pulser machine (Biorad). Cells were 
collected with a plugged Pasteur pipette, transferred to 10ml of pre-warmed 
GMEM/FCS/LIF and replated at a density of 10
6




cat. 3020-100). Relevant drug selection was started 1 or 2 days after replating for 
random transgene integration and targeting of specific loci respectively. Cells were 
cultured until macroscopic colonies appeared, single colonies picked using wide-bore 
plastic pipette tips loaded with 10l 0.025% trypsin solution and transferred to single 
wells of a 96 well plate containing  20l of 0.025% trypsin solution. After 
dissociating cell clumps by pipetting, 200l of GMEM/FCS/LIF were added to 
each well. Cells were subsequently expanded in GMEM/FCS/LIF with appropriate 
selection before freezing and proceeding to further characterisation. 
 




 supertransfectable E14/T ES cells expressing the Polyoma Large T antigen 
(Chambers et al., 2003) were replated in a gelatinised well of a 6 well plate (IWAKI 
cat. 3810-006) 1 hour before transfection. For each transfection 3l of lipofectamine 
2000 (Invitrogen cat. 11668-027) and 3g of circular plasmid DNA were separately 
diluted into 250 l of GMEM. After 5 minute incubation at RT the DNA and 
lipofectamine solutions were combined and mixed by flicking the tubes. After 20 
min incubation at RT with occasional mixing the DNA/lipofectamine mixture was 
added dropwise to each well of E14/T cells and plates returned to the incubator. 
Antibiotic selection was started 1 day after transfection.          
        
2.2:    DNA manipulation 
 
2.2.1:    DNA isolation from bacterial cells 
 
A bacterial colony propagating the plasmid of interest was inoculated in LB broth 
supplemented with the appropriate antibiotics and grown overnight in a shaker 
(37°C/225rpm). Bacterial cells were collected by centrifugation (5000g, 10 min) and 
plasmid DNA isolated using a MINIprep or MAXIprep kit (Qiagen cat. 27014, 




A260/A230) of the DNA were determined using a ND-1000 spectrophotometer 
(Nanodrop).     
 
2.2.2:    Restriction endonuclease digestion 
 
DNA restriction digestions performed for vector construction or diagnostic 
digestions were performed in a total volume of 20l on 1-2 g DNA using an excess 
of restriction enzymes provided by New England Biolabs or Roche at the 
temperature and in the buffer suggested by the manufacturer. Digestion performed to 
linearise circular DNA used in ES cell stable transfection experiments were 
performed as above with the difference that 25-50g of DNA were digested in a total 
volume of 400l using an excess (typically  50-100 units) of each restriction enzyme. 
  
2.2.3:    Polymerase chain reaction (PCR) 
 
PCRs used in vector construction or cloning of coding sequences from ES cell 
derived cDNA preparations were performed using 1U of the PFX high fidelity 
polymerase enzyme (Invitrogen cat. 11708-039) , dNTPs mixture at a final 
concentration of 200 nM (Invitrogen, cat. 10297-018) and synthetic DNA 
oligonucleotides at a final concentration of 300nM  (Integrated DNA Technologies). 
Reactions were performed in a total volume of 50l according to the manufacturers 
instructions in a DNA Engine thermal cycler (Biorad). 100ng or 50ng of DNA 
template were used for amplifications on plasmid DNA or cDNA respectively. 
Annealing was performed at temperatures between 59- to 61°C for 15 sec. Extension 
times of 1 minute/ Kb and 10 sec denaturation times were employed. An initial 
denaturation cycle of 3 min and a final extension cycle of 5 min were performed. 







2.2.4:    DNA fragment ligation 
 
After restriction digestion DNA fragments were separated by electrophoresis using 
1% agarose (Invitrogen cat. 16500-500 or Seachem cat. 50005) 0.5x TBE (Tris 
Borate EDTA buffer) gels. DNA was purified from the gel using a Gel Extraction Kit 
(Qiagen cat. 28704). DNA was eluted in 30 l of nuclease-free water and 
concentration determined using a ND-1000 spectrophotometer (Nanodrop). 
Typically, 50 to 100 ng of linearised vector DNA were ligated to DNA fragment 
present in 3 fold molar excess. Ligation reactions were performed in a total volume 
of 10l for 1 hour at RT using T4 DNA ligase (New England Biolabs cat. M0202L) 
following the manufacturer instructions. Ligated DNA mixtures were transformed 
into chemically competent DH5a E.Coli (transformation efficiency of   10
7
 cfu/g) 
by a 30 min incubation on ice followed by 45 sec heat-shock at 42°C. Bacteria were 
then allowed to recover in LB for 1 hour at 37°C and were plated on LB agar plates 
in presence of the appropriate antibiotic selection. Plates were incubated overnight at 
37°C before colony picking.            
 
2.2.5:    Cloning of PCR products 
 
Cloning of blunt PCR products was performed using the Zero Blunt cloning Kit 
(Invitrogen cat. K280040) following the manufacturer’s instructions and 
transforming DNA into One Shot Chemically Competent E.Coli. (Invitrogen cat 
K280040). 
    
2.2.6:    Cloning by homologous recombination (recombineering) 
 
E.Coli cells harbouring a bacterial artificial chromosome (BAC) containing the 
genomic regions of interest and conferring chloramphenicol resistance were obtained 
from commercial repositories (BioSource). 10 ng of pRedET plasmid (Genebridges 
cat. K001) was electroporated into BAC harbouring cells before plating on LB agar 




hours. The pACYC177 plasmid region including the ampicillin resistance cassette 
and the origin of replication was amplified by PCR using oligonucleotide primers 
bearing 60 bp long sequences of homology to the 5’ and 3’ ends of the region to be 
subcloned from the BAC. PCR products were purified on column using a PCR 
Cleanup Kit (Qiagen cat. 28104) and digested with DpnI  to avoid propagation of the 
template plasmid in the following steps. Digested DNA was ethanol precipitated with 
the help of 2 g of glycogen carrier and resuspended in nuclease free water.   Single 
tetracycline resistant colonies were inoculated into LB, grown at 30°C and 
electroporated with linear PCR DNA. One hour before electroporation,  RedET 
enzymes were induced by adding L-arabinose to a final concentration of 0.2% to the 
culture medium. Electroporated cells were plated on LB agar in the presence of 
ampicillin and tetracycline selection and incubated at 30°C for 36-48 hours. Single 
clones were picked and expanded at 30°C maintaining ampicillin and tetracycline 
selection. Occurrence of the correct recombination event was assessed by restriction 
digestion on purified plasmid DNA. Cassettes including the desired fluorescent 
protein coding region preceded by a 2a peptide, linked to the hygromycin, blasticidin 
or puromycin resistance gene by an internal ribosome entry site (IRES) sequence and 
followed by a bacterial EM7 promoter driven kanamycin resistance gene were 
amplified by PCR using oligonucleotide primers bearing 60 bp long sequences of 
homology to the region immediately upstream and downstream of the Esrrb gene 
stop codon. PCR products were DpnI treated as before and electroporated into E.Coli 
clones harbouring the correctly recombined plasmids. Colonies were picked and 
inoculated in LB containing ampicillin and tetracycline,  expression of  RedET 
enzymes was induced as described and cells were plated on LB agar plates in the 
presence of kanamycin and incubated at 37°C overnight to induce loss of the 
pRedET plasmid. Colonies were picked and occurrence of the correct recombination 
event was assessed by restriction digestion on purified plasmid DNA. Plasmid DNA 
was digested with a single cutter enzyme, purified on column and self-ligated before 
transforming into chemically competent E.Coli and replating on LB agar plates in the 
presence of kanamycin. This procedure ensured resolution of concatenated repetition 
of modified and unmodified plasmid sequences originated by self-recombination of 




excluded concomitant presence of modified and unmodified plasmid molecules in 
the E.Coli population.  Single colonies were picked and achievement of pure 
preparations of correctly recombined plasmid verified by restriction digestion. 
 
2.2.7:    Recombinase mediated excision of resistance cassettes 
 
DH5 E.Coli cells harbouring PACYC177 based targeting vectors generated by 
recombineering as described above were electroporated with 10 ng of p705-FLP 
plasmid (Genebridges, K001), plated on LB agar in the presence of ampicillin and 
chloramphenicol and incubated at 30°C for 36-48 hours. Colonies were picked, 
inoculated in LB containing ampicillin and grown at 30°C until reaching an OD(600) 
of 0.2. Cells were then transferred at 40°C for 20 min and grown overnight at 37°C 
to cause loss of the p705FLP plasmid. Plasmid DNA prepared from overnight 
cultures was transformed into DH5 and cells plated on LB agar in the presence of 
ampicillin. This procedure allowed the separation of recombined and unrecombined 
DNA molecules concomitantly present in the E.Coli population. After overnight 
incubation at 37°C colonies were picked, inoculated in LB in ampicillin selection 
and grown overnight at 37°C. Plasmid DNA was prepared and successful excision of 
the EM7-kanamycin resistance gene cassette assessed by restriction digestion.  
     
2.2.8:    ES cell genomic DNA isolation 
 
ES cells were grown in gelatinised 25cm
2
 flasks (IWAKI cat. 3100-025) until 
reaching 70-80% confluence. Cells were collected by trypsinisation, washed once in 
PBS and centrifuged (290g, 3 min). Genomic DNA was prepared from cell pellets 
using the DNeasy kit (Qiagen cat. 69504) following the manufacturers instructions 
and performing the elution step twice with 100ul of nuclease free water pre-warmed 
at 42C. Quantity and purity (A260/A280 and A260/A230) of the DNA were determined 





2.2.9:    Southern Blot analysis  
 
4g of genomic DNA were digested overnight with the indicated restriction 
endonucleases. Digested DNA was separated by electrophoresis on a 0.8% w/v 
agarose gel and the gel incubated for 30 min in a water solution of 1g/ml ethidium 
bromide. After crosslinking for 2 min by exposure to 254 nm wavelength UV, the gel 
was incubated twice for 15 min in a 0.5M NaOH, 1M NaCl solution and washed in a 
0.5M Tris, 3M NaCl pH 7.4 solution. DNA was wet transferred to a Hybond XL 
membrane (General Healthcare cat. RPN303-S) soaked in 2X SSC (20X SSC: 3M 
NaCl, 0.3M Tri-sodium Citrate) by capillarity driven flow of a 20X SSC solution. 
The membrane was washed in 2X SSC, dried and baked for 2 hours at 80°C. The 
membrane was blocked with PerfectHyb solution (Sigma cat. H7033) containing 
100g/ml salmon sperm DNA (Sigma cat. D7656) at 68°C in a roller bottle. 25ng of 
probe DNA were labeled with P
32
 -dCTP using a Rediprime II Random Prime 
Labeling Kit (Amersham cat. RPN1633) and cleaned on column. The membrane was 
hybridised with the labelled probe overnight at 68°C, rinsed, and washed twice in 0.5 
SSC 0.1%SDS for 90 and 30 min respectively at 68°C. The membrane was exposed 
to Hyperfilm (Amersham cat. 28906837) at -80C for 1-7 days depending on the 
signal intensity.       
 
2.2.10:    Detection of Esrrb exon 2 excision by quantitative PCR on 
genomic DNA 
 




 cells was isolated using DNeasy minikits 
(Qiagen cat. 69504) as described (Chapter 2.2.8). Real-time RT–PCR reactions were 
performed in triplicate in 384-wells plates with a 480 LightCycler (Roche) using the 
LightCycler 480 Probes Master mix (Roche cat. 04707494001). 100ng of genomic 
DNA diluted in 5l of water were used per reaction. For each sample two sets of 
reactions using primers and Universal Probe Library (UPL) (Roche cat. 
04683641001) probes binding to Esrrb exon2 or exon 6 were performed. For each 




to correct for errors in the quantity of genomic DNA used per reaction. Exon 2/exon 
6 ratios are shown relative to untreated Esrrb
f/fn
 cells. Standard curves of all primers 
were performed to check for efficient amplification (above 85%). PCR primer 
sequences are listed in Table 2.1 
2.2.11:    Genotyping of animals by PCR analysis of DNA from ear 
biopsies 
 
Mice biopsies were incubated overnight at 56°C in 50 l of a 0.45% Tween 20, 
0.45% NP40, Qiagen Taq Buffer (Qiagen cat. 201207), 0.1 mg/ml proteinase K 
(Sigma cat. P5568-1ML) solution in water. Samples were spun down and incubated 
at 95°C for 10-20 min, vortexed and spun down at full speed in a benchtop centrifuge 
for 1 min. 5l of supernatant were transferred to a PCR tube. 25 l of PCR mix 
containing 1U of Taq polymerase enzyme (Qiagen cat. 201207), dNTPs mixture at a 
final concentration of 200 nM (Invitrogen cat. 10297-018), synthetic DNA 
oligonucleotides at a final concentration of 300nM  (Integrated DNA Technologies), 
and Qiagen Taq Buffer (Qiagen cat. 201207) in water were added to each PCR tube. 
Reactions were performed in a DNA Engine termal cycler (Biorad). PCR primer 
sequences are listed in Table 2.1. 
      
2.3:    Gene expression quantification 
 
2.3.1:   RNA isolation and quantitative real-time RT-PCR 
 
Total RNA from cultured cells was isolated using the RNeasy microkit or minikit 
(Qiagen cat. 74004, 74104), and performing on-column digestion with DNase I 
(Qiagen cat. 79254). Reverse transcription reactions were performed on 30ng-2g of 
total RNA in a final volume of 20µL with 100U of SuperScriptIII (Invitrogen cat. 
18080-093), 200ng random hexamers (Invitrogen cat. N8080127) or 250ng of 















TBP ggggagctgtgatgtgaagt ccaggaaataattctggctca 
28S rRNA gaaggcaagatgggtcaca gaacttccgtgggtgactcc 
Oct4 gttggagaaggtggaaccaa ctccttctgcagggctttc 
Sox2 gtgtttgcaaaaagggaaaagt tctttctcccagccctagtct 
Nanog cctccagcagatgcaagaa gcttgcacttcatcctttgg 
Klf4 cgggaagggagaagacact gagttcctcacgccaacg 
Esrrb cgattcatgaaatgcctcaa cctcctcgaactcggtca 
Gli2 tgaaggattcctgctcgtg gaagttttccaggacagaacca 
Foxd3 ccccaacactgaccaacag gtttgctccgccagctta 
Inhbb cgagatcatcagctttgcag ggttgccttcattagagacga 
Inhbb 3’UTR ggaaagaaaaatgttgcaatcg gccctcccctctaagcataa 
Nfib gggactaagcccaagagacc tgggtgtcctatttgacacttg 
Foxn4 agcatcatggacttcgctct ggctgaagctgtcctcctt 
Pgc tgaacttctgcagaccatagga ctgtcgcagctcacaaaatact 
Sorl1 cgcggtgtctctttggtag accacagctgcaacatcagt 
Tet2 gaagagtgcggaaagaatgg agactggatgaaacgcaggt 
Manaba gtggtctccttttacttttcaactg tgcccttctgagagatgttga 
Zic2 caagatccacaaaagaactcataca tcttcctgtcgctgctgtt 
Dax1 accgtgctctttaacccaga ccggatgtgctcagtaagg 
Igf2bp2 gggaaaatcatggaagttgacta cgggatgttccgaatctg 
Tfp1 taacatcgtggttccccagt tctgctggttgaagacacca 
Utf1 gtccctctccgcgttagc ggggcaggttcgtcattt 
Nr5a2 gcatttgggcttttatgcaa gcttcatttggtcatcaacct 
Jarid1b gactgggttcaggatgtgga tgtctctaacactggcacacg 
Rcor2 cagagcatgaagcagaccaat agcgggagttgaacttggta 
Mov10 ggaccctgtggaccagaa ctctctgcgacaccaggaa 
Xbp1 tgacgaggttccagaggtg tgcagaggtgcacatagtctg 
Hhip gtgttcggagatcgcaatg ttttcttgccattgcttggt 
Ncoa1 agcaaggaacaatgggaaac ttgtacactcctggctgtgc 
Itga9 catgctactgaacacagagatactga cgagccatgaactggatga 
Sfrp1 atgtgctccagaagcagacc gtcagagcagccaacatgc 
Tcf4 catatttgtggccattgaagg gtccctaaggcagccattc 
c-kit tttcctctgggagctcttctc gaagccttccttgatcatctt 
A2m gaccttgttgttgacaaggactta acctcattggatgaagactgtg 
Moyf acctctctaaaattgctgcctct cagctcccgaggatgaga 
CD38 aagatgttcaccctggagga actccaatgtgggcaagaga 











ID2 gacagaaccaggcgtcca agctcagaagggaattcagatg 
Klf6 tcccacttgaaagcacatca acttcttgcaaaacgccact 
Aff3 taacctggccaaggaaaaca gtgacaggtcccatgagca 
Dnmt3b atgatcgatgccatcaaggt gggaagccgaagatcctg 
Dnmt3a aacggaaacgggatgagtg actgcaattaccttggctttct 
Sox17 ttcctatttccccaagaggtc gcttctctgccaaggtcaac 
Hes6 acggatcaacgagagtcttca ttctctagcttggcctgcac 
GFP aagttcatctgcaccacc tccttgaagaagatggtggg 
Esrrb pre-mRNA 1  gctaacccaccaggcttct  taagggaactgaggcagcac 
Esrrb pre-mRNA 2 ggatcagattcctgcctgtg tggagctgctcttcagacct 
Esrrb pre-mRNA 3 tgaatgtgtgtgatgctcttgt gcccaacacctggaaactaa 
Rex1  cgctgtgggcattaggtaag gcacactcactctattgagagaagaa 
Stella gatgcacaacgatccagattt tggaaattagaacgtacatactccaa 
T/Bra cagcccacctactggctcta gagcctggggtgatggta 
Foxa2 gagcagcaacatcaccacag cgtaggccttgaggtccat 
Gata6 ggtctctacagcaagatgaatgg tggcacaggacagtccaag 
Lefty1 actcagtatgtggccctgcta aacctgcctgccacctct 
Fgf5 aaaacctggtgcaccctaga catcacattcccgaattaagc 
TdTomato tgttcctgtacggcatggac ggattctcctcgacgtcacc 
Olig2 agaccgagccaacaccag aagctctcgaatgatccttcttt 
 








Exon 1a- Exon 2 gctggaacacctgagggtaa tgaaggagccgcaactagag 
Exon 1b- Exon 2 ctgatggacgtgtccgaact tgaaggagccgcaactagag 
5’ UTR - Exon 2 actcccgcgttctgtgttc tgaaggagccgcaactagag 
Exon 2 - Exon 3 ggcgttcttcaagagaacca ctccgtttggtgatctcacat 
Exon 3 - Exon 4 cgattcatgaaatgcctcaa cctcctcgaactcggtca 
Exon 4 - Exon 5 gaacagcccctacctgaacc tgggaggcatagcatacagc 
Exon 5 - Exon 6 atcaaggccctgaccactct tcatctggtccccaagtgtc 
Exon 6 - Exon 7 ggtgcgcaggtacaagaaac cgcctccaggttctcaatgt 
Exon 6 – alt. 3’UTR ggtgcgcaggtacaagaaac ctcccacagaacccctgaag 
Exon 2 – Intron 2  ggcgttcttcaagagaacca aacccaactagacctgtagaccaa 
Exon 3 – Intron 3 cgattcatgaaatgcctcaa caccaagacaaaccaagtgga 
Exon 5 – Intron 5 atcaaggccctgaccactct ttagcactcttgccctgacc 





















Esrrb 5’ ccctatgtcatcacgccttt cagttgaaaatggggacctg 
Promoter 1(RNAPolII) tagaactgactcccgcgttc atgaaggagccgcaactaga 
Promoter 2 (RNAPolII) ctgctgaaccgaatgtcgt gtggctgagggcatcaat 
Promoter 3 (Nanog) agggtcacatgctgatagcc ctccactcacctgcacagag 
Enhancer cggctggtatcacctgattt gctttgtcctctttgccaat 
Esrrb 3’ actcctccccttacccctgt ggctgtggtcactgcatcta 
 







Esrrb Exon 2 - Intron 2 ggcgttcttcaagagaacca aacccaactagacctgtagaccaa 
Esrrb Exon 6 - Intron 6 ggtgcgcaggtacaagaaac ctcccacagaacccctgaag 
Esrrb Exon 7 - 3’ UTR gtgcccatgcacaaactctt tctccacttggatcgtgtcc 
TdTomato  tgttcctgtacggcatggac ggattctcctcgacgtcacc 
 







Endogenous Nanog cggctcacttccttctgact cgagggaagggatttctga 
Endogenous Esrrb actcccgcgttctgtgttc tgaaggagccgcaactagag 
 


















NSN-iNanog and  








Endogenous Nanog cggctcacttccttctgact cgagggaagggatttctga 
Endogenous Esrrb actcccgcgttctgtgttc tgaaggagccgcaactagag 
Endogenous Oct4 ttccaccaggccccc ggtgagaaggcgaagtctgaag 
Viral Oct4 tcccagtgtggtggtacggg ggtgagaaggcgaagtctgaag 
Viral Klf4 tcccagtgtggtggtacggg gagcagagcgtcgctgacag 




Real-time RT–PCR reactions were performed in triplicate in 384-wells plates with a 
480 LightCycler (Roche) using LightCycler 480 SYBR Green I Master (Roche cat. 
04707516001). Five microliters of cDNA or immunoprecipitated chromatin were 
used per reaction. Standard curves of all primers were performed to check for 
efficient amplification (above 85%), and all melting curves were generated to verify 
production of single DNA species with each primer pair. PCR primer sequences are 
listed in Table 2.1. Values for each gene were normalised to expression of TATAbox 
Binding Protein (TBP) or 28S rRNA (For flavopiridol treatment experiments). 
 




 ESN-NERTc3 cells were plated in separate 25cm
2
 flasks (IWAKI cat. 
3100-025) one day before stimulation. Cells were incubated in GMEM/FCS/LIF 
containing 1M Tamoxifen for the indicated time and harvested by trypsinisation. 
RNA was prepared using a RNeasy minikit (Qiagen cat. 74104). 100ng of RNA were 
reverse transcribed into double stranded cDNA and transcribed/amplified into biotin 
labelled cRNA using an Illumina TotalPrep RNA Amplification Kit (Ambion cat. 
AMIL1791). Labelled RNA was submitted to the WTCRF MRC Human Genetics 
Unit (University of Edinburgh) for further processing. cRNA quality was checked 
using a Agilent 2100 Bioanalyser and  hybridization performed on an MouseWG-6 
v2 BeadChip (Illumina cat. BD-201-0202). Raw data was processed in R using the 
beadarray (Dunning et al., 2007) and limma (Smyth, 2005) packages from the 
Bioconductor suite (Gentleman et al., 2004) Briefly, low-quality probes were 
removed from the input data and sample-effects normalized by centring individual 
replicate groups around the 0-hour baseline. The data was subsequently quantile-
normalized and log2-transformed before assessing differential expression with the 
limma algorithms. Genes were considered differentially expressed if they showed a 
FDR-adjusted p-value of at most 0.05 and a fold change of 1.5 or more for at least 





2.3.3:    DeepSAGE Library Preparing and Sequencing 
 
RNA was submitted for sample preparation and sequencing following the 
manufacturer's protocol for tag profiling using the NlaIII restriction enzyme at the 
GenePool core facilities of the University of Edinburgh. The RCN(t) (1 library) and 
RCNβH(t) (2 libraries) samples were sequenced on a first generation Illumina/Solexa 
Genome Analyzer and the sorted TNG samples were sequenced at a later time point 
on a Illumina GAII.  
 
2.3.4:    Short Read Data Processing 
 
Data analysis of short read sequencing libraries was performed using GeneProf 
(Halbritter et al., 2012). Briefly, reads were trimmed to the significant 17nt portion 
corresponding to the tag sequence and extended by the known recognition sequence 
of the NlaIII digestion enzyme (CATG). The libraries were then filtered removing 
low-quality reads and aligned to the Mouse reference genome (NCBIM37 assembly) 
using the Bowtie alignment tool (Langmead et al., 2009). Aligned reads were 
compared to known gene models (GeneProf reference dataset based on the Ensembl 
58 database (Flicek et al., 2011)) to calculate read counts per gene, which were then 
quantile-normalized. We considered as differentially expressed those genes that 
exhibited a 1.5-fold change between groups and had a minimum (normalized) 
expression level of at least 10 in at least one sample.  
 
2.3.5:    Nanog Target Prioritization 
 
We sought to identify likely Nanog candidate genes from the DeepSAGE data by 
defining an ad hoc ranking criterion called the Nanog Candidate Priority Factor 
(NCPF). Given Ex(g) as the normalized expression intensity of gene g in sample x 
and 
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2
21 gavgEgfc+gfcsgngfc+gfc=gNCPF   
 
2.4:    Chromatin immunoprecipitation 
 




 NERT ES cells were resuspended in 3ml of pre-warmed GMEM/FCS/LIF 
and cross-linked for 10 min at RT with 1% formaldehyde (Sigma cat. F8775-25ML). 
The cross-linking reaction was stopped by adding 0.125mM glycine for 5 min at RT. 
Cells were pelleted (3 min, 300rpm, 4°C) and washed twice with cold PBS. Cell 
pellets were vigorously resuspended in 300µl of swelling buffer (5mM Pipes pH8, 
85mM KCl) freshly supplemented with 1X protease inhibitor cocktail (Roche cat. 04 
693 116 001) and 0.5% NP-40. After 20 min on ice with occasional shaking, nuclei 
were centrifuged (1500rpm, 10 min, 4°C) in 15ml conical tubes and resuspended in 
1.5ml of TSE150 (0.1% SDS, 1% Triton, 2mM EDTA, 20mM Tris-HCl pH8, 
150mM NaCl) buffer, freshly supplemented with 1X protease inhibitor cocktail. 
Samples were sonicated at 4°C in 15ml conical tubes using a Bioruptor (Diagenode) 
for 5 cycles of 10 min divided into 30 sec ON-30 sec OFF subcycles at maximum 
power. The chromatin was then transferred into 1.5ml tubes and microcentrifuged 
(30 min, 14000rpm, 4°C). Soluble chromatin was divided into 250ul aliquots and 
stored at -80°C until use. Twenty microlitres were set apart and used to quantify the 








2.4.2:    Chromatin ImmunoPrecipitation (ChIP) 
 
For each experiment, the required amount of chromatin was thawed and pre-cleared 
for 90 min rotating on-wheel at 4°C in 1 ml of TSE150 containing 50µl of pA/pG 
sepharose beads (Sigma cat. P9424-5ML, P3296-5ML) 50% slurry, previously 
blocked with 500µg/ml of molecular grade BSA (Roche, cat. 5931665103) and 
1µg/ml of yeast tRNA (Invitrogen, cat. AM7119). Pre-cleared chromatin was 
centrifuged (3000rpm, 1 min) in a benchtop microcentrifuge and the supernatant 
transferred into fresh tubes so that 20µg of DNA were used per ChIP. In addition, 
20ug of diluted chromatin was set apart for input DNA extraction and precipitation. 
Immunoprecipitation with in-house made anti-Nanog rabbit polyclonal (2 g /ml) of 
or anti-RNAPII (Euromedex cat. PB-7C2) (2 g /ml) antibodies was performed 
overnight rotating on-wheel at 4°C in a final volume of 500µl of TSE150. 
Immunocomplexes were recovered with 50µl of blocked pA/pG sepharose beads 
50% slurry for 1h and 30 min rotating on wheel at 4°C. Beads were recovered by 
centrifugation for 1 minute at 3000rpm and washed 5 min rotating on-wheel at RT 
with 1ml of buffer in the following order: TSE150, TSE500 (0.1% SDS, 1% Triton, 
2mM EDTA, 20mM Tris-HCl pH8, 500mM NaCl), washing buffer (10mM Tris-HCl 
pH8, 0.25M LiCl, 0.5% NP40, 0.5% Na-Deoxycholate, 1mM EDTA), and twice in 
TE (10mM Tris-HCl pH8, 1mM EDTA). After the last wash, elution was performed 
in 100µl of elution buffer (1% SDS, 10mM EDTA, 50mM Tris-HCl pH8) for 15 min 
at 65°C after vigorous vortexing. Eluates were collected after 1 minute centrifugation 
at 14000rpm in a benchtop microcentrifuge, and the beads rinsed in 150µl of TE-
SDS1%. After 1 minute centrifugation at 14000rpm, the supernatant was pooled with 
the corresponding first eluate. For both immunoprecipitated and input chromatin 
samples, the crosslinking was reversed by incubation overnight at 65°C, followed by 
proteinase K treatment (Invitrogen cat. AM2546), phenol/chlorophorm extraction 
and ethanol precipitation. DNA pellets were resuspended in 200µl of water. Real-
time quantitative PCR reactions were performed as described. PCR primer sequences 





2.5:    Kidney capsule grafts, recovery and processing 
 
Engraftments were performed as described elsewhere (Tam, 1990). 4 weeks after the 
graft was performed, the mice were sacrificed and the kidneys removed in PBS. 
After imaging, the tumour and kidney were fixed in 4% paraformaldehyde (PFA) 
between 1-7 days depending on tumour size. After fixation, the kidneys were 
dehydrated through ethanol series (80% EtOH, 2 hours, 4°C; 90% EtOH, 2 hours, 
4°C; 96% EtOH, 2 hours, 4°C; 100% EtOH, 2 hours, 4°C), cleared in xylene (15-60 
min, 4°C) and embedded in paraffin wax (3x changes: overnight, 2 hours, 2 hours)  
before being sectioned in a microtome. 
 
2.6:    Immunohistochemistry 
 
2.6.1:    Immunostaining on cultured ES cells 
 
Cultured cells were fixed in 4% PFA for 10 min at RT. Permeabilisation was done 
with a solution of 0.1% v/v TritonX100 in PBS (permeabilisation buffer) for 15 min 
at RT. Blocking was performed for 30 min at RT in permeabilisation buffer 
supplemented with 3% serum of the same species the secondary antibodies were 
raised in (blocking buffer). Primary antibodies were diluted in blocking buffer to the 
working concentrations indicated below and applied for 1-2 hours at RT or overnight 
at 4 °C. After three washes in permeabilisation buffer, secondary antibodies were 
diluted to 2μg/ml in blocking buffer and applied for 1 hour at RT. The cells were 
washed at least three times in permeabilisation buffer and in selected cases nuclei 
were stained with 4',6-diamidino-2-phenylindole (DAPI). 
Primary antibodies were used at the following concentrations: Nanog (Abcam, cat. 
ab14959), 2.5ug/ml; in-house made anti-Nanog rabbit polyclonal, 1.2-0.25 g/ml 
(Chambers et al., 2007); Oct4 (Santa Cruz Biotechnology, cat. sc-5279), 1 μg/ml; 
Sox2 (Santa Cruz Biotechnology, cat. sc 17320), 1μg/ml; Esrrb (Persaeus 





2.6.2:    Whole-mount immunostaining of mouse gonads  
 
Gonads were isolated from dissected day E12.5 or E13.5 embryos and briefly 
washed in PBS containing 3mg/ml polyvinylpyrrolidone (PBS/PVP) before fixation 
in a solution of 2.5% paraformaldehyde (PFA) in PBS for 20 min at RT. Fixed 
gonads were permeabilised for 45 min at RT in 0.3% Triton X-100 PBS/PVP, 
blocked for 2 hours at RT in a solution of 0.1%BSA, 0.01% Tween 20, 10% goat 
serum in PBS (blocking buffer). Gonads were then incubated overnight at 4°C with 
anti-Oct4 C10 monoclonal antibody (Santa Cruz Biotechnology, cat. sc-5279) and 
rabbit anti mouse Vasa homolog (mvh) (Abcam, cat. Ab13840) diluted 1:200 in 
blocking buffer, rinsed three times for 15 min in blocking buffer and incubated (2 
hours, RT) with goat anti-mouse IgG (H+L) Alexa fluor-568 (Invitrogen, Molecular 
Probes cat. A-11004) and donkey anti-rabbit IgG (H+L) Alexa fluor-405 (Invitrogen, 
Molecular Probes cat. A-31556) antibodies diluted 1:500 in blocking buffer. After 
washing three times for 15 min in blocking buffer, gonads were mounted on glass 
microscope slides in Vectshiled (Vector Labs cat. H-1000) without DAPI and 
imaged using a Leica DM IRE2 inverted confocal microscope (Leica Microsystems).     
 
2.7:    Immunoblotting 
 
ESN-NERT induction: 1.3 x 10
6
 ESN-NERT cells were plated in separate 25cm
2
 
flasks (IWAKI cat. 3100-025) two days before lysis. One day before lysis cell were 
stimulated with or without 1M tamoxifen. Protein Stability Assays: 10
6
 E14Tg2a 
ES cells were plated in individual wells of a 6-wells plate and 24h later treated with 
30mg/ml Cycloheximide for 1 to 6h. For all experiments: Cell were lysed in 300 l 
of a 0.5% NP-40, 50mM Tris pH 8,150mM NaCl solution with protease inhibitors 
(Roche cat. 04 693 116 001). Protein extract treated with 2 l DNA nuclease 
Benzonase (Novagen, cat. 70664-3) 1 h at 4°C. 50 g of protein were denatured in 
Laemmli buffer at 100°C for 5 min and fractionated on a NuPage-Novex 10% Bis-
Tris gels (Invitrogen, cat. NP0302). Proteins were electro-blotted to a nitrocellulose 




was blocked in PBS 0.01% Tween (PBST), 10% non-fat dry milk for 2 h and 
incubated in 5ml of PBST 5% milk  containing anti Esrrb (Persaeus Proteomics cat. 
PP-H6707-00)(1 g/ml) or anti-Nanog rabbit polyclonal (Chambers, 2005) (2.4 g 
/ml) antibodies or anti HDAC-2 (Upstate cat. 05-814)(1 g /ml) (overnight, 4°C or 
2h, RT). Membranes were washed 3 times for 20 min in PBST and incubated with 
ECL anti-mouse IgG (Amersham cat. NA931) or ECL anti-rabbit IgG (Amersham 
cat. NA934) HRP conjugated secondary antibodies. Membranes were washed in 
PBST and developed using a Super-signal West Pico kit (Pierce cat. 34080) for 5 
min at RT and exposed to Hyperfilm (Amersham cat. 28906837). 
 
2.8:    Imaging 
 
Images were captured using Volocity (Improvision) software in an Olympus IX51 
(for cultured cells), or an Olympus BX61 (for teratocarcinoma sections). Image 
processing was performed using Adobe Photoshop software. ESN-NERT cells 
stained for Nanog were imaged using a Leica DM IRE2 inverted confocal 
microscope (Leica Microsystems). 
 
 
2.9:    Cell line derivation 
 
2.9.1:    Doxycycline inducible expression  
 
E14Tg2a or TC44Cre6 cells were stably transfected with linearised pPyCAG-rtTA-
IRES-BSD
R
 plasmid. After 10 days of hygromycin selection newly formed colonies 
were trypsinised and expanded as a mixed population. Cells were then electroporated 
with linear TetO-TdTomato-2a-Hyg
R
-TK plasmid. Clones were screened for high, 
homogeneous TdTomato expression in doxycycline without continued hygromycin 
selection and low levels of TdTomato in the absence of doxycycline.  An identified 











 and 3ug of pPGK-FLPO. Two days after 
lipofection 10
5
 cells were plated in gelatinised T150flasks (IWAKI cat. 3120-150) in 
in GMEM/FCS/LIF containing puromycin. After two weeks colonies were picked 
and separately expanded before freezing. Successful TdTomato excision was 
confirmed by flow cytometry in induced cells.        
 
2.9.2:    Esrrb fluorescent reporter cell lines 
 







presence of blasticidin, and after 2 weeks colonies were picked and expanded. 






vectors to obtain reporter lines harbouring two targeted Esrrb alleles.  








2.9.3:    Derivation of NS cell lines  
 
RCNH(t) NS cells were derived from the RCNH(t) ES cell line by neural 
differentiation in monolayer, as described elsewhere (Pollard et al., 2006). NS cells 
were propagated in NS cell expansion medium in the presence of FGF and EGF 
(Conti et al., 2005). 
 
2.9.4:    Derivation of Esrrb





 ES cells maintained in zeocin to ensure Cre-ER
T2




once in the presence of 1M PD 0325901 (Axon Medchem, cat. 1408). Cells were 
replated at clonal density in 10 cm diameter dishes and after 16 hours 1 M 
tamoxifen (Sigma, cat. H7904-5MG) was added for 1 hour. Plates were then washed 
with PBS and cells cultured for additional 2 weeks in GMEM/FCS/LIF 
supplemented with 1M PD 0325901. Morphologically distinguishable Esrrb

 
colonies were picked and expanded in the presence of PD 0325901. After expansion, 
Esrrb

 cells were further cultured in GMEM/FCS/LIF.       
 
2.10:    Flow cytometry 
 




 cells were plated in 150 cm
2
 flasks (IWAKI cat. 3120-150) and cultured in 
the absence of any selection for 3 days. Cells were then harvested by trypsinisation, 
and resuspended at 2 x 10
6
 cells/ml in a solution of 10%FCS in PBS (PBS/FCS) 
containing anti SSEA-1 mouse monoclonal antibody from ascitic fluids (DSHB cat. 
MC-480) diluted 1:1000. Cells were incubated for 15 min on ice, washed in ice-cold 
PBS, centrifuged (290rpm, 3 min) and resuspended in PBS/FCS containing goat anti-
mouse IgM-Alexa647 secondary antibody (Molecular Probes cat. A-21238). After 15 
min on ice, cells were washed in ice-cold PBS, centrifuged as before and 
resuspended in PBS 10%FCS and analysed using a LSR II flow-cytometer system 
(Becton, Dickinson). 
 
2.10.2:    FACS based cell sorting of fluorescent reporter lines 
 
ES cells plated and stained for SSEA-1 as described (Chapter 2.10.1) were purified 
using a FacsARIA cell sorter (Becton, Dickinson). After sorting, cell purity was 
determined using the same instrument. For timecourse culture experiments on sorted 
populations, cell purity was confirmed with LSR II Fortessa flow-cytometer system 




of 24 well plates and cultured for the indicated time. Cells were harvested every day, 









 TNG Esrrb-TdTomato cells were trypsinised and 
replated at day 1, 2 and 3 for analysis at day 4, 5 and 6 respectively to prevent 
overgrowth. Data was analysed using the FlowJo software suite (Tree Star). For 
clonal density plating 600 sorted cells were replated in duplicate in 6 well plates. 
Cells were cultured in the indicated conditions for six days prior to colony scoring. 
For cultures in N2B27/2i/LIF, cells were replated in 6 well plates coated overnight 
with Poly-L-ornithine 0.01% (Sigma cat. P4957), washed and coated 2 hours with 
laminin (Millipore, cat. CC095) 5 g/ml in PBS.  
 




 cells were resuspended and fixed in 2 ml of 0.25% PFA/PBS (1h, RT) on a tube 
roller. After 1 wash in PBS (5ml), cells were resuspended in 2 ml of 70% v/v 
methanol/PBS pre-cooled to 4°C and incubated for 1 hour at 4°C on a rotating wheel. 
After centrifugation, cells were resuspended in 1ml of PBS containing 5% donkey 
serum. 100µl (10
5
 cells) of cell suspension were transferred into single wells of a 96 
well/V-bottom microtitre plate. Cells were centrifuged (450g, 3 min) and 
resuspended in 100l of staining buffer (1% BSA, 3mg/ml PVP, 0.1% TritonX-100, 
and 10% donkey serum in PBS) pre-cooled to 4°C. After incubating (30 min, RT) 
cells were centrifuged and resuspended in 100µl of pre-cooled staining buffer 
containing goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, cat. SC-8628) and 
mouse monoclonal anti-Klf4 (Abcam, cat. Ab75486) antibodies at final 
concentrations of 1.25µg/ml and 10µg/ml, respectively. Plates were incubated 
overnight at 4°C and then washed (3x, 20 min, 4°C) in 200µl of pre-cooled staining 
buffer. After centrifugation, cells were resuspended in 100µl of pre-cooled staining 
buffer containing donkey anti-mouse IgG (H+L) Alexa fluor-647 (Invitrogen, 
Molecular Probes cat. A-31571) and donkey anti-goat IgG (H+L) Alexa fluor-568 
(Invitrogen, Molecular Probes cat. A-11057) antibodies at a final concentration of 
4µg/ml. Cells were incubated (2 hours, RT) in the dark and washed (3x, 20 min, 4°C) 




of PBS containing 5% donkey serum and analysed using a LSR II Fortessa flow-
cytometer system (Becton, Dickinson).  Data was analysed using the FlowJo 
software suite (Tree Star). To set the appropriate gates for Klf4, Oct4 and 
Nanog:GFP negative cells, RA-differentiated E14Tg2a cells were stained in parallel. 
For all analyses of Klf4 and Nanog:GFP heterogeneity in E14Tg2a ES cells, only 
Oct4
+
 cells representing the undifferentiated population were taken into account. 
 
2.11:    Flavopiridol treatment 
 
For analysis of transcriptional speed, 1.6 x 10
6
 EF4 ES cells were plated in separate 
10 cm
2
 dishes (BD-Falcon, cat. 35-3001) on the day before analysis. Cells were 
treated for 3 hours with 1µM Flavopiridol (Sigma cat. F3055-1MG) in 
GMEM/FCS/LIF. Cells treated for 3 hours with equivalent amounts of DMSO were 
used as controls. Cells were quickly washed in warm PBS and cultured for the 
indicated time in medium without flavopiridol before transfer to ice, washing with 
ice-cold PBS, and direct lysis on plate with RLT (Qiagen cat. 74104) buffer, 
followed by RNA purification using a RNeasy minikit (Qiagen cat. 74104). cDNA 
was prepared as described using 2ug RNA per sample and qPCR reactions performed 
as described above using primers listed in Table 2.1.  
 
2.12:    PEG mediated ES x NS cell fusion experiments 
 
For all fusions,  4x10
6
 ES cells were fused to 4x10
6
 NS cells as previously described 
(Silva et al., 2006) and plated in GMEM/FCS/LIF. For fusions of E14/T NS cells to 
E14Tg2a, EF4 or EfEsrrb ES cells, puromycin and G418 selections were applied one 
day after fusion and cell hybrids cultured for 14 days prior to colony scoring. For 
fusions of RCNH(t) NS cells to Tc44c6 or ESN-CAGE ES cells, puromycin and 
hygromycin selection were applied one day and four days after fusion respectively. 
Cell hybrids were cultured for 14 days prior to colony scoring. For fusions of 
RCNH(t) Red NS cells to ESN-iNanog or ESN-iEsrrb ES cells, blasticidin and 




cultured for additional 15 days prior to colony scoring. Doxycycline was added only 
to the required plates and kept for the duration of the experiment. For plating of 
sorted hybrids from fusions of RCNH(t) Red NS cells to ESN-iNanog Blue or 
ESN-iEsrrb Blue ES cells 48 h after fusion, cells were trypsinised and stained with 
7-AAD (Molecular Probes cat. A1310). 7-AAD negative hybrids (live cells) were 
purified based on the concomitant expression of EBFP and TdTomato using a FACS-
ARIA cell sorter (Becton, Dickinson). After sorting, cell purity was determined using 
the same FACS-ARIA cell sorter or a LSRII Fortessa flow-cytometer (Becton, 
Dickinson) and data analysed using the FlowJo software suite (Tree Star). Purified 
hybrids were replated in GMEM/FCS/LIF. Blasticidin and hygromycin selections 
were applied one day after sorting and cell hybrids were cultured for additional 15 
days prior to colony scoring. Doxycycline was added to the culture medium for the 
duration of the experiment. 
 
2.13:    NS cells retroviral transduction for generation of pre-iPS 
cells 
 
For virus preparation, 10
6
 Plat-E cells were seeded into 10mm diameter dishes in 
GMEM/FCS/LIF without LIF on the day before transfection. Separate dishes of 
Plat-E cells were transfected with 3 g of either pmX-Oct4, pmX-Klf4, pmX-cMyc 
or pmX-dsRed (Takahashi and Yamanaka, 2006) using 27l of Fugene6 (Promega 
cat. E2693). 24 hours after transfection, medium was replaced and supernatant 
collected after additional 24 hours. Freshly harvested supernatants were filtered 
through a 0.45 m cellulose acetate filter, pooled and supplemented with 4 g/ml 
polybrene (Sigma cat. 107689). 2ml of pooled viral supernatants were added to NS 
cells replated at a density of 10
5
 cells per 10cm
2
 dish the previous day. 24 hours after 
infection viral supernatants were removed and NS cell cultured for 2 additional days 
in NS cell expansion medium. Infected NS cells were then transferred to 
GMEM/FCS/LIF. When pre-iPS colonies started emerging, cells were replated on 










 pre-iPS cells were plated on STO feeders in 10cm
2
 dishes and cultured in 
GMEM/FCS/LIF in the presence or absence of 1 g/ml doxycycline. After 2 days 
(timecourse day 0) cells were transferred to GMEM/FCS/LIF containing either 
1g/ml doxycycline, 3M 5-azacytidine, 1g/ml doxycycline plus 3M 5-
azacytidine or no drugs. Pre-iPS cells were collected every day for 6 days using 
trypsin and replated in ungelatinised 10mm diameter dishes to allow STO feeders 
attachment. After 1 hour unattached cells were collected and DsRed and GFP 
expression quantified by flow cytometry. DAPI staining was used to exclude dead 





Chapter 3: Identification of Nanog transcriptional targets 
 
In ES cells, Nanog expression levels correlate with self-renewal efficiency 
(Chambers et al., 2003; Chambers et al., 2007). These functional differences among 
single ES cells are likely the consequence of differential expression of Nanog target 
genes. Such genes were therefore identified using a combination of different 
transcriptional profiling strategies and their contribution to Nanog function was 
investigated.  
 
3.1:    Gene expression profiling of a series of Nanog mutant ES cell 
lines 
 
Recent publications identified a list of potential Nanog target genes analysing the 
genome-wide transcriptional alterations that occur in ES cells after Nanog is 
downregulated by RNA interference (Ivanova et al., 2006; Loh et al., 2006). Despite 
providing useful indications, studies based on gene knockdown present a number of 
limitations. In all these studies RNA interference led to the presence of a significant 
proportion of differentiated cells in the populations analysed. It is therefore difficult 
to distinguish whether the observed transcriptional alterations are due to variation in 
Nanog levels or are a consequence of cellular differentiation. In addition, cellular 
stress and perturbation of the RNA degradation machinery is likely to impact on the 
observed expression profiles. Similarly, these results do not provide solid ground to 
investigate the transcriptional differences resulting from the dynamic fluctuations in 
Nanog expression continuously occurring in ES cells.  
 
To overcome these limitations, this study compared the transcriptional profiles of ES 
cells expressing unaltered levels of Nanog with profiles generated from Nanog null 
ES cells. (Respectively RCN(t) and RCNH(t) ES cell lines (Chambers et al., 2003; 
Chambers et al., 2007)). In addition, a reporter line, in which a GFP cassette has been 




sorted ES cells populations showing high or low levels of Nanog transcription (TNG 
(Chambers et al., 2007)). By analysing this dataset, it was possible to identify a list of 
genes the transcript levels of which correlate with Nanog expression in ES cells 
(Table 3.1). Imposing a 1.5 fold change threshold, differentially expressed genes 
could be divided in four different groups:  
 
A) 661 genes that that show higher expression in RCN(t) compared to RCNH(t) and 
in TNG
high
 compared to TNG
low
 sorted populations.  
 
B)  1002 genes that that show reduced expression in RCN(t) compared to RCNH(t) 
and in TNG
high
 compared to TNG
low
 sorted populations.  
  
C) 1948 genes that show higher expression in the TNG
high
 compared to TNG
low
 
populations but no correlation with Nanog levels in other cell lines.  
 
D) 1839 genes that show reduced expression in the TNG
high
 compared to the TNG
low
 
populations but no correlation with Nanog levels in other cell lines.  
 
Genes belonging to group A and B should be respectively induced and repressed by 
Nanog. Genes included in group C and D should be enriched for positive and 
negative regulators of Nanog expression. Since the aim of this project is to identify 
genes that are transcriptionally regulated by Nanog, subsequent analysis focussed on 
genes belonging to the first two groups. Differentially expressed genes were ranked 
according to a Nanog correlation coefficient that weighted the combined fold 
changes in transcript levels in both RCN(t) compared to RCNH(t) cells and in 
TNG
high
 compared to TNG
low
 populations against absolute gene expression levels 
(see Chapter 2.3.5). 
 
This approach permitted to exclude from the analysis genes that showed high relative 
fold changes as a consequence of their marginal absolute levels of expression. Of 
500 top ranking upregulated or downregulated genes, Esrrb was the transcription 









(fold change≥1.5, Group A), closely followed by Klf4 (Figure 3.1). Amongst 
downregulated transcription, factors ID1 and ID2 showed the greatest response and 
consistent variations in both datasets. It is interesting to note that these genes have 
been reported to be crucial in regulating ES cell self-renewal, stressing the possibility 
that other less characterised targets identified by this analysis might also be 
important in this process.     
 
The expression level of 69 genes belonging to group A or B was validated by 
quantitative PCR in cDNA samples prepared from two different cell lines 
overexpressing Nanog (RCN, EF4), two ES cell lines with wild-type levels of Nanog 
expression (E14Tg2a, RCN(t)), two cell lines in which one of the two Nanog alleles 
has been deleted by homologous recombination (TC44,RCN(t)) and two Nanog 
null cell lines (TC44c6, RCNH(t)) (Chambers et al., 2003; Chambers et al., 2007). 
Using multiple cell lines should reduce the possibility that the observed variations in 
expression are due to differences between the cell lines other than the levels of 
Nanog. In addition, cells were replated at the same density on the day before RNA 
extraction to minimise the differences resulting from variations in cell-cell 
interactions or in the concentration of factors secreted in the culture medium.  The 
results from three independent experiments are shown in Figure 3.2. 39 out of 69 
genes (57%) analysed showed good accordance with the results from high-
throughput sequencing. 
 
3.2:   Transcriptional dynamics following Nanog nuclear 
relocalisation in ESN-NERT cells  
 
The existence of a direct relation between Nanog transcriptional activity and the 
expression levels of a subset of validated target genes was then assessed. With this 
aim, Nanog was linked to a mutated form of the human estrogen receptor ligand 
binding domain (ER
T2
) generating a tamoxifen responsive Nanog-ER
T2










Figure 3.1: Transcriptional changes in response to variations in Nanog levels 
 
Deep-SAGE profile of sorted Nanog positive (GFP+) and Nanog negative (GFP-) 
TNG cells, ES cells with wild-type levels of Nanog expression (RCN(t)) and Nanog-/- 
ES cells (RCNH(t)). Genes were ranked according to the expression level and fold 
difference in expression in TNG+ versus TNG- and RCN(t) versus RCNH(t); the 
plot shows the first 250 most upregulated (top) or downregulated (bottom) genes. 
Names of the top 5 upregulated (group A) or downregulated (Group B) transcription 
factors are shown on the right. Colours; expression above (yellow) and below 
average (blue).  
 
The raw data used to produce Figure 1 was kindly provided by Violetta Karwacki-
Neisius. All bioinformatic analysis was performed in collaboration with Florian 















Figure 3.2:Validation of Nanog target gene expression in multiple ES cell lines.  
 
Quantitative PCR analysis of gene expression in two cell lines overexpressing 
Nanog (RCN, EF4), two lines with wild-type levels of Nanog expression (E14Tg2a, 
RCN(t)), two cell lines in which one of the two Nanog alleles has been deleted by 
homologous recombination (TC44,RCN(t)) and two Nanog null cell lines 
(TC44c6, RCNH(t)). Expression values, normalised on TBP transcript levels, and 
relative to EF4 are plotted for genes that are positively (A) or negatively (B) 
regulated by Nanog. Error bars: standard deviation of gene expression values 





protein. Fusion to ER
T2
 is a well established system used to modulate subcellular 
protein localisation (Feil et al., 1997). While the fusion protein is confined to the 
cytoplasm in the absence of tamoxifen, addition of the drug results in prompt nuclear 
relocalisation. The Nanog-ER
T2
 expression vector was stably transfected in Nanog 
null TC44c6 ES cells and three clones showing different transgene expression 
levels were selected (ESN-NERT ES cells (NERT))(Figure 3.3A, 3.3B). Nanog 
localisation in the presence or in the absence of tamoxifen was analysed by 
immunohistochemistry and confocal microscopy. Since both Nanog alleles are 
deleted in TC44c6 ES cells, only expression of the fusion protein is detected in 
these cells. Predominant nuclear localisation of the fusion protein was observed as 
soon as 15 minutes after addition of tamoxifen. (Figure 3.3C). 
 
The transcriptional effects of inducing nuclear translocation of Nanog in ESN-
NERT cells were then tested by preparing total RNA and protein lysates from cells 
stimulated for 24 hours with tamoxifen. 7 out of 9 genes analysed showed variations 
in the level of expression in three independent ESN-NERT lines (A2m and Sox17 
did not show notable changes, Figure 3.4).  
 
Next, the dynamic of Nanog transcriptional control over its target genes were 
investigated. With this aim, timecourse experiments were performed in ESN-NERT 
cells using the line that showed the highest target gene induction levels in previous 
experiments (Clone 3, Figure 3.3B). ESN-NERT c3 cells were stimulated with 
tamoxifen over a period of 6 hours and total RNA was prepared at 1 hour intervals. 
The mRNA level of 12 different transcripts was measured over time and compared 
with the basal levels of expression detected in the parental TC44c6 cells. In 
agreement with prior observations, 9 positively regulated genes showed increased 
transcript levels, and one negative target was downregulated, after tamoxifen 
addition (Figure 3.5). Different kinetics of induction were detected among the 
responding genes, ranging from changes in transcript levels one hour after tamoxifen 
stimulation for Klf4,Esrrb or ID1 to a period of 3 hours before detecting induction of 












Figure 3.3: Characterisation of ESN-NERT ES cells. 
 
A: Schematic representation of the genetic manipulations performed on ESN-
NERT ES cells. B: Transcript level of Nanog in ESN-NERT lines cultured in the 
presence (+) or in the absence (-) of tamoxifen for 24 hours. Relative transcript 
levels normalised to TBP expression are presented for three independent clones. 
Error bars: standard deviation of the technical errors in gene expression 
quantification in one experiment. C: Immunohistochemical analysis of the 
intracellular localisation of Nanog in ESN-NERT c3 ES cells treated with 1M 














Figure 3.4: The identified target genes respond to Nanog nuclear localisation 
in ESN-NERT ES cells. 
 
Transcript level of 9 Nanog target genes in ESN-NERT lines cultured in the 
presence or in the absence of tamoxifen for 24 hours. Relative transcript levels 










Figure 3.5: Nanog nuclear localisation induces prompt upregulation of its 
target genes in ESN-NERT c3 cells. 
 
Kinetics of transcript upregulation for 12 Nanog target genes in ESN-NERT c3 cells 
stimulated with tamoxifen for 0, 1, 2, 3, 4, 5 or 6 hours. Relative transcript levels 
normalised on TBP expression. Error bars: standard deviation of gene expression 







reporter allele present in TC44c6 ES cells was detected, validating the observation 
that Nanog represses its own expression (Navarro, 2012). Only one gene, CD38, 
showed an opposite trend compared to the results obtained in previous experiments 
(Figure 3.2), indicating that the levels of expression observed in Nanog mutant lines 
could be consequent to indirect regulation. Interestingly, Sfrp1 was strongly 
upregulated in ESN-NERT cells compared to the parental TC44c6 line even in the 
absence of tamoxifen. This observation suggests that the Nanog-ER
T2
 fusion protein 
must not be completely excluded from the nucleus in untreated cells, that very low 
levels of Nanog activity are sufficient to alter the transcription of some target genes 
and that Sfrp1 is exquisitely sensitive to Nanog.  
 
Genes showing longer response time are less likely to be direct targets of Nanog. In 
an attempt to discriminate more clearly between direct or indirect regulation of gene 
expression, the transcript levels of 12 target genes were measured in ESN-NERT 
cells stimulated with tamoxifen in the presence or in the absence of cycloheximide. 
Inhibition of protein synthesis should exclude the possibility that the observed 
transcriptional modulation is mediated by indirect changes in the levels of a second 
Nanog-regulated factor. Based on results from previous timecourse experiments, it 
was possible to select 3 hours as the earliest time-point at which robust 
transcriptional induction or repression occurs for most target genes. For this reason, 
RNA was collected from cells cultured for 3 hours in the presence of tamoxifen. 
Cycloheximide was added to the cells 30 minutes before tamoxifen to allow for 
complete inhibition of protein synthesis before inducing Nanog translocation to the 
nucleus. Strikingly, 8 out of 12 Nanog target genes showed induction or repression in 
response to cycloheximide treatment, independently of tamoxifen stimulation 
(Figure 3.6). Consequently, it was difficult to detect an additional effect of 
tamoxifen stimulation for the genes which responded to cycloheximide. For example, 
cycloheximide did not impair tamoxifen induced downregulation of ID1 but resulted 
in an overall increase in the transcript levels of this gene. 4 (Nanog:GFP, CD38, 
Itg9a, Sfrp1) out of 12 Nanog responsive genes were not affected by treatment with 










Figure 3.6: Identification of Nanog direct transcriptional targets. 
 
Relative transcript levels of 12 Nanog target genes in TC44c6 and ESN-NERT c3 
cells cultured for 3 hours in the presence or in the absence of tamoxifen and 30 
g/ml of cycloheximide. Cycloheximide was added to the culture medium 30 










could not be suppressed by cycloheximide while protein synthesis inhibition could 
suppress tamoxifen induced repression of CD38 and induction of Itga9. Considering 
that Itg9a also shows a long response time after Nanog nuclear relocalisation, it is 
probable that this gene is not directly activated by Nanog. Overall, the complex 
response that cycloheximide treatment elicits in ES cells complicates the 
interpretation of these results. Treatment of the cells for shorter time periods could 
help reducing the general perturbation of transcription observed in these experiments. 
As an alternative to the use of protein synthesis inhibition, claims of direct regulation 
should be based on the analysis of transcriptional output after short times of 
tamoxifen stimulation in ESN-NERT cells (1 hour or less). 
 
The genome-wide analysis presented in Figure 3.1 identified a list of genes whose 
transcript levels respond to stable alternations in Nanog levels or to fluctuations in 
Nanog expression occurring in ES cells over a period of days (ref chambers 2007). 
As discussed, such analysis does not distinguish between direct or indirect 
transcriptional regulation. To solve this limitation, the scope of the observations 
made on a limited number of target genes was extended by performing microarray 
analysis of Nanog induction timecourse experiments in ESN-NERT cells. Such 
experiments, analysed in conjunctions with the available transcriptional profiling 
data, consolidated the identified list of targets of Nanog (Table 3.1) and shed light on 
the dynamics of Nanog control over its target genes at the genome-wide level. 
 
Microarray analyses were performed in triplicate at 1 hour time intervals over a 6 
hour period following Nanog nuclear re-localisation in ESN-NERT c3 cells. Only 
64 genes showed a differential gene expression pattern (fold change≥1.5, p≤0.05) 
during the time course (Figure 3.7A, Table 3.1). This was surprising, since 2 
independent ChIP-Seq studies (Chen et al., 2008; Marson et al., 2008) identified 
more than 5000 common Nanog biding sites in the ES cell genome. Using the  
publically available GeneProf software (Halbritter et al., 2012), 49 out of 64 Nanog-
sensitive genes were determined to be reproducibly bound by Nanog (Chen et al., 








Figure 3.7: Genome-wide analysis of the transcriptional response to Nanog 
nuclear re-localisation 
 
A: Venn Diagram showing the intersection of significantly up- or downregulated 
genes (fold change ≥ 1.5; p≤0.05) identified in the ESN-NERT timecourse analysis 
compared to genes bound by Nanog according to two independent genome-wide 
ChIP studies. B: Venn Diagram showing the intersection of significantly up- or 
downregulated genes (fold change ≥ 1.5; p≤0.05) identified in the ESN-NERT 
timecourse analysis, comparing lines stably expressing different Nanog levels 
(RCN(t) vs. RCNH(t)) and analysing the effects of fluctuations in Nanog expression 
(TNGhigh vs. TNGlow). C:Plot showing expression dynamics of significantly up- or 
downregulated genes (Fold change≥1.5, p≤0.05) after ESN-NERT stimulation with 
tamoxifen as indicated; only transcription factors showing non-contradicting changes 
in all the datasets and significant expression levels (r.p.m≥50) were selected. Mean 
expression levels in three independent experiments. 
 
All bioinformatic analysis was performed in collaboration with Florian Halbritter using 





Nanog targets by ChIP are insensitive to changes in Nanog over the time course of 
the analysis (Figure 3.7A). These results show that most of the genes to which 
Nanog is bound are impervious to changes in the levels of Nanog protein in the cell, 
possibly because the presence of other transcriptional factors at the regulatory 
regions of these genes is sufficient to sustain their expression. 
 
It was then decided to determine the overlap between differentially regulated genes 
identified by 1) comparing lines stably expressing different Nanog levels ( RCN(t) 





) or 3) monitoring rapid kinetics of transcriptional activation 
after Nanog induction (NERT timecourse). Interestingly, a progressive reduction in 
the total number of differentially expressed genes was observed comparing datasets 
that are increasingly stringent in excluding the effects of indirect regulation (1: 2012 
; 2: 1527 ; 3: 37 positive targets; 1: 2303 ; 2: 1578 ; 3: 27 negative targets 
respectively) (Figure 3.7B). The low number of targets identified in the timecourse 
experiments is partially attributable to the stringent 1.5 fold threshold imposed 
during the analysis (Fold change>=1.5, P<=0.05), since a more relaxed criteria (Fold 
change>=1.25, P<=0.05) yields 185 differentially expressed genes. Nonetheless, this 
comparison suggests that the analysis of the long term effects of manipulating the 
levels of a transcription factor has a poor ability to identify its direct transcriptional 
targets. 
 
Strikingly, Esrrb was the transcript showing the most pronounced induction in this 
timecourse analysis (Figure 3.7C). Of the other 63 targets, 10 (Klf4, Klf5, Xbp1, 
Ets2, Lmo4, Sox21, Tcf15, Otx2, Hmgxb4, ID1) are transcription factors expressed 
at significant levels (reads per million >50 in at least one deep-sequencing dataset). 





 datasets (Figure 3.7C, Table 3.1). Among these, 
the gene showing the greatest positive change at 6 hours after Esrrb is Klf4. 
Confirming the results obtained in prior deep sequencing studies, ID1 is the 





3.3:   Transcriptional dynamics following Nanog nuclear 
relocalisation in ESN-iNanog cells 
 
The reduced number of Nanog transcriptional targets identified by tamoxifen 
induction of ESN-NERT cells raised the possibility that the Nanog-ERT
2
 fusion 
protein expressed in this line might not be fully functional, and could therefore fail to 
activate part of wild-type Nanog target genes.  
 
To investigate this possibility, it was decided to test the effects of overexpressing 
Nanog-ER
T2
 or wild-type Nanog proteins in an identical Nanog
-/-
 background. 
Tc44c6 derived ESN-NERT or ESN-iNanog ES cells (which carry a 
doxycycline inducible Nanog transgene; See Figure 5.6) were replated at clonal 
density in the presence or absence of LIF, inducing or not inducing Nanog function. 
After 7 days plates were stained for alkaline phosphatase (AP) expression and colony 
morphology scored. Nanog-ER
T2
 induction was able to sustain LIF independent self-
renewal to an extent comparable to wild-type Nanog protein (Figure 3.8A), arguing 
in favour of an unaffected functionality of the fusion protein.    
 
To directly compare the transcriptional functionality of Nanog-ER
T2
 and wild-type 
Nanog, timecourse microarray analyses were performed following induction of wild-
type Nanog in Nanog-/- ESN-iNanog ES cells. Full transcript induction in ESN-
iNanog cells is achieved by 6 hours of doxycycline treatment (Figure 3.8B). Gene 
expression was therefore analysed after inducing ESN-iNanog cells for 0, 6 or 12 
hours. In this system, only 31 genes showed ≥1.5-fold change in expression after 12 
hours of induction (p≤0.05) (Figure 3.8B). The lower number of genes identified is 
likely to result from the slower induction of nuclear Nanog in ESN-iNanog 
compared to ESN-NERT cells.  The vast majority of targets (21/31) were also 
identified in ESN-NERT cells and 8/10 of the remaining genes are differentially 










Figure 3.8: Timecourse microarray analysis of doxycycline induction in ESN-
iNanog and ESN-iEsrrb cells 
 
A: Number and type of colonies formed 7 days after clonal density plating of 
TC44c6, ESN-NERT or ESN-iNanog cells in the presence or absence of LIF, 
with or without doxycycline or tamoxifen. Error bars: standard deviation (n=3).  B: 
Nanog mRNA expression in ESN-iNanog (iN) cells cultured in the presence of 
doxycycline for the indicated times. Error bars: standard deviations of 3 independent 
experiments. C: Intersection of significantly up- or downregulated genes identified by 
doxycycline stimulation of ESN-iNanog (iN) for 12 h and tamoxifen stimulation of 





Taken together these results demonstrate the full functionality of the Nanog-ER
T2
 
fusion protein used in this analysis and identify a reliable list of Nanog responsive 
genes with which to explore the mechanisms of Nanog activity in ES cells. 
 
3.4:    Nanog control over Esrrb expression  
 
Among the target genes identified by this study is Esrrb, an orphan nuclear receptor 
that participates in the pluripotency transcriptional network (Chen et al., 2008; 
Ivanova et al., 2006; Kim et al., 2008; Loh et al., 2006; van den Berg et al., 2010; 
van den Berg et al., 2008; Wang et al., 2006a; Zhang et al., 2008). Esrrb expression 
sustains ES cell self-renewal (Ivanova et al., 2006; Loh et al., 2006; Zhang et al., 
2008) and promotes reprogramming of mouse embryonic fibroblasts (Feng et al., 
2009). Since Esrrb function in ES cells has not been studied extensively, the 
transcriptional regulation of Esrrb was investigated in greater detail.      
   
The murine Esrrb gene is more than 100 kb long, is constituted by 8 different exons, 
and can produce 4 different described transcript variants by alternative splicing 
(Figure 3.9A). To determine which of these transcript variants are expressed in ES 
cells, primers were generated that amplify all exon-exon junctions across the gene, 
the 3 alternative transcript start sites and the two alternative 3’ untranslated regions 
(UTR) of the different messenger RNAs (Figure 3.9A). In ES cells the most 
abundant transcript starts from exon 2 and ends at exon 7, including a 2.5 kb long 3’ 
UTR sequence (Figure 3.9B).  
 
Esrrb transcript levels correlate with Nanog expression in different ES cell lines in a 
Nanog mutant series (Figure 3.10A). A robust correlation of Esrrb and Nanog 
expression in the cells could also be observed at the protein level (Figure 3.10B). 
Pre-mRNA levels, measured with primer pairs designed to cover the entire transcript 
length, accurately recapitulated the differences in expression observed for mature 
Esrrb mRNA (Figure 3.10C,D), indicating that the observed variations in Esrrb 
mRNA levels resulted from a direct control of Nanog over Esrrb transcription and 














Figure 3.9: Determination of Esrrb transcript variant expression in ES cells. 
 
A: Schematic representation of the structure of four described murine Esrrb 
transcript variants. Black boxes: exons. White boxes: 5’ and 3’ untranslated 
regions (UTR). Solid lines: introns. Black and white circles connected by 
dashed lines: forward and reverse primer pairs used in panel B. B: Relative 
transcript levels measured using primer pairs that amplify different exon-exon 
junctions, the 3 alternative transcript start sites and the two alternative 3’ 










Figure 3.10: Esrrb and Nanog mRNA levels correlate in ES cells 
 
A: Relative Esrrb and Nanog transcript levels in two cell lines overexpressing Nanog 
(RCN, EF4), two lines with wild-type levels of Nanog expression (E14Tg2a, RCN(t)), 
two cell lines in which one of the two Nanog alleles has been deleted by 
homologous recombination (TC44,RCN(t)) and two Nanog null cell 
lines(TC44c6, RCNH(t)). Error bars: standard deviation of gene expression values 
measured in 4 independent experiments. B: Western blot analysis of Esrrb and 
Nanog protein levels in different ES cell lines. C,D: Esrrb mRNA and pre-mRNA 
levels in EF4, E14Tg2a and RCNH(t) ES cells. Relative expression levels 
measured using primer pairs amplifying successive positions along the transcript. 
Error bars: standard deviation of the mean for gene expression levels measured in 5 
independent experiments. E: Relative Esrrb, Nanog and Oct4 mRNA levels in 
RCNH cells treated for 1, 2 or 3 days with tamoxifen to induce loss of Nanog 
expression driven by a floxed transgene present in this cell line. Error bars: standard 




In order to show that loss of Nanog activity directly results in decreased Esrrb 
expression, RCNH cells were treated with tamoxifen to induce excision of the 
floxed Nanog transgene present in this cell line. An almost complete loss of Nanog 
transcript was detected as soon as 1 day after treatment, with no residual mRNA 
detectable at day 2 or day 3. Esrrb expression was significantly reduced after 2 days 
of treatment, and further decreased on day 3 (Figure 3.10E). Induced cell 
differentiation could not explain these effects, since Oct4 levels were stable over the 
course of the experiment. 
 
ESN-NERT cells were then employed to investigate whether Nanog exerts direct 
transcriptional control over Esrrb expression. As previously shown, a 1.5 to 2 fold 
induction in Esrrb mRNA was detected when ESN-NERT cells were treated with 
tamoxifen for 24 hours (Figure 3.4). The fold change in Esrrb levels correlated well 
with the expression of the Nanog-ER
T2
 transgene in the three different lines analysed 
(Figure 3.3B). Similarly, a significant increase in Esrrb protein levels was detected 
by western blot (Figure 3.11A). Crucially, Esrrb pre-mRNA increases as early as 20 
minutes after tamoxifen treatment of ESN-NERT cells (Figure 3.11B), with mature 
transcript levels showing an increase after 1 hour (Figure 3.5). Finally, ChIP assays 
showed that Nanog binds to both Esrrb promoter and enhancer (Chen et al., 2008). 
Restoring Nanog binding in ESN-NERT cells resulted in a 2 fold increase of 
RNApolII recruitment at the Esrrb promoter (Figure 3.11C).  
 
Taken together these results establish Esrrb as a major positive target of direct 
transcriptional activation by Nanog in ES cells.  
 
3.5:    Nanog control over Esrrb transcriptional elongation and 
pause release 
 
Esrrb was then used as a model to characterise in greater detail the dynamics and 








Figure 3.11: Nanog directly regulates Esrrb transcription 
 
A: Western blot analysis of Esrrb and HDAC-2 protein expression in three 
ESN-NERT lines cultured in the presence or in the absence of tamoxifen for 
24 hours. B: Kinetic of Esrrb pre-mRNA upregulation in ESN-NERT cells 
stimulated with tamoxifen for 0, 10, 20, 30, 40, 50, 60 or 120 minutes. 
Relative transcript levels normalised on TBP expression. Error bars: standard 
deviation of gene expression values measured in three independent ESN-
NERT clones. C: Chromatin from ESN-NERT cells treated with 1M 
tamoxifen for 0 or 24 hours was immunoprecipitated with Nanog or total 
RNAPolII antibodies. Enrichment relative to the ArpP0 promoter is measured 







The length of the Esrrb transcription unit expressed in ES cells is 51.3kb (Figure 
3.9). This is relatively long and could be a point of controlling Esrrb levels by 
influencing RNAPII progression across the gene. In an attempt to test this 
hypothesis, the time required from initiation of transcription to the production of a 
mature messenger RNA was measured in Nanog overexpressing (EF4) or Nanog null 
(RCNH(t)) ES cells. Cells were treated for 3 hours with flavopiridol (Chao et al., 
2000; Chao and Price, 2001), an inhibitor of CDK9 (P-Tefb active subunit) which 
blocks RNA synthesis by RNA Polymerase II (RNAPolII). Under these conditions, 
recruitment of RNA PolII to gene promoters is unaltered, but release of the 
polymerase is blocked, resulting in widespread accumulation of paused enzyme at 
active loci throughout the genome (Rahl et al., 2010). When flavopiridol is removed, 
productive initiation of transcription and elongation can take place. By measuring the 
level of nascent messenger RNA, using primers amplifying successive position from 
5’ to 3’ along the gene (Figure 3.12a), it is possible to measure the transcriptional 
speed of elongating RNAPolII (Singh and Padgett, 2009). Esrrb pre-mRNA levels 
were measured every 5 minutes in cells released from flavopiridol. As shown in 
Figure 3.12b, complete transcription of the 50 kb long Esrrb pre-messenger RNA in 
EF4 requires approximately 15 minutes, at an average speed of more than 3 kb/min. 
This is in broad agreement with the rate measured for 9 large human genes in a 
previous study (average speed 3.8 kb/min)(Singh and Padgett, 2009), suggesting that 
in the presence of Nanog Esrrb elongation is not subject to substantial delays.  
 
Interestingly, comparison of the Esrrb transcription rate in Nanog
-/-
 ES cells (Figure 
3.12b) showed that in the absence of Nanog, RNAPII initiation of productive 
elongation (Exon 2-Intron 2) and consequently, progression across Esrrb were 
inhibited. Given that RNAPII is detected (Figure 3.10c) and would be expected to 
accumulate at the Esrrb promoter during Flavopiridol treatment in both Nanog 
overexpressing cells and Nanog
-/-
 cells, the reduced progression of RNAPII across 
Esrrb in Nanog
-/-
 ES cells following wash-out of Flavopiridol suggests that, in 







Figure 3.12: Kinetics of Esrrb mRNA transcription and splicing in ES cells 
 
A: Schematic representation of the Esrrb transcript variant expressed in ES cells. 
Black boxes: exons. White boxes: 5’ and 3’ UTR regions. Solid lines: introns. Black 
and white circles connected by lines: forward and reverse primer pairs used in 
panels B (bottom) and panel C (top). B: EF4 or RCNH(t) cells were released from 
flavopiridol after 3 hours of treatment and relative levels of Esrrb pre-mRNA 
measured at the indicated times using primers amplifying successive exon-intron 
junctions along the gene (see A). Transcript levels normalised to ribosomal RNAs. 
Error bars: standard deviation of the mean in 3 (EF4) and 4 (RCNH(t)) independent 
experiments. C: Relative levels of spliced or unspliced Esrrb pre-mRNA measured 
using primer pairs amplifying the exon 5-intron 5 or exon 5-intron 6 junctions after 
release of EF4 cells from flavopiridol. Relative transcript levels normalised on 
ribosomal RNAs. Error bars: standard deviation of the mean for gene expression 





Finally, the time required for completion of the splicing events that will generate a 
mature mRNA from the nascent transcript was determined using the primers 
schematised in Figure 3.12A. As shown for the exon 5-intron 6 junction, 
approximately 5 minutes are required to first detect the products of the splicing 
events that join successive exons along the gene (Figure 3.12C). This observation, 
together with the finding that Esrrb transcription requires 15 minutes, suggests that 
splicing of Esrrb messenger RNA occurs co-transcriptionally in the nucleus of ES 
cells. 
 
Taken together the data presented in this chapter suggest that Nanog controls 
expression of its target genes by influencing RNApolII recruitment at promoters. In 
addition, Nanog might be involved in modulating RNApolII initiation of 
transcription and progression of productive elongation of its targets. Further studies 
are now required to extend the preliminary observations made on Esrrb to other 
Nanog responsive genes and to fully understand the causes of the observed delayed 
transcriptional initiation in RCNH(t) cells. In particular, it will be crucial to 
determine whether RCNH(t) cells show reduced levels of RNApolII accumulation 
at the promoters of Nanog target genes after treatment with flavopiridol, since this 
could explain the extended time required to detect initiation of transcription in these 
cells.   
 










 ES cells, 
and by taking advantage of Nanog
-/-
 cells with distinct inducible Nanog function, a 
reliable list of the direct targets of Nanog transcriptional activity in ES cells was 
identified. The described approach presents three main advantages compared to 
previous attempts to characterise the transcriptional response to Nanog (Ivanova et 
al., 2006; Loh et al., 2006; Lu et al., 2009). First, the use of genetically null lines 
ensures complete abrogation of Nanog expression in the cells. Previous studies relied 




vectors. In knock-down experiments the possibility that heterogeneous attenuation of 
Nanog expression occurs in the ES cell population cannot be excluded. Thus, a 
second advantage of the approach used in this thesis is that the use of inducible 
Nanog expression in a null background allows early responses to be characterised in 
a relatively uniform responding population. A third advantage is that, in all 
knockdown studies, Nanog downregulation coincides with widespread differentiation 
in the cultures, due partially to the long timescales employed. Many of the 
differentially expressed genes identified in the prior experiments are therefore likely 
to be modulated in response to the general dismantling of the pluripotency gene 
regulatory network (GRN) triggered by differentiation and not specifically 
responsive to Nanog activity in the cells.  
 
The fact that knock-down of Nanog, and other pluripotency factors such as Esrrb, 
results in ES cell differentiation is a point of interest, given that stable knock-out ES 
cell lines for both genes are able to self-renew ((Chambers et al., 2007), and see 
Chapter 8). The observation that increased differentiation was observed upon 
derivation of Nanog (Chambers et al., 2007) and Esrrb (see Chapter 8) stable knock-
out lines suggest that ES cells are able to adapt to the deprivation of key components 
of the pluripotency GNR. This adaptation is not consequent to genetic abnormalities 
acquired during the derivation of the lines, since both Nanog and Esrrb cells retain 
the ability to contribute to chimaeric embryos (Chambers et al., 2007; Martello et 
al.).  
The analysis presented in this chapter was able to discriminate between direct and 
indirect transcriptional regulation. This study characterised the transcriptional 
alterations occurring as a consequence of the spontaneous fluctuation in Nanog 
protein levels observed in ES cells. Nanog fluctuations occur over a period of days 
(Chambers et al., 2007). This time frame ensures that the observed differences are 
not consequent to long-term adaptations to elevated or reduced Nanog levels in the 
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(around 4200 and 3000 respectively, Figure 3.7B). Many of the transcripts showing 








from genes that share common regulators with Nanog or are Nanog regulators rather 





 cells may be indirectly activated or 
repressed in the cells as a consequence of Nanog activity on other transcriptional or 









 datasets permitted to overcome the reciprocal limits 
of these two approaches and identify   1000 potential direct Nanog targets, in contrast 
with the 1531 genes identified by knockdown studies (Ivanova et al., 2006). Most 
importantly, the use of Nanog
-/-
 ES cell lines in which Nanog function can be re-
instated in a rapid and controlled way allowed the investigation of the kinetics of 
Nanog control over transcription. It was possible to identify transcripts showing 
induction or repression as soon as 1 hour (Figure 3.7C) after Nanog nuclear re-
localisation in ESN-NERT ES cells. Such rapid kinetics of transcriptional 
regulation strongly suggest a direct activity of Nanog on the identified target genes. 
Strikingly, only 64 genes showed a greater than 1.5 fold change 6 hours after 
induction of Nanog in this cell line. The ability to detect transcriptional alterations by 
genome-wide microarray analysis depends on mature messenger RNA accumulation 
or degradation. The short timescale of the analysis in ESN-NERT cells might 
preclude the detection of part of the Nanog regulated network as a consequence of 
the long time required for these processes to achieve a detectable effect. In particular, 
since the average half-life of transcripts in mammalian cells is 6.9 hours (Tani et al., 
2012), it is possible that a significant proportion of repressed genes was not 
identified in these experiments. Further experiments should directly measure the 
stability of ID1 and Tcf15 mRNA in flavopiridol treated ES cells, and compare it to 
the half-life of other mRNAs showing a slower decrease in response to Nanog 
induction. It is notable in this respect that lowering to 1.25 the differential expression 
threshold used to analyse the ESN-NERT timecourse data led to the identification 
of 185 target genes, with a vast proportion of the newly included genes showing less 
pronounced but steady and consistent variations over the 6 hour period of sampling. 
Overall this study revealed that transcriptional profiling studies based uniquely on 
the comparison of cell lines stably overexpressing or lacking expression of one given 




Recent genome-wide ChIP studies have shown that multiple transcription factors 
bind in proximity to one another forming clusters at the regulatory elements of the 
genes controlled by the pluripotency GRN (Chen et al., 2008; Kim et al., 2008; 
Marson et al., 2008). This may imply that pluripotency factors exert combinatorial 
control over the expression of  their target genes, a concept previously proposed in a 
more widespread context by  Ptashne and Gann (2001). However, it is unclear to 
what extent changes in the level of a single factor influence the expression of the 
pluripotency GRN targets (Chambers and Tomlinson, 2009). Analysis of published 
data with the publically available GeneProf software suite (Halbritter et al., 2012) 
showed that Nanog is reported to bind to more than 5000 genes in at least two 
independent studies (Chen et al., 2008; Marson et al., 2008).  Combined with the 
observation that only 64 genes show a greater than 1.5 fold change in expression 
after Nanog induction in ESN-NERT cells (Figure 3.7A), this implies that gain of 
Nanog binding is not sufficient to alter the transcription rate of most of these putative 
Nanog targets. It is possible that Nanog binding is not required for the efficient 
recruitment of other pluripotency factors to many of these genes. This might be due 
to the fact that these pluripotency factors recognise DNA sequences present at the 
regulatory elements of Nanog bound genes with sufficient affinity to ensure their 
independent recruitment to these regions. Alternatively, the presence of neighbouring 
binding sites for multiple pluripotency factors might result in the stabilisation of their 
association with the DNA at these regulatory regions, so that the additional presence 
of Nanog becomes irrelevant (Khalil et al., 2012). In any case, binding of these 
factors is able to drive activation of the transcriptional machinery in the absence of 
Nanog.  
 
In order to further understand the dynamics of transcriptional regulation in ES cells 
and the robustness of the pluripotency GRN, future studies should determine whether 
combinatorial control may also limit the transcriptional response to changes in the 
level of pluripotency factors other than Nanog. Esrrb modulation also results in 
transcriptional changes for a limited number of genes (See Chapter 8.3). It is possible 
that the ability to elicit a transcriptional response in limited numbers of genes is a 




cells. In this respect, it is relevant that acute Oct4 depletion have a much wider effect 
on transcription, with 2714 genes showing a ≥1.5 fold change in expression only 5 
hours after Oct4 ablation (Hall et al., 2009). The radical differences observed 
between the modulation of Oct4 and Nanog is supported by genetic evidence 
showing that tight control of Oct4 levels is necessary to maintain the pluripotent state 
(Niwa et al., 2000), while fluctuations in Nanog confer flexibility to the network 
(Chambers et al., 2007). It might therefore be that some pluripotency factors, like 
Oct4, lie at the heart of the housekeeping functions performed by the pluripotency 
GRN. If this is the case, binding of Oct4 to the regulatory elements of most GRN 
targets should prove to be necessary to allow the recruitment of additional 
pluripotency factors. Other factors, such as Nanog, and possibly Esrrb, might be 
required to precisely tune the expression of a limited number of genes that set the 
conditions for cell fate decisions. Combinatorial control would then ensure that 
depletion of these factors does not result in widespread alterations in the 
transcriptional output from the pluripotency GRN. Such differences could be 
explained by an hypothetical higher affinity of factors like Oct4 for their DNA 
binding elements, or by their different ability to serve as protein interaction hubs 
(Ding et al., 2012; Pardo et al., 2010; van den Berg et al., 2010; Wang et al., 2006a) 
in the process of stabilising additional binding at the regulatory elements of the 
pluripotency GRN.   
 
Nanog has been cloned because it can confer LIF independence to ES cells 
(Chambers et al., 2003). This analysis characterised the transcriptional response to 
Nanog in cells cultured in the presence of LIF. Since STAT3 and Nanog bind to an 
overlapping set of sites throughout the genome (Chen et al., 2008), it is possible that 
the low number of Nanog responsive genes identified is due to a certain degree of 
redundancy in the transcriptional regulation exerted by Nanog and STAT3. Re-
instating Nanog activity in ESN-NERT cells after LIF starvation, could lead to the 
identification of additional important mediators of Nanog function and shed light on 
the mechanism through which Nanog elevation renders LIF dispensable for ES cell 
self-renewal. Conversely, it might be that some of the target genes identified will fail 




The results presented establish that the use of knock-out cell lines and fusion 
between transcription factor proteins and the ER
T2
 domain (Feil et al., 1997) is a 
powerful tool for studying regulation of gene expression in mammalian cells. It 
would be interesting to apply this system to the investigation of transcriptional 
control by other pluripotency factors. The rapid translocation time achieved in this 
system (Figure 3.3C) made it possible to study the early transcriptional events that 
follow restoration of Nanog function in ES cells (Figure 3.7C, 3.10B). This work 
directly compared the potential of -ER
T2
 fusion to the use of doxycycline inducible 
expression strategies by applying both systems to reinstate Nanog function in an 
identical Nanog
-/-
 background. Analysis of Nanog induction in ESN-NERT and 
ESN-iNanog cells led to the identification of 64 and 31 directly responsive genes 
respectively (Figure 3.8C), highlighting the superior sensitivity of ER
T2
 based 
approaches. One of the main limitations of fusion to ER
T2
 is the unpredictability of 
whether the resulting protein will be functional. Importantly, it was possible to show 
that the Nanog-ER
T2
 protein used in this study is comparable to wild-type Nanog in 
functional and transcriptional assays (Figure 3.8A-C). Potential confounding effects 
deriving from the biological activity of 4-0H-tamoxifen limit the use of this system 
to the study of nuclear receptors. In particular, tamoxifen has been shown to interfere 
with the transcriptional activation mediated by Errg, an orphan nuclear receptor 
closely related to Esrrb, inhibiting its interaction with the co-activator Ncoa-1 
(Coward et al., 2001; Tremblay et al., 2001a) at doses lower than 1M. Despite the 
fact that 4-OH-tamoxifen does not exert a comparable activity on Esrrb (Coward et 
al., 2001) and its effects have not been tested in ES cells, where Ncoa-1 is not 
expressed and Esrrb seems to partner with a different co-activator (Percharde et al., 
2012), the potential antagonistic activity of 4-OH-tamoxifen discourages the use of 
an Esrrb-ER
T2
 fusion protein. Promising alternatives to ER
T2
 fusion could be the use 
of the recently described anchor-away (Haruki et al., 2008) or the ligand induced 
destabilisation (LID) (Banaszynski et al., 2006) systems.  
 
Among the identified Nanog targets, Esrrb is the gene that shows the most 
pronounced transcriptional activation in tamoxifen treated ESN-NERT cells 




promoter and enhancer increases RNAPolII recruitment to the Esrrb promoter 
(Figure 3.10B) and elevates Esrrb pre-mRNA levels within 20 minutes (Figure 
3.10C). Notably the second transcription factor that shows consistent correlation 
with Nanog in all the datasets is Klf4 (Figure 3.1, 3.7C, 3.8C). Esrrb has been 
reported to be involved in the control of pluripotency and to promote reprogramming 
((Chen et al., 2008; Ivanova et al., 2006; Kim et al., 2008; Loh et al., 2006; van den 
Berg et al., 2010; van den Berg et al., 2008; Wang et al., 2006a; Zhang et al., 2008) 
and this thesis). Klf4 has also been shown to sustain ES cell self-renewal in response 
to LIF signalling (Jiang et al., 2008; Niwa et al., 2009) and is a member of the quartet 
of Yamanaka’s reprogramming factors (Takahashi and Yamanaka, 2006). This opens 
the possibility that other target genes also play a role in promoting ES cell self-
renew. In particular, Gli2, the third most responsive transcription factor identified by 
the analysis of Nanog mutant ES cell lines (Figure 3.1), shows prompt upregulation 
in ESN-iNanog and ESN-NERT (1.48 fold change in the latter dataset). Gli 
proteins are zinc-finger transcription factors that mediate the transcriptional response 
triggered by activation of the hedgehog pathway (Hui and Angers, 2011). 
Interestingly, using luciferase based assays, recent studies have shown that Gli2 can 
bind to the Nanog promoter and activate its transcription (Po et al., 2010). Although 
performed in mouse cerebellar neurospheres, in which Nanog is not expressed, these 
finding might suggest that in ES cells Gli2 is engaged in a positive feedback loop 
sustaining Nanog expression. 
      
Unexpectedly, the most downregulated genes in both the ESN-NERT and ESN-
iNanog datasets was the bHLH factor ID1 (Figure 3.7C, 3.8C).The closely related 
protein ID2 was also detected among negatively regulated genes (Figure 3.1). At 
first glance, this finding may seem to be at odds with the notion that ID proteins are 
induced by BMP signalling and play a fundamental role in preventing ES cell neural 
differentiation (Ying et al., 2003). Since ES cells fluctuate between states of high and 
low Nanog expression (Chambers et al., 2007), it is possible that in Nanog positive 
cells ID genes expression is significantly diminished. As a consequence, despite the 
fact that all cells are exposed to similar BMP concentrations, Nanog negative cells 




BMP signals. Elevation of ID levels in response to BMP may help Nanog negative 
cells to remain undifferentiated and eventually reacquire Nanog expression. 
Conversely, downregulation of ID protein expression in Nanog positive cells could 
allow downregulation of Nanog expression . BMP signalling could therefore be a 
driver of dynamic Nanog heterogeneity in ES cells.     
 
In addition to repressing neural fate BMP signalling has been shown to promote 
mesodermal differentiation of ES cells (Finley et al., 1999; Johansson and Wiles, 
1995) and is known to be essential for mesoderm specification during early mouse 
development (Winnier et al., 1995). An explanation to the observed repression of 
ID1 by Nanog could come from studies indicating that Nanog inhibits BMP induced 
activation of Brachyury, and ID1, by binding Smad1 and preventing its interaction 
with the p300 co-activator. The authors propose an additional function for Nanog in 
preventing BMP induced mesodermal differentiation (Suzuki et al., 2006). Nanog 
repression of ID1 could therefore be a consequence of its role in repressing 
mesodermal fate. Interestingly Nanog is expressed in the primitive streak region of 
the post-implantation mouse embryo (Osorno et al., 2012), a region in which BMP 
signalling is also detected (Winnier et al., 1995). In this context, Nanog could 
contribute to preventing premature mesodermal specification of epiblast cells before 
their migration through the primitive streak.      
 
The results presented in this chapter establish that Nanog binding enhances the 
recruitment of RNAPolII at the Esrrb promoter and activates its transcription. 
Transcriptional activation does not depend uniquely on recruitment but also on 
efficient RNAPolII release from active promoters. RNAPolII is initially recruited at 
promoters in a “paused” state in which it engages in multiple rounds of abortive 
transcriptional initiation. Phosphorylation of the second serine in tandem repeats of a 
conserved sequence in the RNAPolII C-terminal domain augments the enzyme 
processivity and allows productive elongation of nascent RNAs (Core and Lis, 2008; 
Margaritis and Holstege, 2008). Pause release is a fundamental point of gene 
expression regulation in human cells (Core et al., 2008; Guenther et al., 2007). c-




gene expression by enhancing release of paused RNAPolII in mouse ES cells (Rahl 
et al., 2010). Nanog might exert a similar role, since flavopiridol treatment 
experiments revealed that RNApolII pause release from the Esrrb promoter is 
significantly delayed in Nanog
-/-
 ES cells. Interestingly, c-Myc was reported to bind 
preferentially to genes that are already active in ES cells, and to act as an 
amplificator of transcription (Lin et al.; Nie et al.). In this respect it is important to 
note that, albeit at low levels, Esrrb is actively transcribed in Nanog
-/-
 ES cells, and 
Nanog activation increases its transcriptional output. Further studies should explore 
the possibility that Nanog might act both as a conventional transcription factor, by 
binding to enhancers and promoting RNApolII recruitment, and as a transcriptional 








Chapter 4:    Nanog and Esrrb fluctuations in single cells. 
Functional relevance of heterogeneous Nanog expression in 
ES cells 
 
4.1:    Creation of Nanog and Esrrb double reporter lines 
 
The functional differences existing between cells expressing high or low Nanog 
levels are likely to be determined by differential expression of key target genes 
involved in promoting ES cell self-renewal. In this context, it is of particular interest 
to study the regulation that Nanog exerts on such factors in single live cells. Since 
Esrrb plays an important role in sustaining pluripotency and is the gene that shows 
the most pronounced transcriptional change in response to Nanog induction in ES 
cells, a series of fluorescence reporter lines were designed to permit concomitant 
tracking of Nanog and Esrrb expression in single cells. 
 
As the complex structure of the gene, its length and the presence of a long 3’UTR 
region could be crucial factors in determining Esrrb transcriptional regulation, it was 
decided to minimise any alteration to the Esrrb gene upon introduction of exogenous 
sequences. Different fluorescent reporter cassettes were knocked-in at the 3’ end of 
the last exon of Esrrb. In a first set of reporter constructs a TdTomato cassette was 
fused in frame to the end of the Esrrb coding sequence, connected through a 13aa 
long peptide linker (Figure 4.1A). The purpose of using a protein fusion was to 
generate a reporter line that would accurately reflect Esrrb protein levels in the cells, 
and could effectively detect any modulation of Esrrb expression exerted at the 
protein level. In addition a second set of reporters was generated in which a 
TdTomato protein was linked to the end of the Esrrb coding sequence by a T2a 
peptide, allowing for cleavage of the fluorescent reporter nascent polypeptide chain 








Figure 4.1: Derivation of Esrrb reporter ES cell lines. 
 
A: Schematic representation of the Esrrb locus structure and targeting vectors used 
to derive E14Tg2a Esrrb-TdTomato cells. B: Immunohistochemical analysis of Esrrb 
protein expression in E14Tg2a Esrrb-TdTomato cells. C: Schematic representation 
of Esrrb before and after targeting. 5’ and 3’ homology arms are red lines, exons are 
red boxes, 3’UTR is in green. Restriction sites and the probe used for Southern blot 
analysis are indicated, as are the expected sizes of the DNA fragments obtained 
after digestion of wild-type and TdTomato-IRES-BSDR targeted alleles. D: Southern 
blot analysis performed on DNA samples prepared from E14Tg2a, TNG, E14Tg2a 
Esrrb-TdTomato, TNG Esrrb-TdTomato, TNG Esrrb-2a-TdTomato and E14Tg2a 
Esrrb-2a-GFPdest1 ES cell lines. DNA was digested with XbaI and the blot 
hybridised to a probe binding 5’ to the targeted genomic position (See panel C). 
Expected fragment sizes relative to the targeting of –TdTomato, 2a-TdTomato and 
2a-GFPDest1 cassettes in combination with Hygromycin or Blasticidin resistance 





of a blasticidin or hygromycin resistance gene was coupled to Esrrb expression by an 
IRES sequence. No polyadenylation signal was included in the vectors so that 
expression of functional messenger RNAs would rely on the endogenous Esrrb 3’ 
UTR sequence (Figure 4.1A).  
 
E14Tg2a and TNG ES cells were electroporated with Esrrb-TdTomato fusion protein 
or Esrrb-T2a-TdTomato targeting constructs including an IRES-blasticidin resistance 
cassette. Single clones were picked, expanded and the presence of a correctly 
recombined allele was assessed by Southern blot. Digestion of genomic DNA from 
targeted lines with XbaI and hybridisation with a probe annealing 5’ to Esrrb Exon 7 
should lead to the detection of a 6.5Kb band corresponding to the WT allele and an 
8.4-8.5Kb band originated by insertion of the TdTomato-IRES-blasticidin cassette at 
the Esrrb stop codon (Figure 4.1C). Homologous recombination occurs with high 
efficiency using these promoterless vectors, since all clones analysed underwent the 
desired recombination event (Figure 4.1D shows the results obtained for three clones 
of each line generated). 
 
E14Tg2a Esrrb-TdTomato ES cells were plated at low density and three days later 
the expression of Esrrb was determined by immunohistochemistry. Under these 
conditions Esrrb expression is mosaic in ES cell colonies (Figure 4.1B). The 
fluorescent signal detected from the Esrrb-TdTomato fusion protein correctly 
reported Esrrb expression in the colonies analysed (Figure 4.1B).  
 
An important point to consider while designing a reporter system able to accurately 
track rapid fluctuations in protein levels is whether the half-life of the fluorescent 
protein used matches the half-life of the endogenous protein of interest. With this 
aim, the half-life of Esrrb was first determined in E14Tg2a ES cells treated with 
cycloheximide for 1 to 12 hours, collecting total protein extracts at 2 hour timepoints. 
As shown in Figure 4.2A Esrrb protein half-life is greater than 2 hours but shorter 











Figure 4.2: Esrrb-TdTomato fusion protein stability in ES cells. 
 
A, B: Esrrb (A) and Esrrb-TdTomato (B) protein half-life in ES cells. E14Tg2a or 
E14Tg2a-TdTomato ES cells were treated with cycloheximide and total protein 
extracts were collected at the indicated times. The 50% and 25% of the total amount 
of protein used for other samples were loaded for untreated cells, and serve as an 
internal reference. Actin B protein levels are shown as a loading control.  F: Esrrb 
pre-mRNA levels in E14Tg2a cells treated for 0, 2, 4 or 6 hours with flavopiridol. 
Relative transcript levels normalised to ribosomal RNAs. Error bars: standard 







half-life of Esrrb-TdTomato is shorter than 3 hours in E14Tg2a Esrrb-TdTomato 
cells (Figure 2B). It was thus possible to verify that Esrrb and the Esrrb-TdTomato 
fusion protein have a relatively similar half-life. 
 
Reporter lines can also be used to detect variations in the transcriptional output from 
an active gene. Supposing that the introduction of exogenous sequences does not 
result in major alterations of the transcript, the time required to detect reductions in 
transcriptional activity will not only depend on the half-life of the fluorescent protein 
chosen but also on the stability of the messenger RNA of the gene of interest. To 
determine Esrrb mRNA stability, ES cells were treated with flavopiridol for 1 to 6 
hours and RNA samples collected every hour. The inferred mRNA half-life in ES 
cells is greater than 6 hours (Figure 4.2C). The stability of Esrrb messenger RNA is 
therefore likely to affect more significantly than the Esrrb-TdTomato protein half-life 
any delay in the decay of the signal detected from expression of these reporters. 
Flavopiridol treatment experiments should be now repeated in targeted reporter lines 
to exclude major differences between the Esrrb and Esrrb-TdTomato mRNA 
stabilities.   
 
Treatment of TNG Esrrb-TdTomato cells with blasticidin results in the selection of 
cells expressing uniformly high Esrrb levels. When TNG Esrrb-TdTomato ES cells 
were released for multiple passages from blasticidin selection, it was possible to 




 cells that progressively increased in 
frequency. When sorted, these cells never reactivated Esrrb-TdTomato irrespectively 
of maintaining or losing Nanog expression. Surprisingly, TdTomato
-
 cells were 
found positive for Esrrb protein by immunostaining (Figure 4.3A). Southern blot 
analysis determined that the progressive increase of this population was due to 
spontaneous recombination events that led to the repair of the TdTomato targeted 
allele (Figure 4.3B). It was therefore decided to target both Esrrb alleles in these 
reporter lines. TNG Esrrb-TdTomato and TNG Esrrb-T2a-Tdtomato cells were 
subjected to a second round of electroporation with Esrrb-TdTomato fusion protein 














Figure 4.3: Progressive loss of the targeted allele in Esrrb-TdTomato reporter 
lines. 
  
A: Immunohistochemical analysis of Esrrb expression in TNG Esrrb-TdTomato cells 
after long term passaging in the absence of blasticidin selection. B: Esrrb+/Nanog+ 
TNG Esrrb-TdTomato cells were released from blasticidin selection for 36 days.  
Southern blot analysis was performed on DNA samples prepared from 
Nanog+/Esrrb+ or Nanog+/Esrrb- and Nanog-/Esrrb- sorted populations or blasticidin 
selected TNG Esrrb-TdTomato cells (as a control). DNA was digested with XbaI and 






IRES-blasticidin resistance cassette present in the original targeting constructs was 
substituted for an IRES-hygromycin resistance cassette. After electroporation, cells 
were selected in the presence of blasticidin and hygromycin to isolate clones that 
retained the previously targeted allele and recombined the second wildtype Esrrb 
allele. As previously noticed, the targeting efficiency was relatively high, since the 
majority of the clones analysed underwent the desired recombination event (Figure 
4.1D shows the positive results obtained for three and two clonal lines of TNG Esrrb-
TdTomato and TNG Esrrb-T2a-TdTomato cells respectively). When TNG Esrrb-
TdTomato cells were selected with blasticidin and hygromycin for two passages and 




 cells were never 
detected, even after extensive passaging. These results suggest that the use of double 
targeted lines excluded complications arising from spontaneous repair of the reporter 
alleles.  In addition, the potential confounding effects of asymmetric allelic 
expression are avoided in these lines. 
 
4.2:    Nanog and Esrrb expression correlates in single cells 
 
Next, it was decided to determine how mosaic Nanog and Esrrb expression arises in 
ES cell colonies. TNG Esrrb-TdTomato cells were plated at low density in the 
presence or absence of puromycin or blasticidin and 3 days later GFP and Esrrb-
TdTomato expression was measured by fluorescence microscopy. Nanog and Esrrb 
expression seems to be concomitantly downregulated in the population of cells 
residing at the margins of the colonies (Figure 4.4A). In parallel, cells were 
collected, stained for SSEA-1 and analysed by flow cytometry. Differentiated  
SSEA-1 negative cells were excluded from the analysis. In the absence of selection, 
Esrrb and Nanog expression levels directly correlate in the fraction of cells that 
expresses both Nanog and Esrrb (Figure 4.4B). Cells expressing Nanog at low levels 
but retaining expression of Esrrb, as well as cells that had lost expression of both 
markers, were also detected. Importantly, cells showing high Nanog
 
levels were 






Figure 4.4: Esrrb and Nanog expression correlate in single ES cells.  
 
A: Esrrb and Nanog fluorescent reporter expression in TNG Esrrb-TdTomato cells 
cultured in the presence or in the absence of blasticidin or puromycin. D: Dot plots 
and histograms showing Esrrb and Nanog fluorescent reporter expression in SSEA-
1+ TNG Esrrb-TdTomato cells plated at low density and cultured for 3 days in the 





When cells were plated in similar conditions and blasticidin was added to the culture 
medium, it was not possible to stringently select for Esrrb expression (Esrrb
+
   80%). 
Nonetheless, cells grown in selection tended to form higher numbers of tight colonies 
completely lacking morphological signs of differentiation (Figure 4.4A). Selection 
for Esrrb expression also determined a small increase in the number of cells 
expressing Nanog (66% against 58%, Figure 4.4B). These results are probably due 
to the relatively long time required for blasticidin to achieve effective selection. In 
striking contrast, selection for Nanog transcription completely abolished 
heterogeneity in Esrrb expression (Figure 4.4A-B). This result is supported by the 
observation that Nanog overexpression imposes homogeneous Esrrb expression in 
ES cells (Figure 4.5). Therefore, in the transcriptional hierarchy of ES cells Esrrb 
seems to be placed downstream of Nanog, since heterogeneity in Nanog expression 
is not lost in reciprocal Esrrb overexpression experiments (Figure 4.5). 
 
4.3:    Esrrb downregulation requires loss of Nanog and coincides 
with commitment to differentiation 
 
It was then decided to determine whether ES cells could fluctuate between states of 
positive and negative Esrrb expression, how fluctuation related to Nanog expression; 
the kinetics of interconversion between the different populations were also analysed. 
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populations. Cells could not downregulate 




cells could either regain Nanog expression and maintain Esrrb levels or lose 


























Figure 4.5: Nanog overexpression abolishes Esrrb heterogeneity. 
 
Immunohistochemical analysis of Nanog and Esrrb expression in E14Tg2a, fEsrrb 
(Esrrb overexpressing) and EF4 (Nanog overexpressing) ES cells. Cells were plated 








Figure 4.6: Esrrb downregulation requires loss of Nanog. 
 
A: Dot plots showing Esrrb-TdTomato and Nanog:GFP expression of TNG Esrrb-
TdTomato ES cells after sorting SSEA-1+ Nanog+/Esrrb+, Nanog-/Esrrb+, Nanog-
/Esrrblow or Nanog-/Esrrb- cells and culture for 0 to 6 days in complete ES cell 















Figure 4.7: Esrrb downregulation coincides with commitment to differentiation 
 
A: Brightfield images showing widespread differentiation of sorted Nanog-/Esrrb- 
TNG Esrrb-TdTomato cells 3 days after replating in GMEM/FCS/LIF. B: 
Immunohistochemical analysis of Oct4 expression in TNG Esrrb-TdTomato cells 
cultured for 3 days in GMEM/FCS/LIF in the absence of puromycin or blasticidin 
selection. C: Numbers of alkaline phosphatase positive colonies observed 6 days 
after plating SSEA-1+ Nanog+/Esrrb+ , Nanog-/Esrrb+ , Nanog-/Esrrblow or Nanog-











population were able to regain 




 cells upregulated 
Esrrb, with the majority losing SSEA-1 and differentiating. To rule out the 
possibility that Esrrb
-
 cells were already differentiated at the time of sorting, TNG 
Esrrb-TdTomato cells cultures were stained for Oct4 expression. In addition to 
expressing high levels of SSEA-1, the majority of Esrrb
-
 cells expressed Oct4 at 
similar levels to Esrrb
+
 cells (Figure 4.7B). 
 
To quantify the self-renewal ability of the different populations, sorted cells were 
plated at clonal density in GMEM/FCS/LIF (FCS/LIF) or in N2B27/2i/LIF 
(2i/LIF). Strikingly, cells lacking Esrrb expression were unable to form 
undifferentiated colonies in FCS/LIF and completely lost their ability to grow in 
2i/LIF (Figure 4.7C). Taken together these data suggest that loss of Esrrb expression 
marks the fraction of ES cells that have committed to differentiation. 
 
4.4:   Tracking Esrrb transcription in destabilised GFP reporter lines 
 
In order to investigate in greater detail the early commitment events following loss of 
Esrrb expression, it was next decided to derive an ES cell line in which expression of 
a destabilised GFP protein with a half-life of 1 hour reports Esrrb transcription. 
E14Tg2a ES cells were targeted with vectors derived from the constructs employed 
to generate TNG Esrrb-2a-Tdomato cells by substituting TdTomato for a destabilised 
form of the GFP protein (Li et al., 1998). As before, both Esrrb alleles were targeted 
with vectors harbouring blasticidin or hygromycin resistance genes to prevent loss of 
the reporter alleles. 
 
When E14Tg2a Esrrb-2a-GFPdest1 cells are cultured in FCS/LIF it is possible to 
identify a fraction of the population that has lost Esrrb expression (Figure 4.8A). 
Confirming a connection between loss of Esrrb expression and differentiation, 






Figure 4.8: Esrrb downregulation is not irreversible.  
 
A: Histogram showing GFP expression in SSEA-1+ E14Tg2a Esrrb-2a-GFPdest1 
ES cells cultured in 2i/LIF or GMEM/FCS/LIF. B: Histogrmas showing GFP 
expression detected 0, 1, 2 or 3 days after plating sorted SSEA-1+ GFPhi, GFPmedium 
or GFP- E14Tg2a Esrrb-2a-GFPDest1 cells in GMEM/FCS/LIF. The purity of the 
three sorted population is shown in the top plot along with the GFP expression 
profile of unsorted cells. The percentage of cells falling in the GFPhi, GFPmedium or 





homogeneous expression of GFP in the ES cell population (Figure 4.8A). 
Conversely, release of the cells from blasticidin or hygromycin selection leads to the 
redistribution of GFP expression and allows the identification of cells that have 
recently downregulated Esrrb expression. E14Tg2a Esrrb-2a-GFPdest1 ES cells 









) and cultured for 3 days in FCS/LIF (Figure 4.8B). 
GFP
neg
 cells showed increased signs of differentiation compared to the other 
populations, but maintained a fraction of morphologically undifferentiated cells that 
slowly regained Esrrb expression (12% of the population at Day3). GFP 
downregulation was faster in the GFP
medium
 compared to the GFP
hi
 population, but 
both populations reconstituted a sizable negative fraction after 1 day in culture. In 
agreement with previous results, sorted GFP
neg
 cells showed a strongly reduced 





 cells showed similar self-renewal potential. (Figure 4.9A). 
GFP
neg
 cells completely lost their ability to form colonies in 2i/LIF, and a correlation 





 cells plated in these conditions (Figure 4.9A). 
In parallel, it was decided to analyse the gene expression profile of the three sorted 
populations. All populations retained expression of Oct4, and Sox2 expression was 
only slightly reduced in GFP
neg
 cells, in line with their undifferentiated state at the 
time of sorting (Figure 4.9B). Analysis of Esrrb mRNA levels confirmed the ability 
of the reporter cell line to accurately track Esrrb expression. Interestingly, a 
correlation between the expression of markers characteristic of a pristine 
undifferentiated state and Esrrb expression was observed, with complete loss of ES 
cell specific markers such as Rex1, Klf4, Dax1 and Nr5a2 in the GFP
neg
 population 
(Figure 4.9B). Nanog was the gene that matched more closely Esrrb levels in the 
cells. Conversely, loss of Esrrb coincided with upregulation of genes characteristic of 
cell lines derived from embryos at later stages of development (EpiSC) (Brons et al., 








Figure 4.9: Esrrb downregulation marks progressive loss of naïve 
pluripotency.  
 
A: Numbers of alkaline phosphatase positive colonies observed 6 days after plating 
SSEA-1+ GFPhi, GFPmedium or GFP- sorted E14Tg2a Esrrb-2a-GFPdest1 cells at 
clonal density in GMEM/FCS/LIF or in 2i/LIF. B: Gene expression profile of sorted 
SSEA-1+ and GFPhi, GFPmedium or GFP- E14Tg2a Esrrb-2a-GFPdest1 ES cells. Error 






Taken together these results indicate that loss of Esrrb expression in the Nanog
-
 
population of self-renewing ES cells marks commitment to differentiation. Cell fate 
is progressively locked after downregulation of Esrrb. Cells immediately lose their 
ability to be cultured in non-permissive conditions (2i/LIF) but retain for a short time 
the capacity to regain Esrrb expression and inefficiently self-renew in permissive 
medium (FCS/LIF). The loss of clonogenic ability in non-permissive culture 
conditions mirrors the dowregulation of ground state pluripotency markers and the 
upregulation of early differentiation markers that is then completed in cells that have 
completely silenced Esrrb expression. 
 
4.5:    Nanog null Esrrb reporter lines 
 
The previous results showed that Nanog and Esrrb expression correlate in single 
cells. It was also possible to determine that forced Nanog expression abolishes Esrrb 
heterogeneity, and that loss of Esrrb requires the downregulation of Nanog. Based on 
these observations, it was important to explore the effects of Nanog deletion on the 
dynamics of Esrrb expression at the single cell level. 
 
With this aim, T2a-TdTomato reporter cassettes were knocked in at the stop codon of 
both Esrrb alleles in ESN-NERT cells (See chapter 3 for a description of the line). 
Successful recombination was verified by quantitative PCR on genomic DNA using 
primer pairs amplifying exclusively exon 7 of WT Esrrb alleles. In these reactions, 
the forward primer anneals to the last portion of the Esrrb coding sequence and the 
reverse primer anneals at short distance in the 3’UTR of the gene. In targeted lines 
insertion of a 3Kb long sequence between Esrrb exon 7 and the 3’UTR prevents 
productive amplification.  Amplification using primer pairs binding Esrrb exon6, a 
position not modified by the targeting event, serves to normalise for variations in the 
amount of genomic DNA loaded in each PCR reaction, and gives consistent positive 
amplification in all samples analysed. This system was first validated using genomic 







Figure 4.10: Genomic qPCR confirms correct recombination in ESDN-NERT 
Esrrb-2a-TdTomato ES cells.  
 
A: Quantitative PCR analysis of the relative levels of WT Esrrb exon 7 to Esrrb exon 
6 in TNG, TNG Esrrb-TdTomato and TNG Esrrb-2a-TdTomato ES cells. Error bars 
are the standard deviation of the 3 technical replicates of one experiment. B: 
Quantitative PCR analysis of the relative levels of WT Esrrb exon 7 to Esrrb exon 6 
in E14Tg2a, ESN-NERT Esrrb-2a-Tdtomato (single targeted) and ESN-NERT 
Esrrb-2a-Tdtomato (Double targeted) ES cells. Error bars are the standard deviation 





recombination had been confirmed by Southern blot. Amplification from WT Esrrb 
exon 7 could be readily detected for TNG parental cells, whereas no signal was 
observed in three independent double targeted lines (Figure 4.10A). Next, successful 
recombination was assessed in ESN-NERT targeted lines. Amplification of WT 
Esrrb exon 7 could be detected in E14Tg2a ES cells, was reduced in ESN-NERT 
cells after the first targeting event and was absent in double targeted ESN-NERT 
Esrrb-2a-Tdtomato ES cells (Figure 4.10B). 
 
Once correct targeting had been confirmed, TNG Esrrb-2a-TdTomato and ESN-
NERT Esrrb-2a-TdTomato cells were replated in parallel at low density in the 
absence of any selection and three days after cells were collected, stained for   
SSEA-1 expression and analysed by flow cytometry. Since both TNG Esrrb-T2a-
TdTomato and ESN-NERT Esrrb-2a-TdTomato cells harbour identical Nanog:GFP 
and Esrrb-2a-TdTomato reporter alleles, it was possible to compare how 
transcription from Nanog and Esrrb levels correlate in the presence or absence of 
functional Nanog protein in the cells. ESN-NERT cells expressed overall reduced 
levels of Esrrb protein compared to TNG cells (Figure 4.11A-B). The 
downregulation of Nanog:GFP reporter expression, readily occurring in TNG cells 
released from selection,  was also compromised in this cell line, confirming the 
finding that Nanog repression of its own transcription plays an important role in 





 fraction of ESN-NERT Esrrb-2a-TdTomato cells the 
correlation between Nanog transcriptional output and Esrrb expression was almost 
completely lost (Figure 4.11A). In addition, opposite to what observed in TNG cells, 
Esrrb downregulation occurred in ESN-NERT cells irrespectively of the levels of 
Nanog:GFP expression (Figure 4.11A). These results indicate that the correlation 
between Esrrb and Nanog expression observed in TNG Esrrb-2a-TdTomato cells is 
driven by the different levels of functional Nanog protein present in single ES cells.  
 
The effects of inducing Nanog nuclear relocalisation was then tested in ESN-NERT 











Figure 4.11: Correlation between Nanog transcription and Esrrb levels is lost 
in Nanog null ES cells.  
 
A,B: Dot plots (A) and histograms (B) showing expression of Esrrb-2a-TdTomato 
and Nanog:GFP in undifferentiated SSEA-1+ TNG or ESDN-NERT Esrrb-2a-
Tdtomato ES cells released for three days from puromycin and blasticidin (TNG) or 






expression, fluorescent output from the Esrrb-TdTomato alleles was significantly 
increased in ESN-NERT cells treated with tamoxifen. Esrrb expression in 
tamoxifen treated cells was also significantly more homogeneous (Figure 4.12A).  
 
Next, the amount of time required for fluctuations in Nanog expression to results in 
alteration of Esrrb protein levels was determined. A precise quantification of this 
delay can significantly contribute to the understanding of how fluctuations in one 
pluripotency factor influence the levels of other ES cells regulators and result in 
functional differences among single cells in a genetically identical population. With 
this aim, the time required to elevate Esrrb protein levels was determined in ESN-
NERT Esrrb-2a-TdTomato cells by monitoring the increase in fluorescence signal 
from the TdTomato protein in tamoxifen treatment timecourse experiments. Since 
the T2a linked Esrrb and TdTomato proteins are synthesised in equimolar amounts, 
any increase in TdTomato fluorescence should be linked to an equivalent increase in 
Esrrb protein in this cell line. The first increase in TdTomato protein levels was 
detected 3-4 hours after Nanog induction (Figure 4.12B). TdTomato accumulated 
steadily until 20 hours after addition of tamoxifen and reached plateau levels by 24 
hours. A 2 fold difference in fluorescence levels was observed in treated versus 
untreated ESN-NERT Esrrb-2a-TdTomato cells (Figure 4.12B). These data suggest 
that any elevation in Nanog levels spontaneously occurring in a single ES cell would 
require around 22 hours to result in full induction of Esrrb. In this system, the time 
required to detect the first increase in TdTomato fluorescence is likely to report 
precisely when Esrrb protein levels are first increasing. In contrast, it is possible that 
the different stabilities of TdTomato and Esrrb result in discrepancies in the time at 
which increasing Esrrb and TdTomato protein levels reach plateau. Immunoblot 
analysis of protein extracts from ESN-NERT Esrrb-2a-TdTomato cells treated with 
tamoxifen for increasing time periods could solve this limitation. In any case, it 
would be interesting to perform time-lapse fluorescence microscopy on ESN-NERT 
Esrrb-2a-TdTomato cells treated with tamoxifen to confirm that a 3-4 hour delay in 









Figure 4.12: Nanog nuclear relocalisation in NERT cells results in the steady 
increase of Esrrb protein levels. 
 
A: Histogram showing the expression of Esrrb-2a-TdTomato and Nanog:GFP in 
undifferentiated SSEA-1+ ESN-NERT Esrrb-2a-Tdtomato ES cells maintained 
stimulated or not stimulated with tamoxifen for 24 hours. B: Graph showing the 
mean Esrrb-TdTomato fluorescence intensity detected after stimulating ESN-
NERT Esrrb-2a-Tdtomato ES cells with tamoxifen for the indicated time. Values are 
relative to untreated cells. Blue squares are the average of 2-3 independent replicas 






4.6:    Esrrb transcriptional response to 2i/LIF 
 
It was possible to show that culture of E14Tg2a Esrrb-2a-GFPdest1 cells in condition 
permissive only for completely undifferentiated cells (2i/LIF) results in 
homogeneous Esrrb expression (Figure 4.8A). Since Nanog expression is also 
upregulated by culture in 2i/LIF, it was decided to investigate whether the observed 
effect on Esrrb expression was mediated through upregulation of Nanog.  
 
ESN-NERT or TNG Esrrb-2a-TdTomato cells were replated and passaged four 
times in 2i/LIF before staining for SSEA-1 expression and analysis by flow 
cytometry. ESN-NERT Esrrb-2a-TdTomato cells kept in FCS/LIF and released 
from selection were analysed in parallel. Unexpectedly, SSEA-1 expression declined 
pronouncedly in cells cultured in 2i/LIF. Nonetheless, a fraction of the cells 
remained SSEA-1
+
 and was selected for further analysis. The levels of Nanog:GFP 
expression detected in ESN-NERT Esrrb-2a-TdTomato cells cultured in 2i/LIF 
were higher than in TNG Esrrb-2a-TdTomato cells (Figure 4.13B), indicating that 
autorepression limits Nanog transcriptional  induction under these conditions. 
Culture of Nanog null ES cells in 2i/LIF resulted in homogeneous and elevated levels 
of Esrrb expression compared to cells maintained in FCS/LIF (Figure 4.11A and 
4.13A), suggesting that inhibition of ERK and GSK signalling promotes Esrrb 
expression independently of Nanog. Nonetheless, TdTomato fluorescence levels in 
ESN-NERT Esrrb-2a-TdTomato cells maintained in 2i/LIF were not identical to 
those observed in TNG Esrrb-2a-TdTomato cells cultured in identical conditions 
(Figure 4.13B). This raised the hypothesis that the effects of 2i/LIF could be 
mediated by both a Nanog dependent and independent mechanism. To test this 
hypothesis, ESN-NERT Esrrb-2a-TdTomato cells cultured in 2i/LIF were passaged 
in the presence of tamoxifen to induce Nanog function. Indeed, treatment of ESN-
NERT Esrrb-2a-TdTomato cells with tamoxifen resulted in a drastic increase in the 
levels of TdTomato expression, surpassing the expression levels detected in TNG 
Esrrb-2a-TdTomato cells (Figure 4.13A-B). This indicates that the transcriptional 
output of Esrrb does not reach saturating levels in response to 2i/LIF and that Nanog 











Figure 4.13: Functional Nanog is required for full efficacy of 2i/LIF culture 
conditions. 
 
A,B: Dot plots (A) and histograms (B) showing expression of Esrrb-2a-TdTomato 
and Nanog:GFP in undifferentiated SSEA-1+ TNG or ESN-NERT Esrrb-2a-






Understanding whether this observation holds true for other targets of Nanog activity 
will help clarifying the importance of Nanog in mediating the response to ERK and 
GSK inhibition. In this respect, Nanog activation resulted in a pronounced reduction 
of Nanog:GFP expression in ESN-NERT cultured in 2i/LIF (Figure 4.13B), 
indicating that Nanog might be important in preventing inappropriate expression of 
its negative targets in ground state culture conditions.  
 
4.7:    Determination of pluripotency transcription factor expression 
by flow cytometry.  
 
In order to be able to extend the scope of these observations to other important 
mediator of pluripotency for which reporter lines are not available, it was decided to 
adapt immunofluorescence techniques for use in flow cytometry.  
 
The method employed (Festuccia and Chambers, 2011) is based on a fixation step 
that couples incubation in a diluted 0.25% PFA PBS solution with transfer to a 70% 
methanol solution in PBS at 4°C (See also Chapter 2 for a detailed description of the 
method). This fixation procedure permits to maximise the signal to background ratio 
and ensures consistency in the results generated from independent samples. First, it 
was necessary to test whether Nanog and Oct4 expression could be reliably detected 
with this technique. With this aim, Nanog overexpressing (EF4) and Nanog null 
(RCNH(t)) cells were stained in parallel, and the distributions of fluorescence 
values detected by flow cytometry were compared. A homogeneous population of 
cells with similar size and granularity was readily distinguishable from cellular 
debris after fixation, indicating that cellular integrity is preserved during the 
permeabilisation and staining procedure (Figure 4.14A).  Indeed, it was possible to 
distinguish background fluorescence detected in RCNH(t) cells from the staining 
signal observed in EF4 cells (Figure 4.14B). Staining of the two lines gave rise to 
completely non-overlapping fluorescence distributions, showing that this 











Figure 4.14: Detection of Nanog and Oct4 expression in ES cells by flow 
cytometry. 
 
A: Dot plot showing FSC (size) and SSC (granularity) parameters of the populations 
analysed. B: Histogram showing the distributions of Nanog staining fluorescence 
values in Nanog null (RCNH(t)) and Nanog overexpressing (EF4) ES cells. C: 
Histogram showing the distributions of Nanog staining fluorescence values in EF4 
and in E14Tg2a cells differentiated by culture in the presence of 10-6M retinoic acid 
and absence of LIF for 3 days (E14Tg2a +RA). D: Histogram showing the 
distributions of Oct4 staining fluorescence values in EF4 cells and ZHBTc4.1 cells 
depleted of Oct4 by culture in 1ug/ml doxycycline for 24h (ZHBTc4.1). E: Histogram 
showing the distributions of Oct4 staining fluorescence values in EF4 and 






The validity of this staining method was confirmed by comparison of EF4 and 
E14Tg2a differentiated by culture in the presence of retinoic acid (Figure 4.14C).  
 
Next, ZHBTc4 ES cells treated with tamoxifen for 24 hours were stained for Oct4 
expression and compared to untreated cells. Since tamoxifen treatment of ZHBTc4 
cells results in complete loss of Oct4 protein in as short as 12 hours (Niwa et al., 
2000; van den Berg et al., 2008), these cells were found ideal to test the ability of this 
technique to detect variations in Oct4 expression in two otherwise identical cell 
populations. Treatment of ZHBTc4 cells with tamoxifen resulted in a radical shift in 
fluorescence levels detected after staining for Oct4 (Figure 4.14D). Loss of Oct4 
expression was also detected in differentiated E14Tg2a cells (Figure 4.14E).  
 
It was then decided to assess whether the sensitivity of this technique permitted the 
detection of the fine variations in Nanog levels occurring in an ES cell population. 
E14Tg2a were concomitantly stained for Oct4 and Nanog expression. EF4, 
RCNH(t), and E14Tg2a differentiated by exposure to retinoic acid provided reliable 
controls (Figure 4.15A-B-D). Staining of E14Tg2a cells identified a fraction of the 
population that downregulated Oct4 expression and lost Nanog signal (Figure 
4.15C). It was thus possible to exclude differentiated cells and select Oct4
+
 cell for 
the further analysis of Nanog levels. Consistent with its heterogeneous expression, a 
broad range of fluorescence values was detected after Nanog staining of E14Tg2a 
cells (Figure 4.15D). Importantly the Nanog levels detected fell between the positive 
and negative boundaries set by EF4 and RCNH(t) cells. These results establish that 
transcription factor expression can be accurately quantified by coupling 
immunostaining and flow cytometry. 
It was next determined whether the described technique can be used in cell 
expressing fluorescence reporters of gene expression. TNG cells were stained for 
Oct4 and Nanog expression (Figure 4.16A) and Nanog staining and GFP signals 
compared in Oct4
+ 
undifferentiated cells. Nanog protein levels detected by staining 
correlated well with Nanog:GFP reporter expression (Figure 4.16B), with 61 and 










Figure 4.15: Quantification of Nanog and Oct4 expression in E14Tg2a cells. 
 
 
A,B: Dot plots showing Nanog and Oct4 expression in E14Tg2a cells differentiated 
by culture in the presence of 10-6M retinoic acid and absence of LIF for 3 days (A) 
and in EF4 cells (B) . C: Dot plots showing Nanog and Oct4 expression in E14Tg2a 
ES cells. D: Histogram plot comparing the distribution of Nanog protein levels 













Figure 4.16: Quantification of Nanog and Oct4 levels coupled with use of 
fluorescent reporters. 
 
A: Dot plot showing Nanog and Oct4 expression in TNG cells. B: Dot plot showing 
the correlation between Nanog protein and Nanog:GFP expression in TNG cells. 
C,D: Histograms showing the distribution of Nanog:GFP (C) and Nanog protein (B) 






These results provided a solid basis for applying flow cytometry to the study of 
heterogeneous transcription factor expression in ES cells. It was thus decided to 
extend the results generated analysing Nanog control over Esrrb expression to 
another important target of Nanog activity, Klf4. In particular, it was assessed 
whether the correlation between Nanog and Esrrb expression observed in single cells 
is further linked to variations in Klf4 levels.  
 
TNG Esrrb-TdTomato cells cultured in the presence or in the absence of puromycin 
were stained for Klf4 and Oct4 expression, allowing for concomitant quantification 
of the levels of 4 pluripotency regulators in single ES cells. Oct4 and Klf4 
negative/positive thresholds were set based on the fluorescence levels detected in 
Nanog overexpressing cells and E14Tg2a differentiated by retinoic acid, as shown in 
Figure 4.15. Oct4
+
 cells were readily distinguishable from a minority of 
differentiated cells in the population and were selected for further analysis. The 
fixation procedure did not compromise detection of the Esrrb-TdTomato and 
Nanog:GFP reporters (Figure 4.17A, left panel). It was possible to observe the 
expected correlation between Nanog:GFP and Esrrb levels in fixed cells, with Esrrb 
negative cells found only in the Nanog:GFP
-
 fraction of the population (Figure 
4.17A, left panel). As previously observed, selection for high levels of Nanog 
expression with puromycin completely abolished Esrrb heterogeneity (Figure 4.17B, 
left panel). Strikingly, Nanog and Klf4 levels in single cells showed a correlation 
pattern that was very similar to that observed for Esrrb. Klf4 negative cells were 
mainly found in the Nanog:GFP
-
 fraction of the population, and Klf4 downregulation 
was not observed in cells retaining high expression of Nanog (Figure 4.17A, middle 
panel). In addition, puromycin selection abolished heterogeneous expression of Klf4 
(Figure 4.17B, middle panel). It was next assessed whether the fraction of Nanog
-
 
cells that downregulated Esrrb coincided with cell that had also lost Klf4 expression. 
Indeed, Esrrb and Klf4 levels showed a tight correlation in single cells (Figure 
4.17A, right panel), with the majority of Esrrb
-
 cells also showing reduced Klf4 




 cells was not 














Figure 4.17: Nanog controls Esrrb and Klf4 fluctuations in ES cells. 
  
A,B: Dot plots showing Nanog:GFP, Esrrb-TdTomato and Klf4 protein levels in 







already downregulated Klf4, suggesting that Klf4 downregulation might follow a 
faster kinetic that loss of Esrrb (Figure 4.17A, right panel).  
 
Taken together these results show that Nanog fluctuations control the levels of two 
other important pluripotency regulators, Esrrb and Klf4, in single ES cells. Nanog
+
 
cells retain Klf4 and Esrrb expression and show high self-renewal efficiency whereas 
Nanog
-
 cells are susceptible to Esrrb and Klf4 downregulation, an event that marks 
commitment to differentiation. 
 
4.8:    Nanog and Oct4 fusion protein reporter ES cell lines  
 
The work presented in this chapter explored the functional consequences of gain or 
loss of Nanog expression in single ES cells. The experiments discussed relied on 
fluorescent reporter lines for the quantification of Nanog and Esrrb expression.While 
a variety of reporter systems were developed to track Esrrb protein levels or 
transcriptional output reliably, the quantification of Nanog was based on a GFP 
knock-in allele. Replacing the Nanog coding sequence with a GFP cassette does not 
allow the detection of any regulatory events exerted on Nanog protein or could lead 
to delays in detection of Nanog downregulation due to the long half-life of GFP. To 
overcome these limitations, it was decided to develop Nanog-GFP or Nanog-RFP 
fusion protein reporter lines. 
 
Fluorescent reporters were knocked-in at the 3’ end of the last exon of Nanog 
without introducing an exogenous polyadenylation signal or altering the 3’ UTR of 
the gene. Tag-RFP or GFP were fused in frame to the end of the Nanog coding 
sequence, connected through a five-glycine linker. The presence of an IRES 
sequence ensured expression of either blasticidin or hygromycin resistance genes 
(Figure 4.18A). Correct recombination was assessed by Southern blot (not shown).  
 












Figure 4.18: Nanog-RFP and Nanog-GFP ES cell reporter lines. 
 
A: Schematic representation of the Nanog locus structure and targeting vectors 
employed to generate Nanog-RFP or Nanog-GFP reporter lines. B: Nanog-RFP 
detection by fluorescence microscopy in live cells. Open arrows indicate Nanog- 
cells and solid arrows Nanog+ cells (Cells were identified based on brightfield 
images). C, D: Histograms showing Nanog-RFP fluorescence distributions in EF4 
(That serve as negative) or E14Tg2a Nanog-RFP cells cultured in GMEM/FCS/LIF 





detected as a clear nuclear signal by live cell microscopy (Figure 4.18B). Flow-
cytometry analysis of Nanog-RFP or Nanog-GFP cells detected a reduced fraction of 
Nanog
+
 cells when compared to what generally observed in TNG cells cultured in 
similar conditions (Figure 4.18C). This could be due to an improved ability to track 
downregulation of Nanog expression or degradation of Nanog protein. Alternatively, 
the observed reduction of Nanog
+
 cells may be attributable to an insufficient 
sensitivity in fluorescence detection by flow cytometry. 
 
Nonetheless, E14Tg2a Nanog-RFP cells maintained in 2i/LIF, a culture condition 
that results in  homogeneous and elevated levels of Nanog expression, showed 
fluorescence levels completely distinct from negative cells that do not express 
Nanog-RFP (Figure 4.18D). This indicates that flow cytometry can be used to 
isolate E14Tg2a Nanog-RFP cells expressing high Nanog levels.   
 
Overall, Nanog-RFP or Nanog-GFP fusion protein reporter lines are useful tools to 
track variations of Nanog protein levels in live imaging experiments, but present 
some limitations for use in flow cytometry. 
 
4.9:    Discussion 
 
The results presented in this chapter show that Nanog fluctuations in single ES cells 
influence the expression of its target genes, as determined for Esrrb (Figure 4.4, 4.5) 
and Klf4 (Figure 4.17). A reciprocal regulation is not observed in overexpression 
experiments (Fig 4.5, see also Figure 5.9). This is in contrast with the notion that 
Esrrb can activate Nanog expression (van den Berg et al., 2008). In light of this 
observation, it is possible to imagine that Esrrb generally supports Nanog expression 
but it is not able to dramatically alter Nanog transcriptional status when 
overexpressed. In accordance with these results, timecourse experiments analysing 
the transcriptional response to Esrrb induction failed to detect a strong effect on 
Nanog expression (see Chapter 8.3). Klf4 is also tightly controlled by Nanog (See 
Chapter 3 and Figure 4.17) but knockdown experiments did not result in any effect 




Nanog lies at the top of a transcriptional cascade that modulates the fluctuations of 
heterogeneously expressed transcription factors in ES cells. Relevant to this point, 
heterogeneous expression has been reported not only for Esrrb ( (van den Berg et al., 
2008) and Figure 4.4) and Klf4 (Niwa et al., 2009) but also for the pluripotency 
modulator Rex1 (Toyooka et al., 2008) and Tbx3 (Niwa et al., 2009). Rex1 was 
shown to be promptly modulated by Nanog in tamoxifen treatment timecourse 
experiment, although it presented high variability among samples (1.52 fold change 6 
hours after tamoxifen induction of ESN-NERT cells, p=0.122, see Table 3.1). Tbx3 
also responded to Nanog induction (1.27 fold change at 6 hours, p=0.005, see Table 
3.1). Intriguingly, Stella, another gene heterogeneously expressed in ES cells 
(Hayashi et al., 2008), did not show any variation in these experiments. Since Esrrb, 
Klf4 ((Jiang et al., 2008; Niwa et al., 2009) and see Figure 5.13) and Tbx3 (Niwa et 
al., 2009) all have a functional role in ES cells, it is possible that Nanog specifically 
orchestrates expression of factors involved in sustaining the undifferentiated state. 
 
According to this hypothesis, changes in Nanog levels should be followed by 
changes in expression of a cohort of its target genes in a synchronous, coordinated 
way. Indeed, it was possible to observe that Esrrb and Klf4 fluctuation is single cells 
are linked and both factors show correlation with Nanog expression (Figure 4.17). 
Nanog fluctuations are not rapid, happening over a period of days ((Chambers et al., 
2007) and Figure 4.6). Experiments exploiting inducible Nanog function in ESN-
NERT ES cells carrying an Esrrb-T2a-TdTomato fluorescent reporter show that 
increase in Esrrb protein levels may follow Nanog upregulation with a delay of 
almost 24 hours (Figure 4.12). It would be interesting to follow the modulation of 
Esrrb, possibly in conjunction with Klf4, Rex1 or Tbx3, in time-lapse microscopy 
experiments, to ascertain whether changes in the protein levels of these genes present 
a delayed response to Nanog oscillations and whether reproducible patterns in the 
kinetics of this response can be identified.   
 
The results presented here highlighted a clear correlation between Nanog and Esrrb 
protein expression in single cells (Figure 4.4). In addition, the data presented in 




populations. Whereas Nanog control on the accumulation or reduction of its targets 
at the protein level seems to achieve its effects over prolonged periods of time, it is 
reasonable to expect that Nanog control of transcription is characterised by much 
faster dynamics. Analysis of the transcriptional output from Nanog target genes in 
live cells might possibly reveal an even tighter correlation between Nanog expression 
and target gene activation. Analysis of Esrrb expression employing destabilised 
reporters of transcription detected the appearance of cells completely negative for 
Esrrb:GFPdest1 expression 24 hours after replating sorted Esrrb
medium
 populations 
(Figure 4.8). This shows that silencing of Esrrb transcription follows rapid kinetics 
compared to modulation of Esrrb protein levels (2 days required to see full 
downregulation of Esrrb in Nanog negative cells, Figure 4.6).  
 
Recent studies uncovered that Nanog is monoallelically expressed in ES cells 
(Miyanari and Torres-Padilla, 2012). Observations by this group (Pablo Navarro, 
unpublished data) suggest that Esrrb also presents a predominantly monoallelic 
expression pattern. It would be interesting to determine whether Nanog levels shift 
the proportion of cells transcribing both Esrrb alleles in the ES cell population. 
Esrrb:GFPdest1 reporter lines engineered to express a distinct unstable fluorescent 
protein under the control of the second Esrrb allele could be used in these 
experiments. In this respect, it should be noted that, despite destabilised fluorescent 
reporter systems allow accurate monitoring of transcriptional silencing, detection of 
gene activation probably requires prolonged, continuous transcriptional output from 
these reporter alleles. This could lead to gross underestimation of the fraction of ES 
cells actively transcribing Esrrb. Cells that have recently started transcribing Esrrb 
or undergo less frequent or sporadic rounds of transcriptional firing would be 
detected as negative. In an alternative approach, the relation between Esrrb 
expression and Nanog protein levels in single cells could be explored coupling 
immunohistochemistry and RNA-FISH, but such an approach would preclude 
continuous measures in live cells. The use of two novel imaging techniques that 
allow the visualisation of foci of active transcription in live cells could circumvent 




in ES cells (unpublished method developed by Luke Lee at UCSC Berkley and 
(Daigle and Ellenberg, 2007; Janicki et al., 2004)(see Chapter 9.2).  
 
The experiments discussed in this chapter determined that loss of Esrrb expression 
marks ES cells primed for differentiation. Similarly, Nanog expression was reported 
to correlate with the ability of ES cells to self-renew (Chambers et al., 2007). Taken 
together these results provide a framework to understand the sequential molecular 
events that lead from Nanog downregulation to exit from the pluripotent state. 
Building on the results from transcriptional studies, it was possible to show that 
Nanog influences expression of a number of pluripotency factors in single cells. 
Sorting experiments demonstrate that Nanog downregulation is strictly required for 
ES cells to silence expression of Esrrb (Figure 4.4) and that Nanog
low
 cells are in a 
state in which they are more prone to downregulate expression of this and possibly 
other pluripotency factors (Figure 4.6). Nonetheless, Nanog
low
 cells retain their 
clonogenic potential in condition permissive only for undifferentiated cells (2i/LIF) 
and are still able to re-acquire expression of Nanog (Figure 4.6, 4.7). Complete loss 
of Esrrb in this subpopulation requires 2 days and accompanies progressive 
commitment to differentiation. Esrrb
low
 cells sequentially lose their ability to self-
renew in 2i/LIF and FCS/LIF, and progressively downregulate markers characteristic 
of pristine pluripotency (Figure 4.8).  
 
Esrrb and Nanog double reporter lines capture the progressive nature of exit from 
pluripotency with unprecedented detail and constitute a useful tool for the future 
characterisation of the early transcriptional and epigenetic events underlying this 
process. Interestingly, the results presented indicate that differentiating Esrrb
low
 cells 
acquire a gene expression profile reminiscent of EpiSC (Figure 4.9). This 
observation is in agreement with previous reports showing that Rex1 (Toyooka et al., 
2008) and Stella (Hayashi et al., 2008) expression is heterogeneous in ES cells and 
downregulation of these markers leads to the acquisition of a gene expression pattern 
characteristic of the post-implantation epiblast. In particular it was shown that Rex1
-
 
cells, like the post-implantation epiblast, have lost the ability to differentiate into 




introduced in pre-implantation embryos (Toyooka et al., 2008). These reports and the 
results presented in this chapter seem to indicate that the early steps of in vitro 
differentiation recapitulate in vivo development. Interestingly, Esrrb in not expressed 
in the post-implantation epiblast (Luo et al., 1997) and transient Nanog 
downregulation is observed upon implantation ((Chambers et al., 2003; Osorno et al., 
2012) and Fredrik Wong, unpublished information). It might be that Nanog 
expression is silenced upon implantation to allow downregulation of a number of 
ICM specific factors, including Esrrb, that would otherwise prevent normal 
progression of development. Upon implantation, epiblast cells also embark on the 
process of random X inactivation (Lyon, 1961; Rastan, 1982). It would be interesting 
to determine the X inactivation status in the distinct Esrrb:Tdtomato and Nanog:GFP 
subpopulations identified in this study. The analogies in the results obtained 
employing Esrrb, Rex1 and Stella reporters suggest that Esrrb is not a unique marker 
of early differentiation.  The observation that heterogeneously expressed Nanog 
targets fluctuate in a coordinated way corroborates this interpretation. Despite this, 
the observation that Esrrb has a strong functional role in sustaining pluripotency (see 
Chapter 5 and 8) might indicate that loss of Esrrb has a causal role in triggering the 
differentiation process, rather than merely marking it.  
 
Finally, the results presented highlight the strong influence of both intrinsic and 
extrinsic regulatory inputs on Esrrb expression. Nanog null cells show increasingly 
heterogeneous and overall reduced levels of Esrrb expression (Figure 4.12). In 
addition, 2i/LIF culture conditions strongly enhance Esrrb expression (compare 
Figure 4.11 and 4.12). Augmented Esrrb expression is also observed in Nanog null 
cells grown in 2i/LIF, indicating that ERK and GSK inhibition does not require 
Nanog to exert its effect. This is in agreement with recent reports that the 
GSK/catenin axis directly controls Esrrb expression in 2i conditions through 
modulation of Tcf3 activity (Martello et al., 2012). Nonetheless, the fact that Esrrb 
expression in Nanog null ES cells cultured in 2i/LF is reduced and more 
heterogeneous compared to wildtype cells indicates that Nanog is required for full 
Esrrb induction under these conditions. Nanog elevation could therefore be important 




observation also connects to a point of broader relevance. Nanog induction in ESN-
NERT cells cultured in 2i results in strong upregulation of Esrrb and downregulation 
of GFP (Figure 4.13). This proves that pluripotency factor expression is still strongly 
dependent of intrinsic regulatory inputs in “ground state” conditions, indicating that 
emerging proprieties of the pluripotency GRN that drive ES cell heterogeneity could 








Chapter 5:    Effects of Esrrb overexpression on ES cell 
self-renewal 
 
The data discussed in Chapter 3 identified a reliable list of Nanog target genes. Based 
on these results, the analysis presented in this chapter aims at getting a better 
understanding of the role that specific genes play in mediating Nanog activity in ES 
cells. In particular, experiments were performed to determine whether the 
overexpression of Esrrb is able to functionally complement the loss of Nanog in ES 
cells, and how this relates to the effects of elevating of other Nanog target genes.   
 
5.1:    Esrrb overexpression confers LIF independent self-renewal 
 
Nanog was isolated by its ability to drive LIF independent self-renewal of ES cells 
(Chambers et al., 2003). Thus, experiments were performed to determine whether 
Esrrb overexpression results in a similar phenotype and whether Nanog activity is 




 cells (Chambers et al., 2003) were transfected with an episomal Esrrb 
expression vector and plated at clonal density in the presence or absence of 
IL6/sIL6R. Transfection with Nanog or an empty vector served as controls. Forced 
Esrrb expression resulted in self-renewal in the absence of gp130 signalling (Figure 
5.1A), but seemed to be less efficient than Nanog in episomal experiments. 
 
Next, it was determined whether the observed effect could be recapitulated in clonal 
lines of stable integrants. A loxP-flanked Esrrb transgene was integrated in E14Tg2a 
cells (EfEsrrb cells) (Figure 5.1B). EfEsrrb cells showed robust Esrrb 
overexpression (Figure 5.1C), a phenotype reversed by transient transfection with 
Cre. When plated at clonal density in the presence of LIF, EfEsrrb cells formed a 







Figure 5.1: Esrrb promotes LIF-independent self-renewal. 
 
A: lifr-/-:PyLT+ LRK1 cells were transfected with episomal plasmids encoding Nanog 
or Esrrb (EV; empty vector is shown as a control) and the number of AP-positive 
colonies determined after clonal density plating in the absence of IL-6/sIL6R. Error 
bars: standard deviation (n=3). B: Schematic representation of the genetic 
manipulations performed on EfEsrrb ES cells. C: Relative Esrrb transcript level in 
E14tg2a, EfEsrrb and EfEsrrb-Cre cells.Error bars: standard deviation of the 
technical errors. D: Colony morphology and AP staining of EfEsrrb c1 cultured in the 
presence of hLIF-05.E: Number of AP+ colonies scored after plating at clonal density 
E14Tg2a or Nanog (EF4) and Esrrb overexpressing cells (before and after Cre 
reversion) and culture in the presence or absence of LIF or with hLIF-05 for 7 days. 
Error bars: standard deviation (n=3). F: Chimaeras generated after blastocyst 
injection of EfEsrrb cells passaged twice at clonal density in the absence of LIF and 
transfected with a Cre expression vector to excise the Esrrb transgene. 
 
The data presented in this figures, with the exception of panel C and D, were kindly 




compared to parental E14Tg2a cells. Importantly, in the presence of the LIF 
antagonist hLIF-05 (Vernallis et al., 1997) that completely abolishes LIF signalling, 
EfEsrrb cells were also able to form a sizable number of undifferentiated colonies 
(Figure 5.1D-E). This ability was completely lost after deletion of the Esrrb 
transgene, incontrovertibly indicating that forced Esrrb expression was responsible 
for the observed phenotype (Figure 5.1D-E). As previously observed in episomal 
experiments, EfEsrrb cells self-renewed less efficiently compared to EF4 (Figure 
5.1E), a cell line expressing 6-8 fold wild-type levels of Nanog (Figure 3.10A and 
(Yates and Chambers, 2005)). 
 
To rigorously determine whether Esrrb overexpression is sufficient to maintain 
pluripotency through clonal expansion in the absence of LIF signalling, EfEsrrb cells 
were plated at clonal density in the presence of LIF antagonist and passaged twice at 
clonal density. At this point, control parental cells had completely differentiated and 
could not be passaged further. In contrast, EfEsrrb clones continued to self-renew. 
These cells were treated with Cre and GFP expressing cells that had deleted the Esrrb 
open reading frame (ORF) were expanded in LIF. Injection of these cells into 
C57BL/6 blastocysts gave rise to adult chimaeras (Figure 5.1F), indicating that 
Esrrb overexpressing cells remained pluripotent after repetitive passaging in the 
absence of LIF.  
 
5.2:    Esrrb overexpression promotes LIF independent self-renewal 
independently of Nanog 
 
It was then determined whether Esrrb is able to functionally substitute for Nanog in 
sustaining gp130-independent self-renewal. With this aim, the Esrrb coding sequence 
was cloned in a CAG promoter driven expression vector downstream of a TdTomato 
reporter, linked through a 2a peptide, and the vector was electroporated into Nanog
-/-
 
TC44c6 ES cells (ESN-CAGE ES cells)(Figure 5.2A). The 6 clones isolated 
showed robust transgene expression when compared to parental TC44c6 ES cells 







Figure 5.2: Esrrb promotes LIF-independent self-renewal in the absence of 
Nanog. 
 
A: Schematic representation of the genetic manipulations performed on ESN-
CAGE ES cells. B: Esrrb transcript levels in TC44c6 and ESN-CAGE ES cells. 
Error bars: standard deviation of the technical errors in gene expression 
quantification in one experiment. C: Esrrb protein expression in parental TC44c6 
and ESN-CAGE ES cells. D: Number of AP+ colonies scored after plating at clonal 
density TC44c6 or ESN-CAGE cells and culture in the presence or absence of 
LIF for 8 days. Error bars: standard deviation of the number of colonies counted in 
three different plates. E: TdTomato and Nanog:GFP reporter expression detected in 





(Figure 5.2B-C). Each line was plated at clonal density in the presence or in the 
absence of LIF and the number of alkaline phosphatise (AP) positive colonies was 
scored 8 days after plating. When LIF was added to the culture medium, Esrrb 
expression in ESN-CAGE cells resulted in an increased numbers of AP positive 
colonies compared to the parental line, showing that Esrrb can complement the self-
renewal defects observed in Nanog null ES cells. In the absence of LIF, parental 
TC44c6 ES cells could not form any undifferentiated colony (Figure 5.2D). In 
contrast, Esrrb overexpression led to the formation of tight, morphologically 
undifferentiated AP
+
 colonies, indicating that Esrrb activity is not dependent on 
Nanog (Figure 5.2D).  
 
Prior to staining, the activity of the Nanog:GFP reporter present in TC44c6 cells 
was assessed by fluorescence microscopy. Active transcription from the Nanog locus 
was detected after 8 days of culture in the absence of LIF. Intriguingly, expression of 
GFP was not homogeneous in the culture. It was possible to observe colonies 
showing a tight morphology, generally associated with an undifferentiated state, in 
which part of the cells lacked GFP expression (Figure 5.2E). All the colonies 
observed retained high expression of the Esrrb transgene, as judged by the strong 
TdTomato fluorescence. These data further strengthens the notion that Nanog 
activation is not a crucial component of Esrrb activity in promoting LIF 
independence in ES cells. 
 
5.3:    Design and construction of doxycycline inducible expression 
systems 
 
To conclusively prove that forced Esrrb expression results in LIF independent self-
renewal in cells lacking Nanog, it was necessary to determine whether Nanog
-/-
 Esrrb 
overexpressing cells could maintain their pluripotent state after long-term culture in 
the absence of LIF, showing uncompromised differentiation potential after silencing 





It was thus decided to derive a doxycycline inducible system that would allow for 
tuneable and reversible transgene expression in ES cells. A modified version of the 
pPyPCAG vectors was obtained by substitution of the constitutive CAG promoter for 
a doxycycline responsive element (Figure 5.3A). This element is based on the fusion 
of a minimal CMV promoter with six tandem repeats of the tetracycline operator 
sequence (Courtesy of Keisuke Kaji). 
 
5.3.1:    Rosa26 based rtTA expression 
 
A TdTomato-2a-Esrrb cassette was cloned into this vector and the construct 
randomly integrated into the genome of Rosa:rtTA ES cells, a cell line that expresses 
an improved form of the rtTA transactivator (rtTAMs2) from the Rosa26 locus 
((Urlinger et al., 2000), courtesy of Andrew Smith). Clones were cultured in 
doxycycline and selected for high expression of the TdTomato fluorescent reporter 
by flow cytometry. In conjunction, the basal levels of transgene expression were 
evaluated in untreated cells. After two consecutive screening rounds on a total of 34 
clones, the three lines showing highest transgene induction and lowest basal 
expression were selected for further analysis (Figure 5.3B). A three (clone 17) to 
fourfold (clone 15) induction in the levels of Esrrb transcript was observed in 
Rosa:rtTA TdTomato-Esrrb lines cultured for 24 hours in the presence of 
doxycycline compared to the parental line (Figure 5.3C). Conversely, basal levels of 
transgene expression varied from being almost undetectable (clone 17) to resulting in 
almost a twofold induction in Esrrb transcript (clone 7). An induction in Esrrb 
protein could be detected by western blot (Figure 5.3D). Little or no difference in 
the basal level of Esrrb protein compared to Rosa:rtTA cells was observed for clone 
17, while increased levels were detected for clones 15 and 7. TdTomato reporter 
expression was evident by fluorescence microscopy in all three lines after 24 hours 
of induction, while little or no signal was observed in untreated cells (Figure 5.3E). 
In addition, it should be noted that TdTomato levels appeared to be heterogeneous in 
these lines (Figure 5.3B), and that transgene expression was confined to the 










Figure 5.3: Characterisation of Rosa:rtTA Esrrb-2a-Tdtomato ES cells. 
 
A: Map of the doxycycline inducible Esrrb-2a-TdTomato expression vector. B: 
Histograms showing the distributions of TdTomato fluorescence in three Rosa:rtTA 
TdTomato-2a-Esrrb lines cultured in the presence (brown) or in the absence (blue) 
of 1 g/ml doxycycline for 4 days. The fluorescence profile of cells not expressing 
TdTomato is shown as a negative control (black). C,D: Esrrb transcript (C) and 
protein (D) levels in Rosa:rtTA and three Rosa:rtTA TdTomato-2a-Esrrb ES cell 
lines cultured in the presence or absence of 1 g/ml doxycycline for 4 days. Error 
bars in panel C: standard deviation of the technical errors in gene expression 
quantification in one experiment. E: TdTomato expression in Rosa:rtTA TdTomato-






The potential to finely tune transgene induction was then assessed by culturing 
Rosa:rtTA TdTomato-2a-Esrrb ES cells in the presence of increasing concentration 
of doxycycline. TdTomato and Esrrb transcripts levels in the cells showed a 
sigmoidal response to the concentration of doxycycline, with a nearly linear response 
on a logarithmic scale for doxycycline concentrations ranging from 10ng/ml to 
1000ng/ml (Figure 5.4A). A similar response was observed by flow cytometry for 
the fluorescence levels of the TdTomato reporter (Figure 5.4B). Importantly, the 
distribution of TdTomato fluorescence values became more heterogeneous when 
cells were cultured in the presence of 100ng/ml of doxycyline, suggesting that 
special attention should be used when such inducible lines are used to test the effects 
of low levels of Esrrb expression in ES cells (Figure 5.4C). Finally, the transgene 
expression achieved in these doxycycline inducible lines was compared with the 
levels of Esrrb observed in other overexpressing cells. Total Esrrb levels were 
measured by quantitative PCR in ESN-CAGE and Rosa:rtTA TdTomato-2a-Esrrb 
cells. A three to fourfold induction over TC44c6 levels was observed for 
doxycycline inducible lines while a four to five fold induction was achieved with 
CAG promoter based expression vectors (Figure 5.4D). 
 
The functionality of Rosa:rtTA TdTomato-2a-Esrrb cells was then tested in a LIF 
independence assay. Cells were plated at clonal density in the presence or absence of 
LIF and after 7 days the number of AP positive clones was scored. Culture of 
inducible lines in the presence of LIF and doxycycline resulted in an increased 
numbers of AP positive colonies compared to uninduced or parental Rosa:rtTA cells 
(Figure 5.5A). Nonetheless, in sharp contrast to what observed for CAG promoter 
driven overexpression of Esrrb, addition of doxycycline to cells cultured in the 
absence of LIF did not result in the presence of undifferentiated colonies in the plates 
(Figure 5.5A). Only limited numbers of mixed colonies in which self-renewing ES 
cells were surrounded by differentiating cells could be observed (Figure 5.5B). This 
result may be explained by the previous observation that transgene expression is 
heterogeneous in Rosa:rtTA TdTomato-2a-Esrrb cells, in particular in differentiated 







Figure 5.4: Tunable transgene induction in Rosa:rtTA TdTomato-2a-Esrrb ES 
cells. 
 
A: Esrrb and TdTomato transcript levels in Rosa:rtTA and Rosa:rtTA TdTomato-2a-
Esrrb ES cells cultured in the presence of the indicated concentrations of 
doxycycline (ng/ml) for 4 days. Error bars: standard deviation of the technical errors 
in gene expression quantification in one experiment. B: Mean TdTomato 
fluorescence values detected in Rosa:rtTA and Rosa:rtTA TdTomato-2a-Esrrb cells 
cultured in the presence of the indicated concentrations of doxycycline (ng/ml) for 4 
days. C: Histograms showing the distributions of TdTomato fluorescence in 
Rosa:rtTA TdTomato-2a-Esrrb lines cultured in the presence of the indicated 
doxycycline concentration for 4 days. The fluorescence profile of cells not 
expressing TdTomato is shown as a negative control. D: Esrrb transcript level in 
TC44c6 and 6 ESN-CAGE lines compared to Rosa:rtTA and 3 Rosa:rtTA 
TdTomato-2a-Esrrb lines cultured in the presence of 1 g/ml doxycycline for 4 days. 
Error bars: standard deviation of the technical errors in gene expression 











Figure 5.5: Doxycycline inducible Esrrb expression fails to promote LIF-
independent self-renewal in Rosa:rtTA TdTomato-2a-Esrrb ES cells. 
 
A: Number of AP+ colonies scored after clonal density plating of Rosa:rtTA 
TdTomato-2a-Esrrb cells and culture in the presence or absence of LIF and 1 g/ml 
doxycycline for 7 days. Error bars: standard deviation of the number of colonies 
counted in three different plates. B: Colony morphology and TdTomato expression 
in Rosa:rtTA TdTomato-2a-Esrrb cells plated at clonal density and cultured in the 





This ensures controlled genomic alteration and ubiquitous expression of rtTA during 
development, making this cell line suitable for in-vitro and in-vivo studies. However, 
optimal levels of rtTA expression could not be achieved in this system. 
 
5.3.2:    Randomly integrated rtTA system 
 
To test whether variations in the rtTA expression levels might result in higher 
transgene induction or lower background expression in inducible lines, a CAG-rtTA 
cassette was randomly integrated into the genome of TC44c6 Nanog null ES cells. 
Stably transfected clones were pooled and electroporated with a version of the 
previously described doxycycline inducible vectors modified to allow for 
recombinase mediated cassette exchange (RMCE) (ESN-iTdT cells, Figure 5.6A). 
In this system cells are initially transfected with a vector driving expression of 
TdTomato and a hygromycin resistance - thymidine kinase (Hygro-TK) fusion 
protein. Once clones showing optimal expression are identified, negative selection 
ensured by thymidine kinase can be exploited to insert different sequences at the 
integration site by RMCE, using Flp recombinase and heterotypical FRT sites 
(Raymond and Soriano, 2007) (Figure 5.6A). This system allows the insertion of 
sequences encoding any gene of interest in substitution or downstream of the 
TdTomato fluorescent reporter present in the integrated construct. It is therefore 
possible to compare the effects of forced expression of different genes in ES cell 
lines with identical genetic background. This excludes phenotypic differences 
resulting from alterations caused by the random insertion of the transgene into the ES 
cell genome. In addition, similar levels of expression should be achieved for all 
genes, facilitating direct comparison of the results. 
 
After electroporation of the TC44c6 line, ESN-iTdT cells were selected with 
hygromycin in the presence of doxycycline and blasticidin for 8 days. At this time 
hygromycin and blasticidin selection were withdrawn and cell cultured for additional 










Figure 5.6: Doxycycline inducible ESN-iNanog or ESN-iEsrrb lines. 
 
A: Map of the inducible TdTomato-2a-HygroR-TK and Nanog or Esrrb shuttle 
vectors. B: Schematic representation of the genetic manipulations performed on 
ESN-Nanog or ESN-Esrrb ES cells. C: Histograms comparing the distribution of 
TdTomato fluorescence in ESN-iTdT cells cultured in the presence of doxycycline 
and hygromycin, or in the presence of doxycycline after releasing from hygromycin 
selection for 2 weeks. Fluorescence levels of untreated cells are shown in the left 
panel. D: Quantitative PCR analysis of the relative levels of TdTomato to Esrrb exon 
6 performed on genomic DNA from E14Tg2a, ESN-iTdT or 5 ESN-iNanog and 







the absence of selection. In addition, since neomycin selects for active transcription 
from the Nanog locus in TC44c6 ES cells, nascent colonies were cultured in the 
absence of neomycin to allow for low levels of spontaneous differentiation to occur 
in the ES cell population, (Figure 5.5B). 35 colonies showing intense fluorescence 
and sustained expression in differentiated cells at the rim of the colony were selected. 
After picking, clonal lines were expanded and screened for TdTomato expression by 
flow cytometry. Neomycin selection was then restored and cells were expanded in 
the absence of blasticidin and hygromycin for 14 additional days. Each clone was 
then replated in the presence or in the absence of doxycycline and after 4 days 
TdTomato fluorescence was assessed again by flow cytometry. The distribution of 
fluorescence intensities varied extensively in different ESN-iTdT clones. While 
complete loss of transgene expression was rarely observed, most of the clones 
showed greatly reduced TdTomato levels and a broad distribution of fluorescence 
values. Only two clones maintained satisfactorily high levels of transgene expression 
in the absence of continuous selection. One clone that showed the highest levels of 
transgene expression and presented a tight distribution of fluorescence values 
(Figure 5.6C) was selected for RCME. ESN-iTdT cells were transiently co-
transfected with a plasmid driving expression of the Flp recombinase and a shuttle 
vector carrying an Esrrb or Nanog-IRES-puromycin resistance gene cassette flanked 
by heterotypical FRT3 and FRT5 sites. Cells were replated at low density and after 
48 hours puromycin selection was applied. 4 days after replating ganciclovir was 
added to the culture medium. Clones showing loss of TdTomato expression formed 
viable colonies and 10 days after replating could be picked and expanded. Successful 
recombination was assessed by qPCR on genomic DNA using primer pairs binding 
to the TdTomato cassette present in parental ESN-iTdT cells. Amplification of an 
unrelated genomic locus (Esrrb exon 6) served as a control to normalise for the 
amount of template DNA loaded in each reaction. Esrrb exon 6 was detected in all 
samples analysed and amplification of TdTomato was robust in genomic DNA 
samples from parental ESN-iTdT cells. No TdTomato amplification was detected in 
inducible Nanog clones (Figure 5.6D). Interestingly, two out of 5 inducible Esrrb 
clones analysed, retained the TdTomato cassette. Since a greatly reduced number of 




to inducible Nanog lines, these results might indicate that the Esrrb expression levels 
achieved in this system are detrimental to optimal self-renewal of ES cells. 
Nonetheless, 3 inducible Esrrb clones that had undergone correct exchange of the 
TdTomato cassette could be identified (Figure 5.6D). 
 
Expression of Nanog and Esrrb transgenes was evaluated in two independent clones 
for both inducible Nanog and Esrrb lines after culture in the presence or absence of 
doxycycline. A three to four fold induction in Esrrb or Nanog levels over E14Tg2a 
ES cells was detected for all clones analysed. As expected, levels of expression were 
similar in the two clones selected for each line (averaged expression values are 
presented in Figure 5.7A). Background levels of expression in untreated cells were 
almost undetectable for both ESN-iNAnog and ESN-iEsrrb clones. Since 
TC44c6 ES cells lack functional Nanog alleles, the low levels of Nanog transcript 
detected in ESN-iNanog lines confirm the absence of leaky transgene expression. 
Finally, induction of Nanog was accompanied by uniform morphological changes, 
characteristic of Nanog overexpression, in ESN-iNanog cells (Figure 5.7B), 
indicating that homogeneous expression is achieved in this line. 
 
5.4:    Esrrb expression sustains Nanog null ES cell self-renewal 
after long-term passaging in the absence of LIF 
 
It was then tested whether the sustained and homogenous transgene expression 
achieved in ESN- inducible lines would allow for their use in functional assays. 
With this aim ESN-iNanog or ESN-iEsrrb cells were plated at clonal density in 
the presence of LIF or LIF antagonist, with or without doxycycline. 
After 7 days in the absence of LIF, only ESN-iEsrrb or ESN-iNanog cells cultured 
in the presence of doxycycline formed undifferentiated colonies expressing 
Nanog:GFP reporter. Esrrb overexpression resulted in the presence of tight self-
renewing colonies (Figure 5.8A), although in lower numbers compared to Nanog 













Figure 5.7: Doxycycline inducible ESN-iNanog or ESN-iEsrrb lines. 
 
A: Esrrb and Nanog transcript levels in E14Tg2a, TC44c6 and ESN-iNanog or 
ESN-iEsrrb ES cells cultured in the presence or in the absence of 1g/ml of 
doxycycline. Error bars: standard deviation of gene expression measured in two 
independent clones (ESN-iNanog or ESN-iEsrrb) or three independent 










Figure 5.8: Esrrb expression induces LIF independent self-renewal in Nanog 
null ES cells. 
 
A: Colony morphology and Nanog:GFP expression  in ESN-iNanog or ESN-iEsrrb 
cells plated at clonal density and cultured for 8 days in the presence of LIF or LIF 
antagonist, with or without 1g/ml of doxycycline. B: Number of AP+ colonies scored 
after clonal density plating of ESN-iNanog or ESN-iEsrrb cells and culture for 8 






cells overexpressing Nanog, ESN-iEsrrb cells showed heterogeneous Nanog:GFP 
expression. To substantiate the above observations, the experiment was repeated and 
after 7 days of culture at clonal density cells were harvested to quantify GFP 
expression by flow cytometry. As shown in Figure 5.9B, TC44c6, ESN-iNanog 
and ESN-iEsrrb cultured in the presence of LIF and absence of doxycycline were 
indistinguishable. In the presence of LIF, Nanog induction resulted in decreased but 
homogeneous levels of Nanog:GFP expression in undifferentiated SSEA-1 positive 
cells (Figure 5.9C). Conversely a clear GFP
-
 population appeared when Esrrb 
expression was induced (Figure 5.9C). This difference was maintained when cells 
were cultured in the absence of LIF, with Esrrb induction resulting in the 
concomitant presence of bright GFP
+
 cells and cells that had lost GFP expression in 
the same population. Nanog expression resulted in homogenously reduced GFP 
expression in the same conditions (Figure 5.9D). 
 
Since these experiments were performed in Nanog null ES cells, it is possible to 
conclude that the ability of Esrrb to confer LIF independent self-renewal to ES cells 
is not mediated by sustained activation of Nanog expression and does not rely on the 
presence of functional Nanog protein in the cells. 
 
ESN-iNanog and ESN-iEsrrb cells could be cultured in the presence of LIF 
antagonist for more than one month. While Nanog induction completely suppressed 
differentiation under these conditions, Esrrb expression resulted in the maintenance 
of self-renewing ES cells accompanied by the presence of differentiating cells 
(Figure 5.10A). After more than one month in the continuous absence of LIF 
signalling cells were transferred to the kidney capsule of congenic mice to assess the 
presence of pluripotent cells in the population. A total of ten animals were used for 
both Esrrb and Nanog inducible lines. 5 animal of each group were administered 
10g/ml doxycycline in the drinking water, while the remaining 5 were not treated. 
Exactly one month after kidney capsule injection, animals were sacrificed to score 
tumour size and evaluate tissue contribution. 8 and 9 animals survived injections 











Figure 5.9: Esrrb elevation does not result in homogeneous Nanog 
expression.  
 
A: Representative contour plot showing the distinct SSEA-1+ and SSEA-1- 
populations indentified in this analysis. B,C,D: Histogram plots comparing the 
distribution of Nanog:GFP reporter expression in SSEA-1+  TC44c6, ESN-iNanog 
or ESN-iEsrrb cells plated at clonal density and cultured in the presence of LIF or 









Figure 5.10: ESN-iNanog and ESN-iEsrrb maintain teratocarcinoma forming 
potential after long term passaging in the absence of LIF. 
   
A: ESN-iEsrrb or ESN-iNanog cells cultured in the presence of LIF antagonist 
and doxycycline for more than one month. B: Morphology of the teratocarcinomas 
recovered from animals injected with ESN-iNanog cells and administered or not 
administered 10g/ml of doxycycline in the drinking water. C: Size of representative 
teratocarcinomas recovered from animals injected with ESN-iNanog or ESN-
iEsrrb cells and examples of the tissue types used for scoring germ layer 
contribution. Ad: adipose tissue; B: bone; C: cartilage; Mu: muscle; K: keratinised 
epithelium; En: Endoderm; N: mature neural tissue; IN: Immature neural tissue. 




(4 +doxycycline/ 5 –doxycycline) respectively. All the animals that survived showed 
evident teratomas, except for one animal injected with ESN-iEsrrb cells                  
(-doxycycline group) (Table 5.1). There was no marked difference in size between 
tumours generated by injection of Esrrb or Nanog inducible cells. Similarly, 
treatment with doxycycline did not affect the tumour size significantly (Table 
5.1).All tumours recovered from animals that were not administered doxycycline in 
the drinking water showed the presence of tissues derived from the three germ layers 
(Figure 5.10C, Table 5.1). At a first visual inspection, tumours recovered from 
animals injected with ESN-iNanog cells and administered doxycycline presented a 
clearly distinct morphology and tissue composition compared to untreated controls 
(Figure 5.10B). These teratomas were mainly composed of embryonal carcinoma 
(EC) cells and necrotic tissue. A similar difference in cell type composition could not 
be observed after Esrrb induction (Table 5.1).  
 
Taken together these data demonstrate that ES cells overexpressing Esrrb can 
indefinitely self-renew in the absence of LIF, retaining the ability to differentiate into 
tissues derived from the three germ layers. Furthermore, they support the notion that 
forced Esrrb expression counteracts differentiation of ES cells, but to a lesser extent 
than Nanog. 
 
5.5:    Esrrb overexpression blocks neural differentiation in Nanog 
null ES cells 
 
Nanog overexpression affects the ability of ES cells to undergo neural differentiation 
in vitro (Chambers et al., 2003). To verify whether expression of high levels of Esrrb 
could result in a similar phenotype, two ESN-CAGE cell lines that showed robust 
LIF independence were differentiated for 9 days in defined N2B27 medium in the 
presence or in the absence of BMP and LIF, fixed and stained for Tubulin III (TuJ) 
expression. As expected, addition of BMP to the culture medium suppressed neural 












Table 5.1: Tissue composition of ESN-iNanog and ESN-iEsrrb derived 
teratomas. 
 
Table showing tumour size and tissue contribution observed after kidney capsule 
injection of ESN-iEsrrb or ESN-iNanog cells cultured for more than one month in 
the presence of LIF antagonist and 1g/ml of doxycycline. Animals were 
administered or not administered 10g/ml of doxycycline in the drinking water and 











Figure 5.11: Esrrb overexpression block neural differentiation of Nanog-/- ES 
cells. 
 
Tubulin III (TuJ), Nanog:GFP and TdTomato expression  in TC44c6 and ESN-






parental TC44c6 ES cells cultured in N2BB27 alone or in the presence of LIF 
(Figure 5.11). Importantly, Esrrb overexpression prevented neural differentiation of 
ESN-CAGE cells cultured in unsupplemented N2B27 (Figure 5.11). In accordance 
with its role in sustaining the transcription of Nanog (Chambers et al., 2003), LIF 
addition to the culture medium resulted in increased expression of the Nanog:GFP 
reporter in both Esrrb overexpressing cells and controls (Figure 5.11). 
 
In order to confirm these results and compare the efficiency of Esrrb and Nanog in 
preventing neural differentiation, the experiment was repeated on ESN-iNanog and 
ESN-iEsrrb lines. Cells were plated in N2B27 with or without LIF and BMP at the 
density of 5 x 10
4
 cells/well in 6 well plates, with the exception of ESN-iNanog 
cells cultured in N2B27 +LIF and BMP that had to be plated at 5 x10
3
 cells/well to 
prevent overgrowth. After 9 days in culture in the presence or absence of 
doxycycline, cells were stained for Tubulin III (TuJ) expression and analysed by 
fluorescence microscopy. Overt neural differentiation was observed for both ESN-
iNanog  and ESN-iEsrrb cells cultured in N2B27 without doxycycline. Conversely, 
culture of inducible Esrrb or Nanog lines in N2B27 supplemented with doxycycline 
blocked neural differentiation (Figure 5.12). Sparse cells showing very low levels of 
TuJ staining could be detected for the ESN-iEsrrb line under these conditions, but it 
was not possible to identify cells which underwent productive neural differentiation. 
In addition, Esrrb induction resulted in robust but heterogeneous expression of the 
Nanog:GFP reporter (Figure 5.12). Similarly, culture in N2B27 +LIF in the absence 
of doxycycline resulted in neural differentiation of all lines, although with reduced 
efficiency. In these conditions expression of the Nanog:GFP reporter was retained by 
a substantial proportion of the cells. As observed for culture in N2B27 alone, 
addition of doxycycline to Esrrb and Nanog inducible lines blocked neural 
differentiation (Figure 5.12). Non-neural differentiation was observed when cells 
were cultured in the presence of N2B27 supplemented with BMP in the absence of 
doxycycline. Induction of Esrrb and Nanog expression under these condition resulted 
in the presence of self-renewing colonies actively expressing the Nanog:GFP 



















Figure 5.12: Both Nanog and Esrrb overexpression block neural differentiation 
of Nanog null ES cells. 
 
Tubulin III (TuJ) and Nanog:GFP expression  in ESN-iNanog and ESN-iEsrrb 
cells after 9 days in N2B27 in the presence or absence of BMP and LIF and with or 





LIF and BMP (Figure 5.12). These results show that Esrrb is able to block neural 
differentiation of ES cells and sustains ES cell self-renewal in the absence of BMP 
signalling. As observed in LIF withdrawal experiments, Esrrb ability to block ES cell 
differentiation is less pronounced than that observed for Nanog.    
 
Taken together with the results from previous experiments, these observations 
suggest a general role for Esrrb in counteracting ES cells differentiation, a function 
that seems to be exerted independently of Nanog. 
 
5.6:    Esrrb sustains LIF independent self-renewal at lower doses 
than Nanog 
 
The work heretofore presented identified two transcription factors that that show a 
prompt transcriptional activation in response to Nanog elevation: Esrrb and Klf4. 
Esrrb was shown to confer LIF independent self-renewal upon overexpression in ES 
cells. A similar ability was described for Klf4 (Niwa et al., 2009).  
 
It was thus decided to compare the efficiency with which Nanog, Esrrb and Klf4 
promote LIF independence in ES cells. To this end, RMCE was used to introduce 
doxycycline-inducible transgenes into the same locus of E14Tg2a cells, as already 
described for the derivation of ESN-inducible lines (Figure5.13A; details in 
experimental procedures). ES-iNanog, ES-iEsrrb or ES-iKlf4 cells were plated at 
clonal density with or without LIF, in increasing doxycycline concentrations. 
Maximal self-renewal efficiency was observed at 3g/ml doxycycline for Nanog and 
Klf4, but at 1g/ml for Esrrb. In fact, excessive Esrrb induction resulted in 
widespread differentiation (Figure 5.13 B-C). At optimal levels of induction, 
overexpression of Esrrb and Nanog showed comparable ability to drive LIF 













Figure 5.13: Esrrb promotes LIF independent self-renewal at lower doses than 
Nanog. 
 
A: Schematic representation of the genetic manipulations used to make ES-iNanog, 
ES-iEsrrb or ES-iKlf4 cells. B: Colony morphology of ES-iNanog (iNanog), ES-iEsrrb 
(iEsrrb) or ES-iKlf4 (iKlf4) cells plated at clonal density and cultured in 1000 or 3000 
ng/ml doxycycline and in the absence of LIF for 8 days. C:  Numbers of colonies 
positive or negative for alkaline phosphatase scored after plating ES-iNanog 
(iNanog), ES-iEsrrb (iEsrrb) or ES-iKlf4 (iKlf4) cells at clonal density in the presence 
or absence of LIF and with the indicated concentration of doxycycline for 7 days. 





These results indicate that Esrrb exerts its function at lower doses than Nanog and 
that comparable effects are observed after overexpression of these two factors at 
appropriate levels.       
 
5.7:    Discussion 
 
In this chapter evidence is presented that Esrrb overexpression confers to ES cells 
complete independence from gp130 signalling. Esrrb overexpressing cells can be 
passaged at clonal density in the presence of hLIF-05 and maintain the ability to 
contribute to adult chimaeras, a function first described for Nanog (Chambers et al., 
2003). 
 
Another target identified in this analysis is Klf4, which, like Klf2 and Tbx3, has also 
been reported to sustain pluripotency in the absence of LIF, although in conditions in 
which gp310 signalling was not completely abrogated (Hall et al., 2009; Niwa et al., 
2009). The finding that Esrrb, Klf4 and, less pronouncedly, Tbx3 (Table 3.1) are 
controlled by Nanog, coupled with the notion that Esrrb and Tbx3 can positively 
regulate Nanog (Jiang et al., 2008; van den Berg et al., 2008) and that Klf4 is a 
crucial mediator of LIF signalling (Niwa et al., 2009) identifies a circuit composed of 
Nanog, Esrrb, Klf4 and Tbx3 that stabilizes ES cell self-renewal through positive 
feedback (Davidson, 2010; Oliveri et al., 2008). This circuit can integrate intrinsic 
cues, possibly through modulation of the prominent regulator Nanog, and extrinsic 
inputs from LIF signalling, through activation of Klf4, to balance self-renewal and 
differentiation in mouse ES cells.  
 
Interestingly, irrespective of the presence of LIF in the cultures, Esrrb overexpression 
results in the accumulation of a sizable population of Nanog negative cells (Figure 
5.8A, 5.9).This proves that Esrrb is not a strong activator of Nanog transcription and 
might suggest that Esrrb elevation is be able to promote self-renewal of the 
subpopulation of cells that have silenced Nanog expression or that Esrrb is involved 





The results presented further show that Esrrb function in ES cells is not mediated by 
Nanog, since Esrrb overexpression induces robust self-renewal in Nanog
-/-
 cells. LIF 
independence of Nanog
-/-
 cells is also induced by Klf2 (Hall et al., 2009). In addition, 
Klf2 overexpression was reported to promote self-renewal of Nanog
+/+
 cells in 
unsupplemented N2B27 (Hall et al., 2009). The present analysis indicates that, like 
Klf2, Esrrb can suppress differentiation in serum-free medium but remarkably this 
ability is conserved in cells lacking Nanog. Taken together these observations define 
Esrrb, together with Nanog, as the two factors for which the ability to intrinsically 
promote self-renewal in ES cells is best characterised. In support of this conclusion, 
Esrrb induces LIF independence with efficiency comparable to Nanog, and both 
surpass Klf4 (Figure 5.13C). Nonetheless, in all the experiments Esrrb 
overexpressing cells cultured in the absence of LIF gave rise to a fraction of colonies 
that had differentiated margins. This was never observed for Nanog. In addition, the 
teratocarcinomas produced by injecting ESN-iNanog cells into the kidney capsule 
of mice that were treated with doxycycline were predominantly composed of EC 
cells (Table 5.1). Under the same conditions, ESN-iEsrrb cells differentiated into 
tissues derived from the three germ layers. Taken together these observations suggest 
that Nanog is a stronger suppressor of differentiation than Esrrb, confirming Nanog 
at the top of the hierarchy of factors able to sustain the undifferentiated state in ES 
cells. 
  
Analysing data across the entire study, it was noticed that the system employed to 
achieve Esrrb and Nanog overexpression strongly influenced the experimental 
outcome. Whereas Nanog performed better than Esrrb in episomal overexpression 
experiments (Figure 5.1A), comparison of cells in which both factor are induced at 
similar levels (Figure 5.13C), showed that Esrrb confers LIF independence with 
similar efficiency and at lower doses than Nanog. Stable integration experiments 
confirmed that any difference in the effect of Nanog or Esrrb elevation is strictly 
dependent on the level of expression achieved. EF4, an ES cell line in which Nanog 
mRNA and protein levels are increased 6 folds (See Figure 3.9A and (Yates and 
Chambers, 2005)), showed more robust LIF independence than EfEsrrb cells (Figure 




a comparable ability to self-renew in the absence of LIF (see Figure 8.5C) was 
noticed in 6 stably transfected lines overexpressing either Nanog or Esrrb transgenes 
to similar levels (average 6 fold against 4 fold, see Figure 8.4A-B). Interestingly, in 
all the lines derived Esrrb mRNA overexpression was never higher than 4-5 fold over 
WT levels. It seems therefore that ES cells can tolerate higher levels of Nanog 
overexpression than Esrrb, as confirmed by experiments performed in doxycycline 
inducible lines (Figure 5.13C). Preliminary data investigating the effects of 
elevation of other Nanog targets (Jing Chao Zhang, unpublished data) revealed that a 
limited tolerance for overexpression might be a common characteristic of a 
significant proportion of these genes. Given the toxicity observed after excessive 
Esrrb elevation and the differences in the expression levels required to achieve 
maximum effect in overexpression experiments, it would be interesting to directly 
compare the absolute levels of Nanog and Esrrb mRNAs and proteins in ES cells. 
 
The work presented in this chapter is based on the derivation of a doxycycline 
inducible system that permits comparison of the effects of overexpressing different 
genes at the same level and from an identical genomic location (Figure 5.6A). This 
system was designed after observing that the vast majority of the clones analysed 
during the derivation of doxycycline inducible lines that expressed rtTA from 
Rosa26 presented a vastly heterogeneous expression pattern. This phenomenon could 
be due the low levels of rtTA expression achieved in this system. This observation is 
relevant to the interpretation of the results generated in reprogramming studies that 
employed inducible transgenes also based on expression of rtTA from Rosa26 
(Hanna et al., 2008; Woltjen et al., 2009). In alternative heterogeneous expression 
might be entirely dependent on the genomic location in which integration of the 
doxycycline inducible transgenes occurred. The use of RMCE to introduce the ORFs 
of any gene of interest into a previously identified genomic location that ensures 
homogeneous expression circumvented this problem. High and homogeneous 
expression is achieved in ESN-iTdT lines (Figure 5.6C) and ESN-iNanog 
derivative clones (Figure 5.7B). Relevant to this point, when investigating transgene 
induction levels in doxycycline titration experiments on Rosa:rtTA TdTomato-2a-




of doxycycline tended to be more heterogeneous (Figure 5.4C). This should be 
considered when applying this system to genes that require low levels of 
overexpression. Nonetheless, overall transgene expression in these lines can be finely 
tuned (Figure 5.4A-B), presenting undeniable advantages when compared to 
constitutive expression systems. Nanog was originally isolated by episomal 
overexpression of an ES cell derived cDNA library (Chambers et al., 2003). It would 
be interesting to apply the described RMCE transgene exchange system to the 
screening of similar cDNA libraries, avoiding the toxicity effects observed after 
episomal transgene expression and possibly broadening the scope for identification 
novel pluripotency factors. The feasibility of such an approach will depend 
principally on the efficiency of RMCE in these lines. Possibly this system should be 
employed to screen libraries of limited size including a reduced number of 





















Chapter 6:    Esrrb drives reprogramming in the absence of 
Nanog 
 
Nanog exerts a fundamental role in driving the specification and the maintenance of 
different pluripotent cell populations during embryonic development. Nanog null 
embryos fail to develop a structured epiblast, lose expression of Oct4 and arrest 
development before implantation (Mitsui et al., 2003; Silva et al., 2009). A clue to 
understand how Nanog promotes the transition to pluripotency may come from in 
vitro reprogramming experiments. Nanog is able to increase the efficiency of 
reprogramming (Silva et al., 2006). Strikingly, cells lacking Nanog expression 
cannot be reprogrammed to a pluripotent state by fusion with ES cells or 
overexpression of specific transcription factors. The reprogramming process seems 
to stall in an intermediate state, in which cells are dependent of feeders for 
propagation and fail to reactivate transcription from endogenous pluripotency alleles, 
such as Oct4, Nanog, Rex1 and Klf2   (Silva et al., 2009). Using in vitro 
reprogramming as a model, it is possible to test whether Nanog exerts a unique role 
in driving attainment of pluripotency or if other factors can compensate for its 
absence. 
 
6.1:    Esrrb enhances reprogramming by cell fusion 
 
Esrrb has been shown to promote in vitro reprogramming of mouse embryonic 
fibroblasts (MEFs) to induced pluripotent stem cells (iPS) in conjunction with Oct4 
(Feng et al., 2009). Recent studies showed that Esrrb can even drive reprogramming 
in the absence of the canonical reprogramming factors Oct4, c-Myc, Klf4 and Sox2. 
The results presented in chapter 3 and 4 indicate that Nanog regulates Esrrb 
expression. Thus, it was important to test whether Nanog enhances reprogramming 
efficiency through activation of Esrrb and whether Esrrb elevation renders Nanog 





Polyethylene glycol mediated cell fusion has been employed to test the ability of 
Nanog null neural stem (NS) cells to successfully undergo reprogramming, and 
Nanog levels in the ES cell fusion partner have been shown to correlate with the 
efficiency of this process (Silva et al., 2006; Silva et al., 2009). It was thus decided to 
ascertain if Esrrb overexpression could promote reprogramming of NS cells by cell 
fusion. The efficiency of formation of pluripotent hybrid colonies was compared 
following fusion of E14/T NS cells with E14Tg2a, EF4 or EfEsrrb ES cells. 
Interestingly, Esrrb overexpression stimulated the formation of pluripotent hybrid 
colonies with a similar efficiency as that observed for Nanog (Figure 6.1A-B). 
 
6.2:    Esrrb overexpression allows the generation of pluripotent hybrids 
from Nanog null NS cells. 
 
It was then determined whether Nanog activity was strictly required for the 
successful generation of pluripotent hybrids by developing an experimental system in 
which Nanog null NS cells are fused to Nanog null ES cells overexpressing Esrrb. 
NS cells were derived from the RCNH(t) ES cell line by neural differentiation in 
monolayer (Pollard et al., 2006). RCNH(t) NS cells show the characteristic 
morphology of NS cells, can be readily propagated in NS cell expansion medium in 
the presence of FGF and EGF (Conti et al., 2005) and show positive staining for 
Nestin by immunohistochemistry (Figure 6.2A). 
 
During the reprogramming process the transcription of pluripotency genes is 
activated from the NS cell genome as soon as 1 day after cellular fusion (Bhutani et 
al., 2010; Han et al., 2008). In RCNH(t) cells a hygromycin resistance cassette is 
placed under the control of the endogenous Nanog promoter (Figure 6.2B). Thus, the 
use of RCNH(t) NS cells in fusion experiments permitted the selection of cellular 
hybrids that reactivated transcription of Nanog from the NS cell genome by culture 
in the presence of hygromycin. Nanog null RCNH(t) NS cells were fused to two 
different ESN-CAGE lines (clone 17 and clone 21). As a control, RCNH(t) NS 












Figure 6.1: Esrrb promotes reprogramming by cell fusion. 
 
A: Representative plates from ES x NS fusion experiments performed using E14/T 
NS cells and E14Tg2a, EF4 (Nanog overexpressing), or EfEsrrb (Esrrb 
overexpressing) ES cells. ES x NS hybrids were cultured for 12 days in puromycin 
and neomycin selection prior to staining for alkaline phosphatase. B: AP positive 
colony numbers/million NS fused observed in the above experiment; error bars: 
standard deviation (n=4).  
 














Figure 6.2: Esrrb overexpression allows the generation of pluripotent hybrids 
from Nanog null NS cells. 
 
A: Vimentin and GFP expression in RCNH(t) NS cells. B: Schematic representation 
of two Nanog-/- lines used for fusion experiments: ESN-CAGE cells and RCNH(t) 
NS cells. C: Hybrid colonies formed by fusion of RCNH(t) NS cells with the 
indicated Nanog+/+ or Nanog-/- ES cell lines. Hybrids were cultured for 14 days; 
puromycin was applied after 1 day; hygromycin application was delayed until day 4 






to E14Tg2a and TC44c6 ES cells expressing a GFP-IRES-Puromycin transgene. 
One day after fusion, puromycin selection was applied to eliminate unfused NS cells 
from the culture. Four days after fusion, hygromycin selection was applied to 
negatively select ES cells which had not undergone fusion and cell hybrids were 
cultured for additional 10 days prior to colony scoring. As expected, cell fusion in 
the presence of functional Nanog protein gave rise to a sizable numbers of 
morphologically undifferentiated, alkaline phosphatise positive hybrid colonies 
(Table 6.1, Figure 6.2C). No undifferentiated colonies were observed after fusion of 
RCNH(t) NS cells with TC44c6 ES cells. The few Nanog null hybrid colonies 
observed after selection differentiated during the course of the experiment (Figure 
6.2C). In contrast, appearance of undifferentiated colonies could be observed for 
fusions between ESN-CAGE ES and RCNH(t) NS cells (Figure 6.2C, Table 6.1). 
Nanog null Esrrb overexpressing hybrids could be continuously passaged under 
standard ES cell culture conditions without showing signs of differentiation. 
 
Since marked cellular death was observed after the combined addition of puromycin 
and hygromycin to the culture medium, the experiment was repeated without 
puromycin selection. No colonies were observed after RCNH(t) NS x RCNH(t) 
NS control fusions, showing that puromycin selection against unfused NS cells was 
not required. In accordance with the previous experiment, the only Nanog null hybrid 
colony originating from fusion between TC44c6 ES x and RCNH(t) NS cells 
underwent differentiation. The exclusion of puromycin selection resulted in an 
increased number of hybrids colonies from RCNH(t) NS x ESN-CAGE ES cell 
fusions, compared to the previous experiment (Table 6.1). Nonetheless, 
reprogramming by cell fusion in the absence of Nanog showed a significantly 
compromised efficiency. As observed before, the hybrid colonies could be passaged 
in ES cell medium for several passages without apparent signs of differentiation. 
Taken together, these results support the idea that Nanog expression strongly 
favours, but is not strictly required, during NS cell reprogramming by cell fusion. 
Expression of Esrrb can compensate for the lack of Nanog in supporting the 











Table 6.1: Efficiency of Nanog null NS cells reprogramming. 
 
Number of AP positive colonies formed after fusion of RCNH(t) NS cells with the 
indicated ES cell lines in two independent experiments (left panel - right panel). 
Hybrids were cultured for 14 days; puromycin and hygromycin selections were 






It was then necessary to establish that the reprogramming of Nanog null cells driven 
by Esrrb overexpression was complete and stable. With this aim, fusion experiments 
were repeated employing ESN-iNanog and ESN-iEsrrb ES lines (Figure 6.3A). 
RCNH(t) NS cells were transfected with a CAG driven TdTomato-IRES-
hygromycin
R
 transgene and clones selected for high and homogeneous expression of 
the fluorescent protein by flow cytometry. In contrast with previous experiments, 
presence of a constitutively expressed hygromycin resistance gene allowed for 
immediate selection of primary hybrids independently of reactivation of Nanog 
transcription from the NS cell genome. RCNH(t) Red NS cells were fused with 
ESN-iNanog or ESN-iEsrrb ES cells (Figure 6.3A) and primary hybrids replated 
in GMEM/FCS/LIF. Two days after fusion blasticidin and hygromycin selections 
were applied and cell hybrids cultured for additional 14 days prior to colony scoring. 
Fused cells cultured in the absence of doxycycline failed to form self-renewing 
colonies. The few colonies initially observed, progressively differentiated over the 
course of the experiment and could not be expanded (Table 6.2). In contrast Nanog 
and Esrrb induction resulted in the formation of self-renewing colonies (Figure 
6.3B) that stained strongly for alkaline phosphatase and expressed TdTomato, which 
marks the NS cell genome (Figure 6.3D). While restoring Nanog expression resulted 
in the formation of 300 reprogrammed hybrid colonies/10
6
 cells fused, Esrrb 
induction in ESN-iEsrrb ES cells could reprogram NS cells with a 12 fold lower 
efficiency (25 hybrid colonies/10
6
 cells fused: Table 6.2). Nonetheless, Esrrb 
reprogrammed hybrid lines could be expanded and cultured over multiple passages, 
when neomycin selection for active transcription from Nanog was applied (Figure 
6.1C). It was then assessed whether constant expression of the Nanog or Esrrb 
transgenes was necessary to maintain the reprogrammed lines undifferentiated. Cells 
were released from doxycycline and passaged 3 times in the presence or in the 
absence of neomycin. ESN-iEsrrb derived hybrid lines could be serially passaged in 
the absence of doxycycline when neomycin selection was maintained (Figure 6.1C).  
Hybrid cells showed increasing signs of differentiation after withdrawal of neomycin 
selection, as observed for Nanog
-/-
 ES cells. This propensity was eliminated by Esrrb 








Figure 6.3: Reprogramming by cell fusion in the absence of Nanog generates 
stable lines. 
 
A: Schematic representation of the ES and NS cell lines used in the fusion 
experiments: ESN-iNanog and ESN-iEsrrb ES cells and RCNH(t) Red NS cells. 
B: Morphology of RCNH(t) Red NS cells X ESN-iNanog or ESN-iEsrrb ES cells 
primary hybrid colonies. Blasticidin and hygromycin selections were applied two 
days after fusion and cells cultured for additional 14 days in the presence or 
absence of doxycycline. C: RCNH(t) Red NS cells X ESN-iEsrrb ES cells hybrid 
lines cultured in the presence or absence of doxycycline and G418 for 3 passages. 
D: TdTomato expression (marking the NS cell genome) and alkaline phosphatase 
staining of ESN-iNanog or ESN-iEsrrb cells x RCNH(t) Red NS hybrid colonies 













Table 6.2: Efficiency of Nanog null NS cells reprogramming by Nanog or Esrrb 
induction. 
 
Number of alkaline phosphatase positive colonies scored after fusion of to RCNH(t) 
Red NS cells to ESN-iNanog or ESN-iEsrrb cells and culture in the presence or 
absence of doxycycline for 16 days. Hygromicin and blasticidin were applied 2 days 






The stability of RCNH(t) NS cells reprogramming was further confirmed by 
characterising the gene expression profile of hybrid lines cultured in the presence or 
absence of doxycycline or G418. Reprogrammed hybrid had lost NS cell specific 
markers and reactivated endogenous pluripotency genes in all lines analysed (Figure 
6.4A). Activation of transcription of Nanog from the NS cell genome was confirmed 
by PCR analysis on cDNA prepared from ESN-iNanog and ESN-iEsrrb derived 
hybrid lines using primer pairs binding specifically to the hygromycin targeted allele 
present in RCNH(t) cells (Figure 6.4B). Importantly, release from doxycycline did 
not lead to NS cell gene reactivation or silencing of pluripotency genes (Figure 
6.4A). In addition, both Nanog and Esrrb reprogrammed hybrids could be serially 
passaged without doxycycline in 2i/LIF, a condition permissive only for completely 
undifferentiated cells (Figure 6.4C). Hybrid lines released from doxycycline and 
G418 showed elevated GATA6 expression, in line with the acquisition of primitive 
endoderm morphology (Figure 6.4A, 6.3C). 
  
Taken together these results suggest that the reprogramming of hybrids generated by 
Esrrb elevation in the absence of Nanog is stable, since their self-renewal does not 
dependent on continued transgene expression. 
 
The experiments presented showed that reprogramming of Nanog
-/- 
cells by Esrrb 
proceeds with a reduced efficiency compared to that observed after Nanog induction. 
It was then necessary to exclude that the observed differences were attributable to 
variations in the fusion efficiency among the different lines. ESN-iNanog or ESN-
iEsrrb ES cells were stably transfected with a CAG -EBFP expression vector. Fusion 
experiments were performed as before but, 24 hours after replating, primary hybrids 
were purified by FACS sorting on the basis of their concomitant EBFP and 
TdTomato expression (Figure 6.5). After measuring the purity of the sorted 
population, primary hybrids were replated in complete ES cell medium and two days 
after blasticidin and hygromycin selections were applied. Cells were cultured for 
additional 14 days prior to scoring the number of AP positive colonies. Forced 










Figure 6.4: Transcriptional resetting of the NS cell genome in Nanog null NS X 
ES hybrid lines. 
 
A: Gene expression profiles of RCNH(t) Red NS cells, ESN-iNanog (iN) or ESN-
iEsrrb (iE) cells, and NS X ES hybrid lines after 3 passages in the indicated 
conditions. Primers do not detect doxycycline inducible transgenes. Nanog primers 
bind to the Nanog 5’UTR which remains in all targeted alleles. Transcript levels 
normalised to TBP and relative to expression in RCNH(t) Red NS (for Olig2) or 
ESN-iNanog cells cultured in G418 (for all other genes). Error bars: ES x NS 
hybrids: standard deviation of gene expression in three independent lines. ES and 
NS lines: standard deviation of gene expression in two independent experiments. B: 
RT-PCR amplifying transcript from the Nanog:hygromycinR targeted allele on cDNA 
prepared from RCNH(t) ES, RCNH(t) NS cells and ESN-iNanog or ESN-iEsrrb 
derived hybrids. C: RCNH(t) NS cells X ESN-iEsrrb ES cells hybrids cultured in 











Figure 6.5: Sorting of RCNH(t) Red NS cells X ESN-iNanog Blue or ESN-
iEsrrb Blue ES cells primary hybrids. 
 
ESN-iNanog or ESN-iEsrrb cells were transfected with a CAG-EBFP expression 
vector and clones showing high EBFP expression were selected. RCNH(t) Red NS 
X ESN-iNanog Blue or ESN-iEsrrb Blue ES cells primary hybrids were purified by 
FACS sorting 24h after fusion on the basis of EBFP and TdTomato expression. Dot 
plots showing TdTomato and EBFP expression in ES cells, NS cells, in the cultures 
after fusion and in primary hybrids after sorting. The gating strategy used for sorting 
is shown along with an example of the typical fusion efficiency and sorting purity 




reprogramming (Table 6.3). As previously observed, Esrrb overexpression resulted 
in a 15 times lower reprogramming efficiency (0.07%, Table 6.3).      
 
Taken together these data show that Esrrb can functionally compensate for Nanog in 
promoting NS cell reprogramming. 
 
6.3:    Esrrb rescues stalled reprogramming of Nanog null pre-iPS 
 
Reprogramming by cell fusion proceeds with high efficiency and provides a useful 
model to investigate the potential of individual factors in promoting the 
transcriptional and epigenetic changes that accompany the transition to pluripotency. 
Nonetheless, this system generates tetraploid hybrids, precluding the possibility of 
rigorously testing the developmental potential of reprogrammed cells and 
conclusively prove acquisition of pluripotency.  
 
To overcome these limitations, the ability of Esrrb to substitute for Nanog was tested 
during reprogramming by transcription factor overexpression (Takahashi and 
Yamanaka, 2006). Nanog is strictly required for completion of this process  with 
Nanog
-/-
 cells stalling in an intermediate state, termed  pre-iPS, in which they acquire 
the morphology and growth factor dependence of ES cells but do not express 
endogenous pluripotency genes nor silence retroviral transgene expression (Silva et 
al., 2009). NS cells were generated in vitro from ESN-iNanog and ESN-iEsrrb ES 
cells and passaged 10 times in NS medium to ensure complete differentiation. These 
lines express the NS cell marker Olig2 and Sox2 but have completely silenced 
expression of other pluripotency factors (Figure 6.7A). Next, ESN-iNanog and 
ESN-iEsrrb cells were infected with retroviral vectors encoding Oct4, Klf4, c-Myc 
and dsRed. The inclusion of a dsRed fluorescent reporter under the control of viral 
LTRs permitted monitoring of the silencing of pMX transgenes upon completion of 
reprogramming (Figure 6.6A). Five days after infection, numerous colonies 











Table 6.3: Efficiency of reprogramming in sorted RCNH(t) Red NS cells X 
ESN-iNanog Blue or ESN-iEsrrb Blue ES cells primary hybrids. 
 
A: Number of alkaline phosphatase positive colonies scored after culturing sorted 
RCNH(t) Red NS cells X ESN-iNanog Blue or ESN-iEsrrb Blue ES cells primary 
hybrids for 16 days in blasticidin, hygromycin and doxycycline. The table shows the 
sorting purity, the numbers of primary hybrids plated and AP positive colonies 












Figure 6.6: Esrrb can rescue the stunted reprogramming of Nanog-/- pre-iPS 
cells. 
 
A: Experimental scheme used to derive pre-iPSN cells and to induce completion of 
reprogramming upon doxycycline induction. B: Morphology and Nanog:GFP 
expression after culture of pre-iPSN-iEsrrb cells in the absence or presence of 
doxycycline and 5’-azacytidine for 3 days. C: Dot plots showing dsRed (viral 
transgenes) and Nanog:GFP expression in pre-iPSN-iNanog (iN) or pre-iPSN-
iEsrrb (iE) cells treated with doxycycline and 5’-azacytidine for the indicated number 








Figure 6.7: Esrrb can reprogramme Nanog-/- somatic cells to naïve 
pluripotency.  
 
A: Endogenous pluripotency or NS cell specific gene expression in ESN-iNanog 
(iN) or ESN-iEsrrb (iE) cells and derivative NS, pre-iPS, and iPS cells cultured 
without doxycycline for at least 3 passages. The primers do not detect viral 
transgenes. Nanog primers bind to the Nanog 5’UTR which is present in all targeted 
alleles. Transcript levels are relative to expression in NSN-iEsrrb cells (for Olig2) or 
ESN-iEsrrb cells (for all other genes). Error bars: iPS cells: standard deviation in 
three independent clones. ES, pre-iPS and NS lines: standard deviation in three 
independent experiments. B: Expression of retroviral transgenes in ESN-iNanog 
(iN) or ESN-iEsrrb (iE) cells and derivative NS, pre-iPS, and iPS cells cultured 
without doxycycline for at least 3 passages. The primers do not detect endogenous 
transcripts. Transcript levels relative to pre-iPSN-iEsrrb cells. Error bars: standard 
deviation in three independent experiments. C: DsRed and Nanog:GFP expression 
in iPSN-iEsrrb cells cultured in the absence of STO feeders and without 
doxycycline for 3 passages. D: Representative midgestation (E11.5) embryo 
obtained from blastocyst injection of iPSN-iEsrrb cells transfected with a 
ubiquitously expressed TdTomato transgene (right); control embryo (left). Bottom 
panels show Nanog:GFP expression in iPSN-iEsrrb derived primordial germ cells 
observed in dissected gonads at E11.5. E: Number of Nanog:GFP colonies scored 
after clonal density plating (5000 cells/10 cm diameter dish) of pre-iPSN-iNanog or 
pre-iPSN-iEsrrb cells and culture in the presence of doxycycline for the indicated 
number of days. Pre-iPS cells were left to form macroscopic colonies for 6 days 
before addition of doxycycline and 5’-Aza. 5’-Aza was withdrawn from the culture 




indefinitely on feeders without reactivating Nanog:GFP (Figure 6.6B). Pluripotency 
genes other than Sox2 remained silenced in pre-iPS cells and robust expression of all 
viral transgenes could be detected (Figure 6.7A-B). Pre-iPSN-iNanog and pre-
iPSN-iEsrrb cells were then treated with doxycycline to activate the Nanog or Esrrb 
transgenes present in these lines. Induction was performed in the presence or absence 
of the DNA methyltransferase inhibitor 5’-azacytidine, since this drug was shown to 
promote reprogramming (Huangfu et al., 2008) and facilitate the pre-iPS to iPS 
transition (Mikkelsen et al., 2008; Theunissen et al., 2011b). Nanog induction in pre-
iPSN-iNanog cells led to the emergence of Nanog:GFP
+
 cells by day 5 , 
irrespective of the presence of 5’-azacytidine (Figure 6.6C). Strikingly, Esrrb 
induction combined with 5’-azacytidine treatment resulted in a faster and more 
pronounced reactivation of the Nanog:GFP allele. In contrast, Esrrb induction in the 
absence of 5’-azacytidine failed to trigger completion of the reprogramming process 
even after prolonged doxycycline treatment, indicating that an additional component 
of Nanog activity might directly or indirectly involve erasure of DNA methylation 
marks. Despite this difference, G418-resistant Nanog:GFP
+
 colonies could be picked 
and expanded for both pre-iPSN-iNanog and pre-iPSN-iEsrrb cells. The resulting 
iPSN-iNanog and iPSN-iEsrrb cells could be expanded without the need for 
feeder co-culture and were not dependent on continued doxycycline treatment. These 
cells morphologically resembled the parental ES cell lines, maintained Nanog:GFP
+
 
expression and completely silenced the dsRed reporter
 
(Figure 6.7C). Gene 
expression analysis confirmed that both iPSN-iNanog and iPSN-iEsrrb expressed 
endogenous pluripotency genes and had silenced the viral transgenes (Figure 6.7A-
B). 
 
The developmental potential of Nanog null iPS cells could now be rigorously tested. 
Blastocyst injection of iPSN-iEsrrb cells resulted in extensive contribution to 
midgestation embryos (Figure 6.7D; Table 6.4). Furthermore, the presence of GFP 
expressed from Nanog in the genital ridges of E11.5 embryos indicated that injected 
iPS cells were able to colonise the germline (8/19 chimaeras showed germline 


















Table 6.4: Esrrb induces NS derived iPSN-iEssrb chimaera forming capacity. 
 
Quantification of midgestation chimaeras (E11.5) obtained from two blastocyst 
injections of iPSN-iEsrrb c1 cells. Contribution was judged by the proportion of 
TdTomato positive cells present in the chimaeras (High>66.6%; 
66.6%<Medium>33.3%; Low<33.3%). Germline contribution was judged by the 
presence of GFP expressed from the Nanog locus in iPSN-iEsrrb cells colonising 






Doxycycline treatment timecourse experiments indicated that Nanog and Esrrb 
trigger completion of stalled reprogramming with different kinetics. Nanog:GFP 
reactivation was detected as soon as 3 days after Esrrb expression in pre-iPSN-
iEsrrb cells. Interestingly, not all the GFP positive cells observed at this stage 
showed complete silencing of dsRed expression (Figure 6.6C). In contrast, 
Nanog:GFP expression was evident in a minority of iPSN-iNanog cells only 6 days 
after doxycycline induction, but all GFP
+
 cells detected had completely silenced 
transgene expression (Figure 6.6C). This could indicate that Nanog reactivation 
precedes completion of reprogramming in induced pre-iPSN-iEsrrb cells and that 
not all GFP expressing cells eventually give rise to iPS clones.    
 
In order to rigorously compare the reprogramming efficiency after Nanog or Esrrb 
induction, pre-iPSN-iNanog and pre-iPSN-iEsrrb cells were plated at clonal 
density (5000 cells) in 10cm dishes and cultured for 6 days in the absence of 
doxycycline. When macroscopic colonies appeared, doxycycline was added to the 
culture medium and the number of GFP positive colonies monitored over the course 
of 3 weeks. 5’-azacytidine was added to the culture during the first 4 days of 
induction. In line with the observed reprogramming kinetics, GFP positive colonies 
appeared in pre-iPSN-iEsrrb plates soon after doxycycline addition (Figure 6.7E). 
The GFP
+
 colony number reached plateau 10 days after induction, remaining stable 
afterwards. In contrast, Nanog induction resulted in a delayed appearance of GFP
+
 
colonies, but their number steadily increased over the 3 weeks of the experiment. 
Approximately 650 and 250 GFP
+
 colonies were detected after 17 days of continued 
Nanog and Esrrb induction respectively.    
 
These results demonstrate that Esrrb can drive completion of reprogramming in the 
absence of Nanog, indicating that Esrrb can substitute for Nanog in the acquisition of 
pluripotency. Preliminary results also suggest that Esrrb and Nanog trigger 





6.4:    Discussion 
 
Extending the characterisation of the functional similarities between Nanog and 
Esrrb presented before, this chapter shows that Esrrb is able to drive reprogramming 
of NS cells in cell fusion experiments to an extent comparable to Nanog (Figure 
6.1). Fusion to ES cells is a fast and efficient system to drive reprogramming of 
differentiated cells (Bhutani et al., 2010; Han et al., 2008; Tada et al., 2001). NS x 
ES cell fusion drives reprogramming of the NS cell genome without the need for 
expression of additional reprogramming factor (Silva et al., 2006), making it an ideal 
tool to study the role of specific genes in increasing reprogramming efficiency in a 
system in which any additional contribution is easily detected. In addition, the role of 
Nanog in promoting NS cell reprogramming in this context has been extensively 
characterised: Nanog increases dramatically the reprogramming efficiency (Silva et 
al., 2006) and the presence of Nanog is a prerequisite for reprogramming to proceed 
(Silva et al., 2009). Fusion of Nanog null ES cells to Nanog null NS cells leads to the 
formation of unstable intermediates that cannot be expanded. Thus, this system is 
also useful to identify factors that are able to complement loss of Nanog function. As 
discussed before, Esrrb can rescue the impaired self-renewal of Nanog
-/-
 cells and is 
able to substitute for Nanog in conferring LIF independence to ES cells. The data 
presented in this chapter shows that Esrrb can also rescue the reprogramming defects 
of Nanog
-/-
 cells in NS x ES cell fusion experiments. Since Esrrb is a target of 
Nanog, it is possible that part of the activity of Nanog in driving reprogramming is 
mediated through upregulation of Esrrb. Nonetheless, Esrrb and Nanog 
reprogramming efficiencies are not comparable, indicating that additional Nanog 
targets might play a role in this context. Alternatively, Nanog protein might be 
important in recruiting other transcription factors or chromatin remodelers to the 
promoters or enhancers of crucial targets of the pluripotency GRN. To address these 
questions, it will be necessary to test the effects of overexpressing selected Nanog 
targets in NS x ES cell fusion experiments. In addition, it would be interesting to 
determine whether Nanog is able to bind to the regulatory elements of any of the 
pluripotency GRN targets during the early stages of reprogramming, possibly 




different species. The data presented also shows that Nanog
-/-
 reprogrammed hybrid 
lines generated by overexpression of Esrrb correctly reactivate expression of Nanog 
from the NS cell genome (Figure 6.4B), indicating that self renewal of these hybrids 
is not exclusively sustained by expression of pluripotency genes from the already 
active ES cell genome. This suggests that reversion of epigenetic silencing and 
reactivation of expression from the endogenous pluripotency alleles in differentiated 
cells is not strictly dependent on Nanog activity.  
 
Additional cues to the role that Nanog exerts during reprogramming might come 
from experiments demonstrating that Esrrb can substitute for Nanog function in 
completing stalled reprogramming of Nanog
-/-
 pre-IPS cells. Activation of Esrrb in 
pre-iPSN-iEsrrb leads to the reactivation of pluripotency genes (Figure 6.7A), 
triggers silencing of the viral transgenes (Figure 6.7B) and allows reprogramming of 
NS cells to chimaera competency (Figure 6.7D). Importantly, Esrrb requires the 
addition of 5’-azacytidine to complete this process whereas restoring Nanog function 
is independently able to generate fully reprogrammed iPS cells. 5’-azacytidine 
inhibits DNA methyltransferases, leading to gradual genome-wide reduction of 
5mCpG levels after successive cell divisions (Creusot et al., 1982), reversing 
repressive hypermethylation at pluripotency loci and possibly making these genes 
responsive to Esrrb activation. Recent work analysing the transcriptional and 
epigenetic state of different pre-iPS lines, showed that they are trapped in an 
intermediate state between differentiated cells (MEFs) and ES cells. Almost all high-
CpG  promoters (HCP) are marked by H3K4me3 in ES cells. A subfraction of these 
is also marked by the repressive H3K27me3 modification. These domains are 
defined as bivalent (Mikkelsen et al., 2007) and mark lineage specific genes poised 
for activation during the differentiation process. In MEFs HCP resolve to become 
monovalently marked by H3K4me3 or H3K27me3. In addition, some of these 
promoters, including pluripotency genes, lose both marks and become 
transcriptionally silent and hypermethylated (Mikkelsen et al., 2007). During the 
reprogramming process bivalent marks are re-established and methylation of 
pluiripotency genes is reversed (Maherali et al., 2007; Mikkelsen et al., 2008). In 




of both H3K4me3 and H3K27me3, showing elevated CpG methylation. 
Interestingly, 5’-azacytidine treatment of Nanog
+/+
 pre-iPS reverses CpG methylation 
and leads to the spontaneous reactivation of pluripotency gene transcription 
(Mikkelsen et al., 2008). In contrast, in the absence of concomitant transgene 
induction, the appearance of Nanog:GFP
+
 cells was not detected even after long term 
culture of Nanog
-/-
 pre-iPSN-iNanog or pre-iPSN-iEsrrb cells with 5’-azacytidine. 
This difference, and the fact that Nanog restoration in pre-iPSN-iNanog lines can 
complete reprogramming without 5’-azacytidine, indicates that Nanog is directly or 
indirectly involved in reversing silencing at highly methylated pluripotency gene 
promoters. Nanog could perform a pioneering role (Zaret and Carroll, 2011) in 
binding to these loci in pre-iPS cells. An alternative model is suggested by recent 
reports revealing that the most differentially expressed genes between pre-iPS and 
iPS cells, including pluripotency genes, lack clear binding by Oct4 Sox2 and Klf4. 
Nonetheless, in reprogramming intermediates Oct4 and Sox2 often show weak levels 
of binding to these loci (Sridharan et al., 2009). This might indicate that Oct4 and 
Sox2 are the first factors accessing the chromatin of repressed pluripotency genes, 
yet their binding might not be sufficient to activate transcription. Binding of 
additional factors, possibly Nanog, might be required to complete reactivation of 
these genes. Intriguingly, Nanog is not expressed in pre-iPS cells or during the initial 
phases of reprogramming ((Buganim et al., 2012; Mikkelsen et al., 2008; Silva et al., 
2008a; Silva et al., 2009; Sridharan et al., 2009) and Figure 6.7A). It is possible that 
stochastic activation of Nanog expression and its consequent binding to the 
regulatory elements of pluripotency genes in pre-iPS lines or reprogramming 
intermediates leads to the erasure of DNA methylation and contributes to the 
completion of their transcriptional activation. Lack of Nanog could impair this 
process and result in the stalled reprogramming observed in Nanog-/- cells. It would 
be interesting to determine the genome-wide pattern of Nanog binding after Nanog 
re-induction in pre-iPSN-iNanog cells, and determine whether restored Nanog 
binding correlates with reversion of DNA hypermethylation at its target genes. In 
light of the data presented, it is possible that Esrrb is able to bind to a similar set of 
targets in pre-iPS cells but fails to trigger complete epigenetic resetting. To test this 




selected pluripotency genes in doxycycline treated pre-iPSN-iNanog and pre-
iPSN-iEsrrb cells. In this regard, it is interesting to note that whereas Esrrb requires 
5’-azacytidine for triggering completion of pre-iPS reprogramming, its 
overexpression in NS x ES cell fusion experiments independently leads to 
reprogramming of Nanog
-/-
 cells. It is reasonable to imagine that among the number 
of factors contributed by the undifferentiated ES cells in fusion hybrids must be 
elements driving the reversion of repressive epigenetic marks at the regulatory 
elements of pluripotency genes. Interestingly in this respect, recent reports indicate a 
role for activation-induced cytidine deaminase (AID) in mediating DNA 
demethylation at the Oct4 and Nanog loci in ES x B cell heterokaryons (Bhutani et 
al., 2010).   
 
The need for additional 5’Aza treatment during Esrrb driven reprogramming of 
Nanog-/- cells could also be a consequence of the fact that pre-iPS might represent 
abnormal intermediates of the reprogramming process. In pre-iPS cells endogenous 
pluripotency genes are not expressed, the transcription of genes characteristic of 
differentiated cells is repressed, viral transgenes are not yet silenced (Figure 6.7A-B 
and (Mikkelsen et al., 2007; Silva et al., 2008a; Silva et al., 2009; Sridharan et al., 
2009)) and X chromosome inactivation persists in female cells (Silva et al., 2008a; 
Sridharan et al., 2009). Analysis of the transcriptional and epigenetic events 
accompanying the generation of iPS cells seems to indicate that reprogramming 
intermediates progress through a similar state. Early events during reprogramming 
are the silencing of genes expressed in differentiated cells, an increase in the 
proliferation rate and the completion of mesenchymal to epithelial transition (Li et 
al., 2010; Samavarchi-Tehrani et al., 2010). Acquisition of alkaline phosphatase and 
SSEA-1 expression precedes reactivation of pluripotency markers (Brambrink et al., 
2008), which is accompanied by X chromosome reactivation and re-expression of 
telomerase (Stadtfeld et al., 2008). However, whereas most of the cells that activate 
SSEA-1 expression during reprogramming have already silenced expression of the 
viral transgenes, and SSEA-1 expression in these cells correlates well with the 
potential to form colonies of fully reprogrammed cells (Stadtfeld et al., 2008), in 




transgene silencing, DNA methylation status or potential to complete reprogramming 
(Mikkelsen et al., 2008). Similarly, whereas the sporadic activation of endogenous 
Oct4 transcription detected in pre-iPS lines is abortive (Silva et al., 2008a; 
Theunissen et al., 2011b), and does not imply epigenetic resetting  nor completion of 
reprogramming (Theunissen et al., 2011b), Oct4 reactivation correlates well with the 
ability to achieve full reprogramming during the derivation of iPS cells (Buganim et 
al., 2012; Stadtfeld et al., 2008). It might therefore be that stable pre-iPS lines are 
derived from cells trapped in states that are particularly unfavourable for the 
progression of reprogramming. Even if pre-iPS cells are still able to be rescued by 
ERK and GSK inhibition (Silva et al., 2008a) or overexpression of single 
reprogramming factors (Theunissen et al., 2011b), they might not represent likely 
transition states for the rare cells that successfully originate iPS colonies. In light of 
these observations, it would be interesting to perform experiments inducing Esrrb 
elevation from the initial phases of the reprogramming of Nanog
-/-
 cells. Esrrb 
elevation may be able to avoid trapping of these cells in a refractory state and lead to 
successful reprogramming without need for 5’-azacytidine addition.  
 
Another indication that Esrrb and Nanog might not be exerting completely 
overlapping roles during reprogramming comes from the observation that these two 
factors trigger the pre-iPS to iPS transition with radically different kinetics. Whereas 
Esrrb leads to fast reactivation of Nanog:GFP expression in pre-iPS lines but its 
action seems to plateau quickly, Nanog requires longer time to act, but results in 
efficient reprogramming in an exponentially increasing number of cells over time 
(Figure 6.7E). The delayed activation of Nanog transcription observed in 
doxycycline induced pre-iPSN-iNanog cells could be explained by the notion that 
Nanog represses its own transcription. In these cells Nanog:GFP expression might 
not be directly driven by Nanog binding to its own regulatory elements, but could 
require activation of other pluripotency factors not expressed in pre-iPS cells. Nanog 
expression in this line would therefore be a stringent reporter of full reprogramming. 
Conversely, the ability of Esrrb to directly activate Nanog transcription (van den 
Berg et al., 2008) might result in early expression of Nanog:GFP in pre-iPSN-




Reprogramming driven by Esrrb proceeds in Nanog
-/-
 NS cells with significantly 
reduced efficiency compared to WT. It was recently shown that Esrrb can reprogram 
EpiSC to naïve pluripotency with higher efficiency than Nanog (Festuccia et al., 
2012). Intriguingly, Esrrb is able to compensate for the absence of Nanog also in this 
setting, but reprogramming is inefficient in Nanog
-/-
 EpiSC. This indicates that Esrrb 
and Nanog act cooperatively to induce pluripotency, similarly to what observed in 
LIF independence assays (See Chapter 5). Such cooperativity may be important for 
the generation of iPS cells, since Nanog and Esrrb expression are upregulated at 
similar times during reprogramming (Samavarchi-Tehrani et al., 2010). The data 
presented in this thesis also show that the ability of Nanog overexpression to confer 
LIF independence is abrogated in the absence of Esrrb (See Chapter 8). It would be 
now interesting to determine whether Nanog ability to promote reprogramming is 
similarly dependent on Esrrb expression. In addition, given that Nanog is required 
for the progression of reprogramming, it would be important to test whether a similar 
requirement exists for Esrrb. Esrrb might be required for establishment of 
pluripotency, but dispensable once pluripotency is attained (see Chapter 8), further 
underscoring its functional similarity with Nanog (Silva et al., 2009).   
 
Finally, the current model postulates that Nanog exerts a function in the last stages of 
the reprogramming process (Silva et al., 2009; Theunissen and Silva, 2011), 
implying that similarities might exist between Nanog function in the establishment of 
pluripotency in the ICM and its role in completing reprogramming. Although this is 
an intriguing possibility, there is no definitive evidence that reprogramming in vitro 







Chapter 7: Esrrb complements Nanog function in germline 
development 
 
ES cells lacking Nanog fail to contribute to the germline; in chimaeric embryos, 
primordial germ cells (PGC) derived from Nanog null ES cells are lost between 11.5 
and 12.5 days of development (Chambers et al., 2007). Interestingly, Nanog is not 
required for the initial specification of the founder PGC population that occurs in the 
proximal epiblast between E6.25 and E7.25 (Ohinata et al., 2009; Ohinata et al., 
2005; Sato et al., 2002; Yamaji et al., 2008). Epiblast cells lacking Nanog are able to 
maintain the expression of both transcriptional regulators associated with 
pluripotency, like Oct4, and acquire expression of germ cell markers, like Mvh 
(Chambers et al., 2007). Instead, Nanog activity seems to be crucial in the 
maintenance of the already specified PGC population (Chambers et al., 2007) and in 
the promotion of its survival (Yamaguchi et al., 2009). Results in previous chapters 
have shown that Esrrb can substitute for Nanog in sustaining the acquisition and 
maintenance of pluripotency. Importantly, developing PGCs undergo complex 
transformations that specifically involve epigenetic resetting and reactivation of the 
pluripotency network, with parallels to those observed during the specification of the 
pluripotent ICM in pre-implantation embryos (See chapter 1.1.2), a process for 
which Nanog is required (Mitsui et al., 2003; Silva et al., 2009). In addition, Esrrb 
has also been shown to be important for PGC development. Reduced numbers of 
PGCs are detected in the genital ridges of Esrrb null embryos after E11.5 (Mitsunaga 
et al., 2004).  Thus, it was decided to determine whether Esrrb expression in Nanog 










A construct encoding for (Flag)3Esrrb was inserted at the Nanog locus in RCNH(t) 
ES cells (Figure 7.1A). In the resulting cell line (RCNH(t) Esrrb Knock-In (Esrrb 
KI)), the (Flag)3Esrrb transgene is expressed under the control of the endogenous 
Nanog regulatory elements; since this is an insertion and not a replacement, no 
additional loss of genetic information from the already disrupted Nanog locus occurs. 
In chimaeric embryos generated by blastocyst injection of Esrrb KI cells, the Esrrb 
transgene should be expressed in PGC precursors derived from injected cells when 
Nanog transcription is reactivated around E7.75 and expression should persist 
beyond migration to the genital ridges until E14.5 in female and E15.5 in male 
embryos respectively (Yamaguchi et al., 2005). Thus, in this cell line, Esrrb will be 
continuously expressed from the Nanog locus during the whole period before and 
beyond the time when the Nanog null phenotype is manifest at E11.5-12.5.    
Correctly targeted Esrrb KI clones were identified by Southern blot analysis (Figure 
7.1A-B). Two clones that had undergone correct recombination at either the Geo 
(clone 4) or the Hygro
R
 (clone 5) targeted alleles were selected for further analysis. 
In Esrrb KI ES cells, Esrrb expression is higher in comparison to the parental 
RCNH(t) cell line and wild-type E14Tg2a ES cells (Figure 7.2A). This is explained 
by the fact that expression of Esrrb driven from Nanog in this cell line adds to the 
endogenous Esrrb levels. The (Flag)3Esrrb protein encoded by the KI transgene can 
be distinguished from the endogenous Esrrb protein by virtue of its increased 
molecular weight. As expected, expression of both wild-type and (Flag)3Esrrb  
protein was detected in Esrrb KI cells, with no evidence of negative feedback by 
Esrrb protein on Esrrb (Figure 7.2B). 
 









Figure 7.1: Derivation of RCNH(t) Esrrb KI ES cells. 
 
A: Schematic representation of the Nanog locus structure in RCNH(t) Esrrb KI ES 
cells, showing the hygromycin and -geo targeted alleles in the parental RCNH(t) 
lines and the respective Esrrb knock-in alleles, along with the restriction sites and 
DNA probes used for Southern blot analysis. The expected sizes of the DNA 
fragments obtained after digestion are shown on top of each diagram. The 
homology arms of the targeting vector are shown in red. Nanog exons are shown in 
orange. The Nanog 5’UTR is in blue. B: Southern blot analysis performed on DNA 












Figure 7.2: Esrrb expression in RCNH(t) Esrrb KI cells. 
 
A: Esrrb transcript levels in E14Tg2a, RCNH(t) and RCNH(t) Esrrb KI ES cells. 
Error bars: standard deviation of the technical errors in gene expression 
quantification in one experiment. D: Esrrb protein levels in RCNH(t) and RCNH(t) 





for RCNH(t) parental Nanog
-/-
 cells. In RCNH(t) ES cells, GFP is expressed from 
a constitutively active CAG driven transgene, allowing for accurate tracing of the 
injected cells in chimaeric embryos (Chambers et al., 2007). Thus, dissected E13.5 
chimaeric embryos could be easily distinguished from their wild-type littermates on 
the basis of GFP expression (Figure 7.3A). Pictures of every embryo were taken 
before dissection to ensure that a correct staging could be subsequently established. 
After dissection, pictures were also taken for all genital ridges isolated (Figure 
7.3A). The levels of somatic contribution were determined by flow cytometry on cell 
suspensions obtained by mechanical dissociation and trypsinisation of the embryo 
bodies, after removal of the genital ridges (Figure 7.3B, Table 7.1). Next, the genital 
ridges were stained for Oct4 and Mvh and contribution to the germline of GFP 
positive cells was assessed by confocal fluorescence microscopy. No GFP
+
 cell 
expressing Mvh or Oct4 could be detected after control injections of the RCNH(t) 
parental line (Figure 7.4B). In contrast and unexpectedly, Esrrb KI cells positive for 
Mvh and Oct4 expression, and displaying a round morphology typical of PGCs, 
could be readily identified in the genital ridges of E13.5 chimaeric embryos (solid 
arrows, Figure 7.4A-B), along with PGCs derived from the host embryo (open 
arrows). 
A summary of the results from all injection performed is shown in Tables 7.1-7.2. It 
is important to note that parental RCNH(t) cells showed consistently higher somatic 
contribution than Esrrb KI cells. This observation may be due to intrinsic differences 
between the clonal lines employed (Esrrb KI clone 4 and RCNH(t) c1one 12 
(Chambers et al., 2007))  or by the hypothesis that elevated levels of Esrrb protein 
may partially block differentiation of Esrrb KI cells during early embryonic 
development. 10 out of the 26 embryos analysed after injection of Esrrb KI cells 
showed contribution to the germline at E13.5 (38%). Despite this elevated frequency, 
the levels of germline contribution were consistently low in all sets of injections 
performed (<5%-20% of Esrrb KI derived PGCs).  
 
These results indicate that, at least up until E13.5, Esrrb can rescue the defective 
development of Nanog
-/-











Figure 7.3: Blastocyst injection of RCNbH(t) Esrrb KI ES cells. 
 
A: GFP expression in E13.5 chimaeric embryos derived from blastocyst injections of 
RCNH(t) Esrrb KI ES cells and in the dissected gonads. GFP marks Esrrb KI ES 
cells B: Histogram plot showing the distribution of GFP expression in cell 
suspensions obtained by mechanical dissociation and trypsinisation of chimaeric 
embryos after removal of the gonads. Cells from non-chimaeric embryos served as 
controls and are shown in red. Somatic contribution was determined by analysing 







Figure 7.4: Esrrb knock-in extends the development of Nanog null PGCs 
beyond E11.5. 
 
A: Oct4 and Mvh expression in the genital ridges of E13.5 embryos derived from 
blastocyst injections of RCNH(t) Esrrb KI cells. B: Mvh expression in the genital 
ridges of E13.5 embryos derived from blastocyst injections of RCNH(t) Esrrb KI 
cells (top) or RCNH(t) cells. Esrrb KI and RCNH(t) cells are GFP+. Solid arrows: 
GFP+ PGCs derived from RCNH(t) Esrrb KI ES cells. GFP- PGCs derived from the 
host embryo. Right panels in A show a higher magnification image of PGCs in the 









Table 7.1: Germline contribution potential of Nanog-/- RCNH(t) ES cells. 
 
Somatic and germline contribution observed in E13.5 (or E12.5) embryos 
after 5 independent sets of blastocyst injections using RCNH(t) Esrrb KI ES 
cells. Contribution to the germline was scored comparing the numbers of 
GFP+/Mvh+/(and Oct4+, as specified above each table) PGCs  and GFP- 













Table 7.2: Germline contribution potential of Nanog-/- RCNH(t) ES cells. 
 
Somatic and germline contribution observed in E13.5 embryos after 
blastocyst injection of RCNH(t) ES cells. Contribution to the germline was 
scored comparing the numbers of GFP+/Mvh+/Oct4+ PGCs and GFP- PGCs 





7.2:    Generation of Esrrb KI mice 
 
From the previous results, it is possible to hypothesise that precocious and elevated 
Esrrb expression is able to compensate for the lack of Nanog during PGC 
development. Nonetheless, the low levels of germline contribution observed for 
rescued Nanog
-/-
 ES cells might indicate that the observed PGCs are not correctly 
developing, and that Esrrb KI may only result in a delayed loss of Nanog
-/-
 PGCs in 
chimaeric embryos.       
 
It was therefore decided to determine whether Nanog
-/-
 Esrrb KI PGCs could develop 
normally to later embryonic stages, and give rise to functional gametes in adult 
animals. With this aim, Esrrb knock-in at the Nanog locus was repeated in E14Tg2a 
ES cells (Figure 7.5A-B) and clones which underwent correct recombination were 
identified by Southern blot. Two clones, clone 16 and clone 18, were selected for 
blastocyst injection and chimaeric mice derived from this line. Germline 
transmission was achieved in all chimeras generated by both clones and the Esrrb KI 




 (Mitsui et al., 2003) or Nanog
+/Esrrb KI
 animals were then mated to mice in 
which a Cre transgene is put under the control of the Prdm1 regulatory elements, 
ensuring that recombinase expression is confined to the PGC compartment (Ohinata 
et al., 2005). Male or female Nanog
+/-
 / Prdm1:Cre or Nanog
+/Esrrb KI
 / Prdm1:Cre  
animals have now been crossed to mice carrying two floxed Nanog alleles    
(Nanog
fl-STOP-GFP 
). In these animals, Nanog deletion by Cre recombinase is 
accompanied by activation of GFP expression from the same locus   (Chambers et 
al., 2007) (Figure 7.6A-B). Some progeny of Nanog
+/-
 / Prdm1:Cre animals will 
inherit one Nanog
fl-STOP-GFP
 allele, one Nanog
-
 allele and the Prdm1:Cre transgene. 
Likewise, some progeny of Nanog
+/Esrrb KI
 / Prdm1:Cre animals will inherit one 
Nanog
fl-STOP-GFP
 allele, one Nanog
Esrrb KI
 allele and the Prdm1:Cre transgene. PGCs in 
these embryos should recombine the Nanog
fl-STOP-GFP
 allele soon after Blimp1 






Figure 7.5: Derivation of E14Tg2a Esrrb KI ES cells. 
 
A: Schematic representation of the Nanog locus structure in E14Tg2a and E14Tg2a 
Esrrb KI ES cells, showing wild-type and targeted Esrrb alleles, along with the 
restriction sites and DNA probes used for Southern blot analysis. The expected 
sizes of the DNA fragments obtained after digestion are shown on top of each 
diagram. The homology arms of the targeting vector are shown in red. B: Southern 
blot analysis performed on DNA samples prepared from E14Tg2a and E14Tg2a 







Figure 7.6: Experimental scheme for Esrrb KI mice crosses. 
 
A: Scheme   showing the   planned   crosses   between   Nanog / - Prdm1:Cre  and 
Nanog fl-STOP-GFP / fl-STOP-GFP animals, along with two of the possible genotypes 
expected in the progeny. B: Scheme showing the planned crosses between Nanog 
EsrrbKI / + Blimp1:Cre and Nanog fl-STOP-GFP / fl-STOP-GFP animals, along with two of the 
possible genotypes expected in the progeny. The Nanog fl-STOP-GFP allele is a 
conditional knockout Nanog allele in which recombination leads to excision of Nanog 
and expression of GFP under the control of the Nanog regulatory elements (shown 
as Nanog GFP). Prdm1:Cre is expressed from a random integrated BAC transgene 









 allele and the Prdm1:Cre transgene will serve as controls 
(Figure 7.6A-B). It will be possible to follow the development of Nanog null PGCs 
avoiding the limitation imposed by chimaera experiments. In addition, the presence 
of a Nanog fluorescent reporter will potentially permit sorting and characterisation of 
the developing PGC population.  
 
Adult animals derived from the discussed crosses will be genotyped and       
Nanog
Esrrb KI / GFP
 mice mated to wild-type animals. Potential transmission of a 
recombined floxed Nanog allele to the progeny of Nanog 
Esrrb KI/GFP
 animals would 
strongly suggest that fully functional PGC developed in these animals in the absence 
of Nanog. 
 
7.3:    Discussion 
 
During their migration to the genital ridges, PGCs undergo a series of transcriptional 
and epigenetic changes that culminates in major wave of epigenetic resetting after 
their entry into the gonads (Hajkova et al., 2008; Hajkova et al., 2002; Hajkova et al., 
2010; Seki et al., 2005; Seki et al., 2007). Migratory PGCs, that have not yet 
completed erasure of methylation marks at imprinted loci (Hajkova et al., 2002), still 
display detectable levels of genomewide DNA methylation (Seki et al., 2005), but 
have already started reactivation of the inactive X chromosome (de Napoles et al., 
2007; Sugimoto and Abe, 2007) and established high levels of H3K27me3 (Seki et 
al., 2007), are in a state that present analogies to that observed in the pluripotent cells 
of the pre-implantation epiblast. Furthermore, throughout migration, PGCs show 
expression the key pluripotency regulators Oct4, Sox2 and Nanog (Avilion et al., 
2003; Chambers et al., 2003; Chambers et al., 2007; Kurimoto et al., 2008; 
Yamaguchi et al., 2005; Yeom et al., 1996; Yoshimizu et al., 1999), which are also 
required for correct germline development. (Chambers et al., 2007; Kehler et al., 





The function of this transitory acquisition of traits characteristic of pluripotent cells 
still remains unclear, and little is known about the role that single pluripotency 
factors play in sustaining the migratory PGC population. Possibly, reactivation of the 
pluripotency network is required in PGCs to set the stage for further epigenetic 
changes occurring after day E10.5 (Hajkova et al., 2008; Hajkova et al., 2010). In 
alternative, it might simply be important for PGCs to escape somatic differentiation 
during their migration to the genital ridges. In both instances, Nanog absence could 
result in defective maintenance of pluripotency. The results presented in chapters 5 
and 6 have shown that Esrrb is able to substitute for Nanog in driving the attainment 
and sustaining the maintenance of pluripotency. Esrrb expression is normally lost in 
the epiblast after implantation and is reactivated when the founder PGC population 
reaches the developing gonads at day E11.5 (Mitsunaga et al., 2004). Conversely, 
Nanog expression is reactivated around day E7.75 (Yamaguchi et al., 2005), soon 
after PGCs are specified. As a consequence, in PGCs derived from Esrrb KI cells, 
Esrrb should be expressed for a prolonged period of time, throughout migration to 
the genital ridges. It is possible that Esrrb expression during this time could help 
maintaining pluripotency genes expression in migratory PGCs. 
 
Nanog could also be instrumental in driving reactivation of the pluripotency GRN in 
the founder PGC population. Although Nanog null PGCs express Oct4 at day E 11.5 
(Chambers et al., 2007), this factor is never downregulated in PGC precursors. In 
contrast, Sox2 is transiently lost in PGCs accumulating in the posterior 
extraembryonic mesoderm region (Kurimoto et al., 2008; Yabuta et al., 2006). It 
would be interesting to determine whether Nanog null PGCs show perturbed 
reactivation of Sox2 and fail to upregulate other pluripotency or germline markers, 
such as Klf2 and Prdm14, that are not expressed in the post-implantation epiblast and 
have been shown to be instrumental in promoting the reversion of EpiSC to naïve 
pluripotency (Gillich et al., 2012). In particular it should be ascertained whether 
Nanog null PGCs are able to sustain expression of Prdm14 after its activation at E6.5 
(Yamaji et al., 2008), since this gene is crucial in driving germ cell specification 
(Yamaji et al., 2008) and, although expressed at low levels in ES cells, shows good 




response to Nanog induction in ESN-NERT and ESN-iNanog cells (Figure 3.1, 
Table 3.1).  
 
As mentioned, during their migration to the genital ridges, PGCs gradually reverse 
random X inactivation (Sugimoto and Abe, 2007). This process initiates in migratory 
PGCs soon after reactivation of Nanog expression (Yamaguchi et al., 2005). This is 
in agreement with the notion that Nanog plays a direct role in suppressing X 
chromosome inactivation by repressing Xist transcription in conjunction with Oct4 
and Sox2 (Navarro et al., 2008). It would be interesting to check the extent of X 
chromosome inactivation in Nanog null PCCs before their disappearance at E12.5. 
Since Esrrb binds to Xist (Pablo Navarro, unpublished observation), the X 
inactivation status should be also determined in Esrrb KI PGCs at similar stages of 
development.     
 
Intriguingly, onset of Esrrb expression at E11.5 (Mitsunaga et al., 2004) coincides 
with the time at which the phenotype of Nanog null cells manifests in the germline 
(Chambers et al., 2007), opening the additional possibility that the observed defects 
of Nanog
-/-
 PGCs might arise as a consequence of defective Esrrb reactivation. 
Ablation of Esrrb results in reduced number of PGCs after E11.5 (Mitsunaga et al., 
2004) but does not determine their complete loss, arguing against the hypothesis that 
failure to reactivate of Esrrb can explain the total absence of Nanog
-/-
 PGCs at E12.5 
(Chambers et al., 2007). Nonetheless, it is worth noting that lack of Esrrb expression 
in Nanog null PGCs would result in the concomitant absence of both Nanog and 
Esrrb in the developing germline. Since both ablation of Esrrb and Nanog results in a 
severely compromised ability to self-renew in ES cells ((Chambers et al., 2007) and 
see Chapter 8), it is possible that a severe phenotype could arise from the 
concomitant absence of these two factors in germ cells. In this case, Esrrb KI cells 
could partially or fully overcome this phenotype by ensuring Esrrb expression in 
Nanog
-/-
 PGCs. To test this possibility, it will be first necessary to determine the 
dynamics of Esrrb expression in developing Nanog null PGCs soon after their entry 





Finally, in vitro models could help explore the mechanisms underlying the ability of 
Esrrb to rescue the phenotype of Nanog
-/-
 PGCs during development. Recent work 
demonstrated that ES cells derived epiblast-like cells can be converted into cells 
resembling developing PGCs (PGCLCs) by in vitro culture in the presence of a 
combination of instructive signals including BMP4/8, LIF, SCF and EGF (Hayashi et 
al., 2011). Since EpiSC can also be reverted to an ES state in vitro and Nanog is 
required for this transition (Silva et al., 2009), it would be interesting to determine 
whether Nanog is dispensable for the generation of PGCLC cells. The generation of 
relatively high numbers of cells acquiring PGC character through transitions that 
mirror in vivo development could help dissecting the contribution of Esrrb in 
alleviating the consequences of loss of Nanog. In addition, in such in vitro settings it 
would be possible to induce Esrrb elevation to levels that are not achieved in Esrrb 
KI cells (Figure 7.2a). If Esrrb expression levels prove to be correlated with the 
extent of the rescue observed, it could be useful to derive cell lines that will allow 
PGC restricted overexpression of Esrrb under the control of a strong inducible 
promoter. A possible strategy could involve targeting of the rtTA transactivator to 








Chapter 8: Effects of Esrrb ablation and identification of 
Esrrb target genes 
 
The results presented so far define Esrrb as an important factor controlling ES cell 
self-renewal and driving acquisition of pluripotency. Next, the effects of Esrrb 
ablation in ES cells were investigated. Since Esrrb is a prominent transcriptional 
target of Nanog, to conclusively prove that part of Nanog function in ES cells is 
mediated through activation of Esrrb, the effects of loss of Esrrb were studied in 
Nanog overexpressing cells. 
 
8.1:    Self-renewal in Esrrb knockout cells 
 
Esrrb knockdown has been shown to affect the self-renewal of ES cells (Ivanova et 
al., 2006). However, these studies did not explore the consequences of complete loss 
of Esrrb, since they were limited by the potential for residual heterogeneous 
expression in the ES cell population. It was thus decided to incontrovertibly 
determine whether Esrrb expression is required for ES cell self-renewal. With this 
aim, cells homozygous for a conditional Esrrb knockout allele (Esrrb
f/fn
) were 
generated by two successive rounds of homologous recombination using a previously 
described targeting construct in which loxP sites are placed at either side of Esrrb 
exon 2 (Figure 8.1A-B)(Chen and Nathans, 2007). ES cell that showed correct 
recombination were identified by Southern blot (Figure 8.1B-C) and engineered to 
stably express a tamoxifen inducible Cre-ER
T2
 transgene (Figure 8.1A).  
 
The effects of Esrrb deletion were then assessed in Esrrb
f/fn
 ES cells. Tamoxifen 
treatment of Esrrb
f/fn
 cells plated at clonal density severely reduces the number of 
AP
+ 
undifferentiated colonies observed after 7 days of culture in GMEM/FCS/LIF 











Figure 8.1: Derivation of Esrrb conditional knock-out ES cells. 
 
A: Schematic representation of the genetic manipulations performed to derive 
conditional knockout (Esrrbf/fn) ES cells. Esrrbf/fn cells have two floxed Esrrb alleles 
and constitutively express a tamoxifen inducible Cre-ERT2 transgene. B: Schematic 
representation of wild type and conditional knockout Esrrb alleles. The homology 
arms of the targeting vector are shown in red. The restriction enzyme sites used for 
Southern blot analysis are shown above each diagram, along with the expected size 
of the genomic DNA fragment generated by digestion with NcoI or EcoRV and PsiI. 
LoxP sites are shown as black triangles and FRT sites as blue triangles. C: 
Southern blot analysis of Esrrb+/fn, Esrrb+/f and Esrrbf/fn lines generated after the first 
and second targeting events from E14Tg2a ES cells. Two separate double targeted 
Esrrbf/fn lines are shown before and after stable integration of a CRE-ERT2 
transgene. Retention of Esrrbf and Esrrbfn alleles demonstrates that excision does 


















Figure 8.2: Loss of Esrrb compromises ES cell clonogenic potential. 
 
A: Number of colonies formed by Esrrbf/fn cells plated at clonal density, treated or 
not treated with tamoxifen for 1h on the following day, and cultured in the presence 
or absence of LIF for 7 days. B: Morphology of the colonies observed in the same 






Since almost exclusively partially differentiated colonies formed after Esrrb excision, 
it was next important to test whether it was possible to expand these clones and 
isolate ES cells genetically devoid of Esrrb. To this end, Esrrb
f/fn
 cells were plated at 
clonal density in GMEM/FCS/LIF supplemented with 1mM PD0325. In the 
presence of this inhibitor, cells that failed to recombine the Esrrb locus formed tight 
colonies that completely lacked morphological signs of differentiation. In contrast, 
clones that had excised Esrrb showed substantial differentiation, but could be 
selectively picked and expanded. Stable Esrrb

 cell lines that can be propagated in 
FCS/LIF/GMEMwere isolated. Productive recombination of both alleles was 
confirmed by quantitative PCR on genomic DNA samples using primer pairs binding 
to the targeted exon 2 of Esrrb. Amplification of Esrrb exon 6 served as a control to 
normalise for the amount of template used in each reaction. Whereas amplification 
could be detected in Esrrb
f/fn
 cells, no Esrrb exon 2 was present in the genomic DNA 
prepared from Esrrb

 ES cells (Figure 8.3A). As expected, neither Esrrb transcript 
(Figure 8.3B) nor protein (Figure 8.3C) could be detected in these cells. 
Esrrb

cells have a markedly increased propensity to differentiate but the self-
renewing fraction of the cultures maintains Oct4 expression (Figure 8.3C).  
 
The self-renewal ability of Esrrb

cells was then tested in clonal assays. Whereas 
Esrrb
f/fn
 ES cells efficiently formed undifferentiated colonies when plated in the 
presence of LIF, Esrrb

 cells formed reduced numbers of colonies, composed of a 
majority of AP negative cells (Figure 8.3D).  
 
Taken together these results establish that Esrrb is formally dispensable for ES cell 
self-renewal. Nonetheless, in the absence of Esrrb self-renewal is inefficient and cells 
show a severely impaired clonogenic potential. 
 
8.2:    Effects of Esrrb knock-out on Nanog overexpressing ES cells.  
 








Figure 8.3: Esrrb is formally dispensable for ES cell self-renewal. 
 
A: Quantitative PCR analysis of the levels of Esrrb exon 2 relative to Esrrb exon 6 in 
Esrrbf/fn and Esrrb ES cells. Error bars are the standard deviation of the 3 
technical replicates of one experiment. B: Esrrb transcript levels in Esrrbf/fn and 
Esrrb cells. Error bars are the standard deviation of the 3 technical replicates of 
one experiment. C: Morphology and expression of Oct4 and Esrrb in Esrrbf/fn and 
Esrrb cells. D: Number of the colonies formed by Esrrbf/fn or Esrrb cells plated at 




confers LIF-independent self-renewal (Chambers et al., 2003). If the hypothesis that 
Nanog mediates a significant part of its function via Esrrb is correct, then Esrrb 










+Esrrb) were isolated that overexpressed 





+Esrrb cells were plated at clonal density and treated with tamoxifen as 
described to induce deletion of Esrrb. As expected, tamoxifen treatment of 
Esrrb
f/fn
+Esrrb cells did not result in any apparent change in the morphology and the 
degree of differentiation of the colonies formed. Colonies originated from 
Esrrb
f/fn
+Nanog treated with tamoxifen and lost the tight undifferentiated 
morphology characteristic of Nanog overexpressing cells. Nonetheless, tamoxifen 
treatment of Esrrb
f/fn
+Nanog cells never resulted in the evident loss of self-renewal 
ability observed after treatment of parental Esrrb
f/fn
 lines, indicating that Nanog 
overexpression facilitates the self-renewal of Esrrb

 ES cells (Figure 8.4 C).  
 




+Esrrb tamoxifen treated cells 
were picked and expanded and 6 lines that had excised Esrrb exon2 were identified 
by quantitative PCR on genomic DNA (Figure 8.5A). The absence of Esrrb 
transcript was also confirmed in Esrrb
f/fn
+Nanog cells (Figure 8.5B).   
 
It was then tested whether loss of endogenous Esrrb expression in Esrrb
f/fn
+Nanog 
cells would impair Nanog driven LIF independent self-renewal. Six Nanog and six 
Esrrb overexpressing Esrrb
f/fn
 and derivative Esrrb

 lines were plated at clonal 
density in the presence or absence of LIF and the number of AP
+ 
colonies scored 
after 7 days. Esrrb
f/fn
+Nanog cells showed robust self-renewal both in the presence 
or absence of LIF (Figure 8.5C-D). Enforced Esrrb expression gave comparable 










Figure 8.4: Loss of Esrrb affects the phenotype conferred to ES cells by 
Nanog overexpression. 
 
A: Nanog expression in Esrrbf/fn and Esrrbf/fn + Nanog ES cells. Error bars are the 
standard deviation of the 3 technical replicates of one experiment. B: Esrrb 
expression in Esrrbf/fn and Esrrbf/fn +Esrrb ES cells. Error bars are the standard 
deviation of the 3 technical replicates of one experiment. C: Morphology of the 
colonies formed by Esrrbf/fn +Esrrb and Esrrbf/fn +Nanog ES cells plated at clonal 
density, treated with tamoxifen for 1h on the following day, and cultured in the 








Figure 8.5: Esrrb demolishes Nanog driven LIF independent self-renewal. 
 
A: Quantitative PCR analysis of the levels of Esrrb exon 2 relative to Esrrb exon 6 in 
Esrrbf/fn, Esrrb+Nanog and Esrrb+Esrrb ES cells. Error bars are the standard 
deviation of the 3 technical replicates of one experiment. B: Esrrb expression in 
Esrrbf/fn and Esrrb+Nanog cells. Error bars are the standard deviation of the 3 
technical replicates of one experiment. C: Average number of colonies scored after 
clonal density plating of 6 independent Esrrb +Nanog and Esrrb +Esrrb lines 
and culture for 7 days in the presence or absence of LIF. Error bars: standard 
deviation of the results obtained from 6 lines each analysed in triplicate. D: 
Morphology of the colonies formed by the indicated lines after 7 days of culture in 





number was unaltered in Esrrb

+Esrrb ES cells. As observed during the derivation 
of these lines, Esrrb

+Nanog ES cells showed decreased self-renewal efficiency 
when plated in the presence of LIF (Figure 8.5C-D). Strikingly, the defining ability 
of Nanog to promote LIF independence in ES cells was completely demolished by 
loss of Esrrb. Esrrb

+Nanog ES cells primarily formed differentiated colonies in 
the absence of LIF (Figure 8.5c-d). These observations establish that activation of 
Esrrb expression mediates an important component of Nanog function in ES cells. 
 
8.3:    Esrrb and Nanog share target genes 
 
Taken together the results presented in the previous chapters argue in favour of the 
existence of a degree of functional overlap between Esrrb and Nanog activity in 
pluripotent cells. This could be due to similarities in the transcriptional programme 
activated by Nanog and Esrrb expression. Thus, the transcriptional response to 
Nanog and Esrrb elevation was compared by microarray analysis of doxycycline 
treated ESN-iNanog and ESN-iEsrrb cells. Since ESN-iEsrrb cells lack 
functional Nanog protein, it is possible to exclude that the observed effects of Esrrb 
induction are indirectly due to the elevation of Nanog expression (van den Berg et 
al., 2008). Strikingly, an overall similar transcriptional response was detected after 
Esrrb or Nanog induction (Figure 8.6A). Next, the overlap between the 50 genes 
most upregulated in response to Nanog or Esrrb activation was determined. In order 
to focus the analysis on potential direct targets of transcriptional activation by both 
factors, only genes for which binding of Nanog and Esrrb had been reported in two 
independent ChIP-seq studies were considered (Chen et al., 2008; Marson et al., 
2008). 20% of the top 50 upregulated genes were common between ESN-iNanog 
and ESN-iEsrrb cells datasets (Figure 8.6B). Klf4 was the only transcription factor 












Figure 8.6: Esrrb demolishes Nanog driven LIF independent self-renewal. 
 
A: Heatmap showing expression (in ESN-iNanog (iN) or ESN-iEsrrb (iE) cells) of 
the top 250 genes that were induced or repressed in ESN-iNanog (0/12h). Colours: 
expression above average (yellow) and below average (blue). B: Comparison of the 
50 genes most upregulated in ESN-iNanog (iN) and ESN-iEsrrb (iE) after a 12h 
doxycycline treatment. Only Nanog and Esrrb bound genes were considered and 
ranked according to fold induction in ESN-iNanog or ESN-iEsrrb respectively. 
Shared targets are highlighted (orange) and connected by black lines. C: Expression 
of Klf4 in ESN-iNanog (iN) and ESN-iEsrrb (iE) cells after doxycycline treatment 





These results suggest that the observed similarities in the activity of Esrrb and Nanog 
in ES cells might arise from the modulation of a common set of transcriptional 
targets.      
 
8.4:    Discussion  
 
The data presented in this chapter shows that deletion of Esrrb severely impairs the 
ability of ES cells to self-renew, reminiscent of the consequences of loss of Nanog 




 ES cell 
can be derived. It would be now intriguing to determine whether ES cells are able to 
self-renew in the absence of both Nanog and Esrrb. The results presented in this and 
in the previous chapters also reveal that a high degree of mutual dependence exists 
between Nanog and Esrrb function in ES cells and that these two factors conjunctly 
regulate expression of many target genes (Figure 8.6). It is thus crucial to understand 
which pluripotency GRN targets are sensitive to the combined loss of both factors. A 
promising candidate is Klf4. Klf4 is activated by both Nanog and Esrrb (Figure 
8.6C), but its transcriptional elevation in response to Esrrb induction is less 
pronounced than in response to Nanog. Since transcriptional profiling experiments 
were performed in Nanog
-/-
 cells, it is possible that the absence of Nanog binding to 
Klf4 impairs its activation by Esrrb.  To start dissecting the mechanisms of Esrrb and 
Nanog cooperativity, it would be interesting to determine whether Esrrb elevation in 
cells expressing wild-type levels of Nanog results in enhanced Klf4 upregulation. 
Conversely, the response of Klf4, and other target genes, to the induction of Nanog 
should be analysed in Esrrb

 lines. The extent to which Nanog and Esrrb depletion 
reciprocally affect their binding to known target sequences also remains unexplored. 
Few genes radically alter their expression in response to Nanog or Esrrb induction 
(see chapter 3 and Figure 8.6). If Nanog and Esrrb conjunctly regulate transcription, 
the number of responsive genes should increase dramatically in response to 
concomitant restoration of Nanog and Esrrb binding in double knock-out cell lines.  
 
While both Nanog and Esrrb can be deleted, Oct4 and Sox2 expression is absolutely 




Niwa et al., 2000). In addition, Nanog (see Chapter3) or Oct4 (Hall et al., 2009) 
manipulation have profoundly different transcriptional consequences. As discussed 
in chapter 3, this suggests that Oct4 activity is essential for a crucial part of the 
housekeeping functions performed by the pluripotency GRN in ES cells. In contrast, 
other factors, such as Nanog and possibly Esrrb, may be involved in precisely tuning 
the expression of a limited number of genes to confer flexibility to the pluripotency 
network. Deletion of this second class of pluripotency factors could therefore be 
possible as a consequence of the limited transcriptional alterations that ensue in 
knock-out ES cell lines. Alternatively, the deletion of Nanog and Esrrb could be 
achievable in virtue of the ability of one factor to functionally compensate for 
absence of the other. A similar functional complementation has already been 
reported for Klf4, whose depletion does not result in ES cell differentiation (Jiang et 
al., 2008). Knock down studies have demonstrated that Klf4, Klf2 and Klf5 have 
redundant functions and that two but not all three factors can be depleted in ES cells. 
Klf2, Klf4 and Klf5 are highly related proteins and have almost completely 
overlapping binding sites throughout the genome (Jiang et al., 2008). Esrrb and 
Nanog are structurally distinct proteins (Chambers and Tomlinson, 2009; Gearhart et 
al., 2003) and show less extensive binding overlap (Chen et al., 2008). This would 
explain why depletion of single Klf factors has very limited consequences on ES cell 
self-renewal while Esrrb and Nanog null lines show much more severe phenotypes.  
 
Tbx3, another heterogeneously expressed factor, has been shown to be required for 
ES cell self-renewal in knockdown experiments (Ivanova et al., 2006). Despite this, 
and similarly to what observed for Esrrb and Nanog, it could be possible to derive 
Tbx3 null lines. Combinatorial ablation of Nanog, Esrrb, Klfs and Tbx3 and analysis 
of the degree of functional compensation between these factors could expand our 
understanding of the pluripotency GRN topology. Functional studies assessing the 
transcriptional effect of the concomitant elevation or ablation of more than one factor 
will shed light on the extent and the mechanisms of combinatorial control sustaining 






Chapter 9: Concluding remarks and future directions 
 
9.1:    Nanog and Esrrb: overlapping and distinct functions in vitro 
and at different stages of development 
 
Two essential functions have been reported for Nanog during development: Nanog is 
required for the establishment of pluripotency in pre-implantation embryos (Mitsui et 
al., 2003; Silva et al., 2009) and for the progression of germline development beyond 
E12 (Chambers et al., 2007).  In vitro, Nanog is required for efficient ES cell self-
renewal (Chambers et al., 2007) and for completion of reprogramming of 
differentiated cells to pluripotency (Silva et al., 2009). A comprehensive analysis of 
the data presented in this thesis may help clarify similarities and differences amongst 
the multiple roles that Nanog plays in acquisition and loss of pluripotency in these 
different contexts. The results presented in the previous chapters also reveal a high 
degree of mutual dependence between the functions of Nanog and Esrrb in 
pluripotent cells. Therefore, an emergent question is whether the observed overlap in 
function is conserved in different settings.  
 
A central part of this thesis has focussed on the activity that Nanog and Esrrb exert in 
vitro in sustaining pluripotency. Elevation of either Nanog (Chambers et al., 2003) or 
Esrrb (see chapter 4) maintains ES cell pluripotency independently of external 
stimuli whereas genetic ablation of Nanog (Chambers et al., 2007) and Esrrb (see 
chapter 8) results in compromised self-renewal efficiency. In the previous chapter, it 
was shown that the ability of Nanog to relieve LIF dependence in ES cells is 
abrogated in the absence of Esrrb (see Figure 8.5C-D). Conversely, it was possible 
to observe a reduced effect of Esrrb overexpression in LIF independence assays 
performed in Nanog
-/-
 compared to wild-type ES cells (see Chapter 5). Finally, 
concomitant Nanog and Esrrb downregulation coincides with loss of self-renewal 
ability (see Chapter 4). Thus, Nanog and Esrrb activity seem to be pronouncedly 




Esrrb function primarily in pluripotent cells by synergistically regulating the 
expression of a common set of target genes (see Figure 8.6). Relevant to this point, 
since Nanog and Esrrb proteins interact (van den Berg et al., 2010; Wang et al., 
2006a), these two factors may reciprocally enhance their recruitment to common 
target genes. In addition, one factor could bridge the interaction of its partner to 
important transcriptional activators or repressors. Intriguingly, Esrrb has been shown 
to interact with multiple components of the basal transcriptional machinery 
(Percharde et al., 2012; van den Berg et al., 2010) and could be required to mediate 
transcriptional activation by Nanog. Alternatively, both Nanog and Esrrb could 
independently bind and additively activate a common set of targets important for ES 
cell self-renewal, so that maximal induction levels are achieved only when both 
factors are expressed. In any case, Esrrb and Nanog activity in ES cells might not 
merely involve direct activation or repression of transcription, since both factors take 
part in extensive protein-protein interactions (Liang et al., 2008; van den Berg et al., 
2010; Wang et al., 2006a) and might be required to recruit epigenetic modifiers and 
chromatin remodelling complexes to crucial locations in the genome.  
 
After establishment of pluripotency in the pre-implantation blastocyst, Nanog 
expression seems to be dispensable for further progression of somatic development 
(Chambers et al., 2007). Nonetheless, a role for Nanog in regulating the transition 
between pre-implantation and post-implantation pluripotency cannot be excluded. 
Nanog expression is transiently down-regulated in the epiblast immediately before 
implantation (Chambers et al., 2003), becoming detectable again in the posterior 
epiblast before the onset of gastrulation ((Osorno et al., 2012) and see chapter 1). In 
the epiblast, implantation coincides with downregulation of many transcription 
factors that are highly expressed in the Nanog positive pluripotent ICM of the early 
embryo, such as Rex1 (Pelton et al., 2002), Klf5 (Ema et al., 2008), Tbx3 (Bollag et 
al., 1994; Chapman et al., 1996), and Esrrb (Guo et al., 2010; Luo et al., 1997). In 
chapter 3, evidence was presented that some of these pre-implantation markers 
(Esrrb, Rex1, Klf4, Klf5 and Tbx3) are highly responsive to Nanog activity in ES 




expression in the epiblast might be required to allow downregulation of these genes, 
thereby facilitating progression of development.  
 
An important tool for understanding the contribution of Nanog and expression of its 
target genes in regulating the transition from the pre- to post-implantation epiblast 
comes from reprogramming studies of EpiSCs. In parallel with the changes occurring  
during development, the transition between ES cells and EpiSCs is accompanied by 
the silencing of a number of pre-implantation pluripotency markers such as Esrrb, 
Klf4, Rex1, Stella, Nr0b1 and Tbx3 (Festuccia et al., 2012; Guo et al., 2009). Among 
the core pluripotency factors, Oct4 and Sox2 expression is maintained, while, 
notably, Nanog expression is strongly reduced (Guo et al., 2009; Osorno and 
Chambers, 2011). Intriguingly, overexpression of Nanog accompanied by a change 
in culture conditions was shown to drive reprogramming of EpiSCs to ES-like cells 
(Osorno and Chambers, 2011; Silva et al., 2009) and this conversion is accompanied 
by acquisition of a gene expression profile characteristic of “naïve”, pre-
implantation, pluripotency (Silva et al., 2009). A similar reprogramming capacity has 
been reported for c-Myc (Hanna et al., 2009), Nr5a2 (Guo and Smith, 2010), Stat3 
(Yang et al., 2010) and, notably, Klf factors (Gillich et al., 2012; Guo et al., 2009; 
Hall et al., 2009; Hanna et al., 2009) as well as Esrrb (Festuccia et al., 2012). It is 
therefore possible to hypothesise that Nanog action in directing the conversion of 
EpiSC to ES cells is mediated through upregulation of a limited number of its target 
genes, as shown for Klf4, and Esrrb. In support of this interpretation, although Nanog 
expression is limiting for EpiSC reprogramming (Silva et al., 2009), Esrrb elevation 
can bypass this requirement (Festuccia et al., 2012). Notably, Esrrb drives 
reprogramming with compromised efficiency in the absence of Nanog (Festuccia et 
al., 2012). Esrrb is not expressed in EpiSC (Festuccia et al., 2012) and Nanog levels 
are reduced in this population (Guo et al., 2009; Osorno and Chambers, 2011). Given 
the high degree of cooperativity observed between Nanog and Esrrb (see chapter 5, 8 
and (Festuccia et al., 2012)), it is possible that the ability of Nanog to activate a set of 
genes crucial for the maintenance of naïve pluripotency is strongly reduced in EpiSC 




In contrast to mouse ES cells, EpiSC are not responsive to LIF signalling (Tesar et 
al., 2007; Yang et al., 2010). Interestingly, Nanog, Esrrb and Klf4, all factors able to 
drive reprogramming of EpiSC, can confer LIF independence to mouse ESC 
((Chambers et al., 2003; Niwa et al., 2009) and see chapter 4). It is thus possible that 
these three factors (and possibly other Nanog targets) as well as the cascade activated 
by LIF converge on a similar set of targets to impose naïve pluripotency. In support 
of this interpretation, LIF/STAT3 signalling has been shown to be limiting for EpiSC 
reprogramming (Yang et al., 2010), but Nanog and Esrrb expression can bypass this 
requirement (Festuccia et al., 2012; Theunissen et al., 2011b). 
 
Similar to what is observed for murine EpiSC, in human cells Nanog is expressed, 
but Esrrb is absent (Xie et al., 2009). Overexpression of Nanog has been used in 
combination with other canonical reprogramming factors to allow generation of 
human ES cells that present traits of naive pluripotency characteristic of mouse ESC 
(Buecker et al., 2010; Li et al., 2009; Pomp et al., 2011). Naive hESC can be 
established from hESC lines (Hanna et al., 2010) or during direct reprogramming 
from fibroblasts (Buecker et al., 2010; Hanna et al., 2010; Li et al., 2009; Pomp et 
al., 2011). These cells show robust expression of Nanog and other preimplantation 
markers, albeit they remain dependent on transgene expression or complex 
combinations of signal inhibitors (Hanna et al., 2010). In particular, addition of 
Nanog to the canonical reprogramming cocktail OKSM was reported to be strictly 
required for the generation of naive hESC (Buecker et al., 2010). Other investigators 
claimed that conversion of hESC can be achieved in the absence of Nanog using 
reprogramming cocktails that notably always include Nanog targets able to 
reprogramme EpiSC (Hanna et al., 2010). It would be interesting to test the effects of 
ectopic Esrrb expression in hESC lines, and whether naïve hESC can be generated 
and maintained solely by Esrrb elevation. 
 
Extending the conclusions drawn from these in vitro studies to in vivo development, 
it is thus possible that Nanog plays a crucial role in maintaining the unrestricted 
pluripotent state characteristic of the pre-implantation ICM and that loss of Nanog is 




cells upon implantation. Since the overexpression of single Nanog targets is 
sufficient in vitro to drive establishment of naïve pluripotency, it is possible to 
imagine that Nanog might influence the pre- to post-implantation transition mainly 
through its ability to elevate expression of key pluripotency factors. In line with the 
existence of an overlap between Nanog and Esrrb targets, Esrrb is highly efficient in 
complementing Nanog function in this context (Festuccia et al., 2012). 
 
Whereas Esrrb seems to be able to compensate for the absence of Nanog in 
promoting the transition between two pluripotent populations, such as EpiSC and 
ESC, Esrrb driven reprogramming of Nanog null somatic cells requires the additional 
activity of 5’azacytidine (see chapter 6). This compound has been shown to reverse 
methylation marks at the promoter and regulatory elements of pluripotency genes 
and enhance reprogramming (Huangfu et al., 2008; Mikkelsen et al., 2007), 
suggesting that Nanog plays a specific function in driving epigenetic resetting during 
the acquisition of pluripotency. Importantly, 5’-azacytidine alone is not sufficient to 
complete reprogramming of stalled Nanog null pre-iPS cells. These observations 
seem to highlight the existence of two components in the activity that Nanog exerts 
in this context. The first, transcriptional activation of crucial target genes, can be 
functionally complemented by elevation of Esrrb expression. The second, which 
involves triggering epigenetic rearrangement and reversion of methylation marks, 
might be uniquely performed by Nanog. This activity could be mediated through 
protein-protein interactions with chromatin remodelling complexes (Liang et al., 
2008; Wang et al., 2006a) or by inducing expression of epigenetic modifiers. 
Curiously, the levels of Tet2, a member of a class of enzymes involved in the 
hydroxylation of 5meC (Ito et al., 2010; Tahiliani et al., 2009) and erasure of DNA 
methylation, are severely reduced in Nanog null ES cells (see Figure 3.2 and Table 
3.1). Further studies should determine whether defective Tet2 upregulation is also 
noticed during reprogramming of Nanog null cells, and whether reduced Tet2 
expression has functional consequences in this context. In particular, it would be 
interesting to test whether concomitant elevation of Esrrb and Tet2 might result in 





The data presented in chapter 7 shows that precocious and elevated Esrrb expression 
is able to at least partially compensate for the absence of Nanog during PGC 
development. It remains to be established however whether Nanog and Esrrb exert 
their function in this context primarily by sustaining pluripotent gene expression and 
repressing somatic fate during PGCs migration to the genital ridges or whether these 
two factors have an active role in promoting the epigenetic changes that accompany 
germline development (Hajkova et al., 2008; Hajkova et al., 2002; Hajkova et al., 
2010; Seki et al., 2005; Seki et al., 2007). Since broad similarities exist between the 
molecular events underlying germline and pre-implantation development (see 
chapter 1 and 7), it is possible that elevated Esrrb expression might also result in the 
functional complementation of the defects observed in Nanog null blastocysts. This 
possibility should be tested by crossing heterozygous Esrrb KI animals (see chapter 
7.2) and analysing progression of development in homozygous embryos. Relevant to 
the role of Esrrb in pre-implantation development, Esrrb transcripts, and possibly 
Esrrb protein, are likely expressed in maturing oocytes, since high levels of Esrrb are 
detected in 1 cell embryos before activation of the zygotic genome (Guo et al., 2010). 
In addition, Esrrb expression is also detected in the testes of newborn animals 
(Mitsunaga et al., 2004). The function of Esrrb in oogenesis and spermatogenesis has 
never been addressed and, similarly, the role of Esrrb in sustaining development in 
early cleavage embryos remains unexplored. Since conditional knockout alleles are 
available for Esrrb ((Chen and Nathans, 2007) and see chapter 8), future studies 
should assess the consequence of genetic ablation of this factor in postmigratory 
primordial germ cells of male and female animals, or its removal from the egg, by 
tissue specific expression of Cre recombinase (Gallardo et al., 2007; Lewandoski et 
al., 1997). 
 
In summary, in the different in vivo and in vitro contexts examined, Nanog seems to 
exert its activity either through direct transcriptional activation or repression of 
specific targets, a relatively well characterised function, or through modulation of the 
epigenetic state in the cells, a process that remains uncharacterised in its specificity 
and mechanisms of action. Of interest, reactivation of the inactive X chromosome 




and in vitro. Reversion of imprinted paternal X chromosome inactivation is 
specifically completed in the ICM cells of the late blastocyst that maintain Nanog 
expression (Mak et al., 2004; Okamoto et al., 2004). Coincident with downregulation 
of Nanog, random X inactivation also starts in female embryos after implantation 
(Rastan, 1982). Conversely, in vitro reprogramming of EpiSC, a process efficiently 
driven by Nanog, is marked by reactivation of the silent X chromosome in female 
lines (Silva et al., 2009). In addition, X reactivation and expression of endogenous 
Nanog are detected at similar stages during transcription factor based reprogramming 
of somatic cells (Stadtfeld et al., 2008). Finally, during their migration to the genital 
ridges, PGCs gradually reverse random X inactivation (Sugimoto and Abe, 2007) 
and this process initiates in migratory PGCs soon after reactivation of Nanog 
expression (Yamaguchi et al., 2005). This is in agreement with the observation that 
Nanog plays a direct role repressing Xist transcription in conjunction with Oct4 and 
Sox2 (Navarro et al., 2008). Apart from the fact that Esrrb binds to Xist in ES cells 
(Pablo Navarro, unpublished information), the ability of Esrrb to complement Nanog 
activity in repressing X inactivation, and the possible mechanism through which such 
compensation is achieved, remain completely unexplored. 
 
Irrespective of their functional overlap in pluripotent cells, Esrrb has an essential role 
in additional processes in which Nanog is not involved, consistent with its much 
broader expression pattern ((Bookout et al., 2005; Bookout et al., 2006) and see 
chapter 1). In particular, Esrrb is highly expressed in the extraembryonic ectoderm 
and is required for placental development (Luo et al., 1997). Esrrb function in such 
context seems to be related to the maintenance of the proliferating population of  
trophoblast cells responsible for most of the embryonic contribution to placental 
tissues (Luo et al., 1997). Trophoblast stem (TS) cell lines can be can be derived 
from post-implantation extraembryonic ectoderm explants and the trophectoderm of 
pre-implantation embryos (Tanaka et al., 1998). Esrrb is highly expressed in TS cells 
and inhibition of estrogen related receptors by diethylstilbestrol results in TS cell 
differentiation into polyploid trophoblast giant cells (Tremblay et al., 2001b). Taking 




interesting to explore the functional role of Esrrb in sustaining TS cell self-renewal 
and the dynamic control of its expression in this population. 
 
9.2:    Nanog control over transcription: live imaging of 
transcriptional dynamics 
 
The results presented in chapter 3 show that Nanog elevation affects the 
transcriptional output of a limited number of genes, among which are important 
regulators of self-renewal, such as Esrrb and Klf4. In chapter 4, the dynamics of the 
control of Esrrb expression by Nanog were analysed using fluorescent reporter lines: 
Nanog and Esrrb protein levels show a clear correlation in single ES cells. If similar 
expression patterns could be observed for other genes, it would be important to 
determine whether fluctuations in Nanog levels result in the synchronous and 
coordinated transcriptional modulation of a cohort of its targets in individual cells. 
Indeed, Esrrb and Klf4 fluctuations are linked in ES cells and both factors show 
correlation with Nanog expression (Figure 4.17). Since such correlation was 
determined at the protein level, and given that Nanog influences expression of its 
targets at the transcriptional level, it could be particularly informative to extend our 
analysis to the study of active transcription from both Esrrb and Klf4 alleles in single 
cells. qPCR could be employed to quantify expression of Nanog, Esrrb, Klf4 and 
other Nanog target genes in single ES cells. Nonetheless, such an approach would 
only detect eventual correlations in the levels of mature transcripts of these genes. 
Since elevation of mRNA levels results from their accumulation over prolonged 
periods of transcription, and any decrease is influenced by the stability of the 
mRNAs, this technique does not have the potential to establish a direct link between 
Nanog protein levels and transcriptional activity of its target genes. Initially, FISH 
and immunohistochemistry should be employed to determine whether a correlation 
exists between Nanog protein levels and the transcriptional output of Klf4, Esrrb and 
possibly other Nanog targets. Such experiments could reveal: 1) A correlation in the 
numbers of actively transcribing Klf4 and Esrrb alleles and Nanog levels across the 




biallelic transcription of Esrrb and Klf4. 3) Synchronicity in the expression of Esrrb 
and Klf4 in individual cells. 4) Colocalisation of transcribing Esrrb and Klf4 alleles 
to specific nuclear regions. This last point is of particular relevance to the 
understanding of the mechanisms through which transcription is regulated in ES 
cells. Recent reports highlighted the existence of long range interactions between 
different chromatin domains in mammalian (Li et al., 2012) and, more specifically, 
ES (Dixon et al., 2012) cells. Such interactions often involve promoters and 
enhancers of genes located on distant regions on the same chromosome or on 
different chromosomes, and it has been shown that such multigene complexes tend to 
localise to foci of high RNApolII density in the nucleus (Li et al., 2012). The model 
proposing that active alleles segregate to transcription “factories”, first proposed by 
Cook and co-workers (Iborra et al., 1996), refuses the idea that freely diffusing 
RNApolII is recruited to the promoter of actively transcribed genes. This model 
rather hypothesises that the alleles of different genes colocalise to structured, 
possibly pre-existent domains of RNApolII, transcription factor, and splicing factor 
accumulation that show reduced mobility (reviewed in (Edelman and Fraser, 2012; 
Sutherland and Bickmore, 2009)). Recruitment of enhancers and promoters of 
different genes to common regions of the nucleus could provide a basis for the 
coordinated regulation of gene expression (Li et al., 2012) in ES cells. It would be 
interesting to understand whether such long range interactions are bridged by 
transcriptional regulators, like Nanog, and whether Nanog promotes recruitment of 
its target genes to these transcription factories. FISH experiments should be repeated 
in Nanog null ES cells, to determine whether the localisation of active Esrrb and Klf4 
alleles, or other Nanog targets, to particular nuclear domains is lost in the absence of 
Nanog. Since Nanog and Esrrb seem to share a consistent number of target genes, 
including Klf4, similar experiment could be also performed comparing wild-type and 
Esrrb knockout ES cells. 
 
Discussing the results presented in chapter 4, it was proposed to monitor the effects 
of Nanog on Esrrb expression using imaging techniques that allow the visualisation 
of foci of active transcription in live cells. Two alternative techniques could be 




tagged probes (See (Anikeeva and Deisseroth, 2012) for a general review) that can 
be readily introduced in living cells employing common transfection reagents. After 
excitation with a near infrared light source, isolated nanoparticles emit at a 
wavelength that is proportional to their aspect ratio. The proximity of two gold 
particles causes a shift in their emission wavelength that can be used to detect 
hybridisation of a pair of tagged probes to contiguous sequences on an mRNA 
molecule (unpublished method developed by Luke Lee at UCSC Berkley). Probes 
designed to hybridise immediately adjacent to one another on intronic gene regions 
could be employed to exclusively detect accumulation of nascent transcripts 
originating from the active alleles of any gene of interest. A second approach is 
based on the detection of the accumulation of GFP tagged RNA binding proteins, 
such as MS2 (Janicki et al., 2004) or GFP (Daigle and Ellenberg, 2007), in 
confined regions of the nuclear volume. Targeting of tandem repetitions of the 
recognition sequences for MS2 or GFP to the introns of one or both alleles of a 
gene of interest will generate ES cell lines in which GFP is specifically recruited to 
the nascent transcripts accumulating at the sites of active transcription. These cell 
lines should be engineered to expressed RFP fusion reporters for Nanog protein 
expression, as discussed in chapter 4.8. Being able to image transcriptional events in 
live cells could make it possible to address questions otherwise precluded to 
investigation by conventional FISH techniques. In particular, the list of proposed 
experiments could be extended by determining: 1) the temporal pattern and the 
duration of transcriptional firing from Esrrb and Klf4 alleles in individual cells. 2) 
whether Esrrb and Klf4 are transcribed more frequently or for longer time in cells 
expressing high Nanog levels. Such experiments could assess whether the detection 
of active transcription in one cell at a given time is informative to predict the 
likelihood to observe a second transcriptional event in the same cell at a later time 
point. This would ultimately clarify whether active alleles that cease transcription 
remain in a poised state for subsequent rounds of transcriptional firing. 
    
The data presented in Chapter 3 suggest that Nanog influences the kinetics of release 
of paused RNApolII from the promoter of its target genes, as exemplified by Esrrb 




context. It could be possible to monitor the appearance of nascent transcripts using 
nanoparticle tagged oligos annealing to successive intron-exon junctions across the 
Esrrb gene in microscopy timelapse experiments performed on ES cells released 
form flavopiridol block. Such experiments would permit direct comparison of the 
kinetics of RNApolII pause-release in populations of wildtype or Nanog null ES 
cells.    
 
9.3:    Transcriptional consequences of loss of Nanog and Esrrb and 
commitment to differentiation 
 
Loss of Nanog determines a state in which ES cell are still able to self-renew and 
regain Nanog expression (Chambers et al., 2007). It is possible to imagine that in the 
transient absence of Nanog, ES cells are more susceptible to downregulate the 
expression of critical Nanog target genes and that this downregulation represents a 
commitment event. Indeed, results presented in chapter 4 suggest that loss of Nanog 
is required for Esrrb downregulation (see Figure 4.4), which in turn marks 
commitment to differentiate. Quantitative PCR analysis indicates that differentiating 
Esrrb
low
 cells acquire a gene expression profile reminiscent of EpiSC (see Figure 
4.9). It will be now necessary to extend this analysis and determine the genome-wide 
transcriptional changes occurring in cells spontaneously losing expression of either 
Nanog alone, or both Nanog and Esrrb. The identified set of differentially expressed 
genes will help characterise the successive steps that accompany loss of 
pluripotency. It would also be informative to compare the differentially expressed 
genes identified in cells that spontaneously lose Esrrb or Nanog expression with the 
list of Esrrb and Nanog targets identified from the analysis of knockout and inducible 
lines. Such a comparison would clarify the extent to which loss of these two factors 
has a causal role in triggering differentiation and may help identifying the crucial 
targets of Esrrb and Nanog in this process. The results presented in chapter 8.3 lead 
to an initial characterisation of Esrrb responsive genes. It would now be useful to 
derive knockout lines that possess inducible Esrrb function to characterise Esrrb 




chapter 3). In particular, transcriptional profiling of Esrrb null ES cells could clarify 
whether loss of Esrrb is responsible for the downregulation of pre-implantation 
markers observed in Esrrb-2a-GFPdest1 reporter lines (see Figure 4.9) and whether 
Esrrb exerts a direct function in maintaining naïve pluripotency. 
9.4:    Estrogen related receptor genes: unique or redundant 
functions? 
 
The results presented in chapter 8 show that Esrrb is not strictly required for ES cell 
self-renewal. Although with reduced self-renewal efficiency, and almost completely 
compromised clonogenic potential, Esrrb null ES cells can be maintained in culture 
indefinitely and retain expression of Oct4 (see Figure 8.3), and Nanog.  
 
As highlighted in chapter 1.4.3, Esrrb, Esrra and Esrrg proteins present a high degree 
of homology, particularly in their DNA binding domain. (Heard et al., 2000; Hong et 
al., 1999). Furthermore, estrogen related receptors show pronounced structural and 
sequence similarities to ER(Giguere et al., 1988; Heard et al., 2000). As a 
consequence of the high conservation observed among their DNA binding domains, 
ERRs bind to a common TCAAGGTCA consensus motifs and share a consistent 
number of target genes in identical cell types (Chen et al., 2008; Dufour et al., 2007; 
Vanacker et al., 1999b). In addition, different ERRs can form heterodimers (Dufour 
et al., 2007) and interact with ER(Johnston et al., 1997).  
 
In mouse ES cells, Esrrg is absent but Esrra and ER are expressed, although at 
reduced levels compared to Esrrb ((Xie et al., 2009) and Table 3.1). Mass 
spectrometry studies have also shown that Esrra is indeed interacting with Esrrb (van 
den Berg et al., 2010). It is thus possible that Esrra, and less likely ER, can at least 
partially compensate for the absence of Esrrb in knockout cells, as already observed 
for Klf factors (Jiang et al., 2008). Relevant to this point, diethylstilbestrol has been 
shown to bind to estrogen related receptors (Greschik et al., 2004; Tremblay et al., 
2001b) and, similarly to Esrrb knockdown, induce differentiation of ES cells 




the concomitant inhibition of both Esrrb and Esrra activity in the cells. It would be 
thus interesting to determine whether further deletion in Esrra in Esrrb null ES cells 
is compatible with the maintenance of a pluripotent state. Conversely, it should also 
be assessed whether overexpression of Esrra, Esrrg or ER is able to rescue the self-
renewal defects observed in Esrrb null ES cells. Such experiments would directly test 
whether ERRs play redundant or unique roles in pluripotent cells. In a broader 
perspective, results generated in ES cells could help understanding whether the 
overlapping pattern of ERRs expression observed in different tissues (Bookout et al., 
2005; Bookout et al., 2006) is functional to ensuring robustness of the transcriptional 
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